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ABSTRACT 
Studies of the primary structure of protein inhibitors of 
proteolytic enzymes arid oc;-amylase were undertaken. The complete amino 
acid sequence of an ~-amylase inhibitor and a bifunctional trypsin/« -
amylase inhibitor from seeds of ragi (Eleusine coracana Gaertn.) and of 
the proteinase inhibitor PI-I from the Tracy cultivar of soybean 
(Glycine ~ L. Merr) were determined. 
The bifunctional trypsin/ 01.-amylase inhibitor from ragi seeds was 
shown to be a single polypeptide of 122 amino acids with a molecular 
weight of 13400. The two reactive (trypsin inhibitory) sites were also 
determined. Sequence comparisons revealed that this inhibitor seems to 
be divergently related to other trypsin and ((-amylase inhibitors and also 
to the reserve protein from castor bean. In addition it is proposed that 
a new inhibitor family should be added to the existing ones (Laskowski 
and Kato, 1980) to accomodate this bifunctional inhibitor and its related 
proteins. The secondary structure of this inhibitor was also predicted. 
The ot -amylase inhibitor from ragi seeds was shown to be a single 
polypeptide of 95 amino acids with a molecular weight of 9300. The 
existence of two homologous regions in the amino acid sequence of this 
inhibitor seemed. to indicate that the inhibitor molecule has arisen by 
a process of gene duplication. Sequence comparisons revealed that this 
inhibitor has no homology to any other «-amylase inhibitors, proteolytic 
enzyme inhibitors or any other plant.protein of known primary structure. 
In addition the secondary structure of the «-amylase inhibitor from 
rag1 seeds was also predicted. 
The amino acid sequenc~ of the proteinase inhibitor PI-I from the 
Tracy cultivar of soybean (Glycine max L. Merr) was shown to be identical 
to another proteinase inhibitor PI-II) from the same cultivar, which have 
been previously sequenced by Kashlan (1980). 
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1. INTRODUCTION 
The central role played by enzymes in almost every biological 
phenomenon has led to studies on the ways in which their biological 
activities are conJtrolled. One of the ultimate goals of these studies 1s 
the hope that a clear understanding of enzymatic control may eventually 
lead to the manipulation of many biological processes as a means of 
controlling disease, enhancing agricultural productivity and to the 
controlled production for industrial or pharmaceutical purposes of 
biological substances. 
In the last two decades much evidence has been accumulated 
indicating that protein inhibitors of enzymes are widely utilised in 
nature as a means of controlling unwanted enzymatic activity. A list 
of plant protein inhibitors of enzymes 1s presented in Table I. While 
information on the occurrence, distribution and biological function of 
protein inhibitors of enzymes others than proteinases and li -amylases 
is scanty, the amount of information on protein inhibitors of proteinases 
and ~-amylases is considerable, although the level of understanding of 
the chemistry of these inhibitors far exceeds the level of understanding 
of their biological role. This introduction will be limited to a 
discussion of the protein inhibitors of proteinases and ~-amylases, with 
particular emphasis on those of plant origin. 
1.1. Protein Inhibitors of Proteinases 
The protein inhibitors of proteinases can be grouped into 
two completely dissimilar classes: the macroglobulins and the inhibitors 
with class-spec:ific reactive sites. 
TABLE I - Range of enzymes known to be inhibited by proteins from plants and microorganisms 
Enzyme Class 1 Enzyme Source 
Oxidoreductases I Alcohol dehydrogenase 
(E .• C. 1.1.1.2) 
NADH-Nitrate reductase 
(E.C. 1.6.6.3) 
Catalase 
Maize root 
Soybean 
Maize 
Transferase a 
Hydroxylase a 
Lyaaea 
(E.C. 1.11.1.6) 
Peroxidase 
(E.C. 1.11.17) 
Cinnamic-4-hydroxylase 
(1.14.13.11) 
Ornithine aminotransferase 
(E.C. 2.6.1.13) 
Phospho-inositol kinaae 
(E,C. 2. 7.1.67) 
Lipase 
(E.C. 3.1.1.3) 
Avocado 
Cherkina 
Legumes 
Mungbean 
Green pepper 
Nuclease Yeast 
(E.C. 3.1.4.9) 
DNase Tobacco 
(E.c>. 3.1.4.5) 
~-Amylase Various aourcee 
(E.C. 3.2.1.1) 
Ce 11 ulasc sli ... mould 
(E.G. 3.2.1.4) 
Acid invertase Potato 
(E.C. 3.2.1.26 
Endopolygalacturonase Red kidney bean 
(E.C. 3.2.1.39) 
Proteolytic enzymes (e.a. trypsin, Various eources 
chymotrypsin, elastase) 
Una~ ~loo 
(E.c. 3.5.1.5) 
ATPase Yeast 
(E.C. 3.6.1.3) 
Isocitrate lyase 
(E,C. 4.1.3.1) 
Pectin lyase 
(E.G. 4.2.2.2) 
Endopectin lyase 
(E.C. 4.2.2.10) 
L-Phenylalanine ammonia lyase 
(E.C. 4.3.1.5) . 
Guanylate cyclase 
(E,C. 4.6.1.1) 
Banana 
Cucumber 
Cucumber 
Barley 
Bitter melon 
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The macroglobulins are high molecular weight proteins, apparently 
present in the plasma of all mammals and in some invertebrates 
3 
(Travis and Salvesen, 1983) but at this time have not been reported in 
any plants. These proteins ~eem to have an important role in the 
processing of plasma proteinases in the blood. They can form complexes 
with almost any proteinase, but in the complex the proteinase remains 
catalytically active against small synthetic substrates and this 
activity can be inhibited by small protein inhibitors of proteinases such 
as the pancreatic trypsin inhibitor (Kunitz) but not by larger ones 
such as the soybean trypsin inhibitor (Kunitz) (Laskowski and Kato, 
1980; Travis and Salvesen, 1983). A "trap" mechanism was proposed for 
these inhibitors by Barrett and Starkey (1973). According to this 
mechanism, the proteinase hydrolyzes one or more particular susceptible 
peptide bonds in the inhibitor and triggers a conformational change 
in the inhibitor which traps the enzyme molecule. According to this 
mechanism the critical segment in the inhibitor must be rather long 
since it must contain peptide bonds matching the specificity requirements 
of the various proteinases. In this chemical sense the macroglobulins 
are so markedly different from all other known inhibitors that some 
scientists question whether they should be put in this class at all 
(Lask~wski and Kato, 1980; Travis and Salvesen, 1983). 
On the other hand, the inhibitors with class-specific reactive 
sites comprise a very broad class of proteins, which are of widespread 
occurrence in plants, animals and microorganisms (Pusztai, 1967; Liener 
-and Kakade,.l969, 1980; Laskowski and Sealock, 1971; Ryan, 1973, 1979, 
1981; Royer, 1975; Richardson, 1977, 1980, 1981; Laskowski and Kato, 
1980; Whitaker; 1981). As in the case of the macroglobulins, these 
inhibitors form complexes with proteinases, but the enzymatic activity 
of the proteinase in the complex is completely abolished and, at least 
1n the well characterized systems, a particular inhibitory reactive site 
can inhibit only proteinases belon~ing to a single one of the six 
mechanistic classes proposed.by Ryan and Walker-Simmons (1981). 
1.1.1. inhibitors with Class-Specific Reactive Sites 
Substances inhibiting proteolytic enzymes have long been 
known. A first indication of the occurrence of such inhibitors is found 
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in the literature as early as 1878 (Fredericq, 1878). The first indication 
of a proteinase inhibitor in plants was given by Read and Haas (1938). 
This was soon followed by the demonstration of the inhibition of trypsin 
by extracts of Glycine ~ by Ham and Sandstedt (1944) and the first 
isolation of a plant prote.ase inhibitor from Glycine max by Kunitz·: (194.5, 
1946). A year later the first systematic study of plant protease inhibitors 
was made· by Borchers and Ackerson (1947). These early studies were mainly 
r~stricted to the inhibition of trypsin and, to a lesser degree of 
chymotrypsin, at the time the most studied proteolytic enzymes. This fact, 
incidentally, has led to difficulties in interpreting the studies on the 
physiological rble of these proteins in plants, as only a few serine 
endoproteinases have been found in plants (Ryan, 1981; Ryan and Walker-
Simmons, 1981). 
Inhibitors with class-specific reactive sites are often found 
as components of the cytoplasm, secretions and intercellular fluids of 
many organs and tissues in animals (Laskowski and Kato, 1980) and in 
plants are usually found in seeds, tubers, leaves and roots (Table II). 
The inhibitors of plant origin will be the only ones to be considered here. 
Table 11- Plant protein inhibitors of proteolytic enzymes 
Mechanistic Set 
Serine endopeptidase& 
Sulfhydryl endopeptidase 
Acid prote inaae 
Ketalo exopeptidase 
·Enz~ 
Trypsin 
Chymotrypsin 
Trypsin/chymotrypsin 
Subtilisin 
Ente ropcpti do eo 
Papain 
Bromelain 
Cathepsin D 
Carboxypeptidase A 
Carboxypeptidase A 
Inhibitor Source 
~ vulgare (barley) 
~ vulgnre 
~ melongena (eggplant) 
~ sativum (garlic) 
AmL phophallus companulatus 
Anacardium occidentale (cashew nut) 
Bambusaria arundinaria (bamboo) 
Lycopersicum escuientum (tomato) 
Eleusine ~ (ragi) 
Scopolia japonica 
Vigna unsuiculata (cowpea) 
~ vulgare (Barley) 
Ipomoea~ 
Phaseolus vulgaris (kidney bean) 
Glycine ~ (soybean) 
F.lcuaine ~ (rogi) 
~ vulgare (barley) 
Vigno unguiculato (cowpea) 
~brasiliensis 
Phoscolus vulcario (red kidney bean) 
Visna unguiculata (cowpea) 
~ ~ (pineapple) 
~ !.~ (potato) 
~ tuberosum (potato) 
Lycopcrsicum esculcntum (tomato) 
Part of Plant 
Embryo 
Endosperm 
Exocarp 
Bulb 
Tuber 
Nut 
Sprouts 
Leave a 
Seeds 
Callus 
Pods 
Shoot a 
Tuber 
Seeds 
Seeds 
Seed a 
Seeds 
Seeds 
Latex 
Seeds 
Seeds 
Stem 
Tuber a 
Leaves 
Fruit 
References 
Mikola and Kirai, 1972 
Mikola and Kirsi, 1972 
Kanamori !!_ .!.!·, 1975 
Sumathi and Pattabiraman, 1975 
Sumathi and Pattabiraman, 1975 
Xavier-Filho and Ainouc, 1977 
Suguira, 1975 
Nelson !!_ .!.!·, 1981 
Shivaraj and Pattabiraman, 1981 
Sakato !!_ !!·, 1975 
Carasco and Xavier-Filho, 1981 
Kirsi and Hikola, 1977 
Balla and Ryan, 1963 
Puzatai, 1968 
Odani and Ikenaka, 1972 
Shivaraj and Pottobiraman, 1982 
Yoshikawa!!_ .!.!·• 1976 
Vortak !!_ !!·, 1980 
Archer, 1983 
Jacob !!_ .!.!·, 1983 
Vartak !! .!.!·, 1980 
Reddy !!. .!.!·, 1975 
Keilova and Tomaeak, 1976 
Graham and Ryan, 1981 
llaaa and Ryan, 19808 
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Based on mechanistic considerations, s1x sets of proteolytic 
enzymes can be identified. Hartley (1960) originally defined four such 
sets: the serine, thiol, metal and acid proteinases. This classification 
was modified by Walsh (1975) who subdivided the metaloenzymes into an 
endopeptidase and an exopep~idase set, and later Ryan and Walker-Simmons 
(1981) proposed the subdivision of serine proteinases into two sets: 
the serine endopeptidases and the serine exopeptidases, giving a total 
of six mechanistic sets. Apart from inhibitors of metaloendoproteinases · 
and serine exopeptidases, inhibitors of all of the remaining mechanistic 
sets have been found in plants (Table II). A detailed knowledge of the 
mechanism of inhibition is available only for the serine endoproteinase 
and metaloexopeptidase inhibitors (Laskowski and Kato, 1980; Rees and 
Lipscomb, 1982). For the remaining inhibitors there is no definitive 
model for their mechanism of action. 
The overall mechanism of the serine endoproteinase/inhibitor 
interaction, including only those intermediates whose existence has 
been definitely shown, can be written (Laskowski and Kato, 1980) as: 
E + I ~ L --.. C - X - L* -.. E + I* (Eq. 1), 
where E is the enzyme, I and I*, virgin and modified inhibitors, 
respectively, L and L*, noncovalently (rapidly dissociable) complexes 
of E with I and I* respectively, X is the relatively long-lived 
intermediate in the E + I* reaction and C is the stable enzyme-
inhibitor complex. Detailed discussion on this mechanism may be found 
in a recent review by Laskowski and Kato (1980). 
The only metaloexopeptidase inhibitor whose mechanism of 
action is known is the carboxypeptidase A inhibitor from potatoes 
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(PCI), isolated by Ryan~ !l (1974) and sequenced by Hass ~ al (1975). 
The refined crystal structure of the carboxypeptidase A/carboxypeptidase 
0 
A inhibitor (CPA/PCI) complex at 2.SA resolution was determined by Rees 
and Lipscomb (1980, 1982), who proposed the following mechanism of 
inhibit ion: 
CPA + PCI (CPA/PCI) ~ (CPA/PCI + Gly) :=:::; CPA + PCI* + Gly 
(Eq. 2a) 
CPA + PC I* -=;; (CPA/PC I) (Eq. 2b) 
Mechanism 2a refers to the inhibition of carboxypeptidase A by the 
virgin and mechanism 2b refers of the inhibition of carboxypeptidase A 
by the modified inhibitor. 
Like the serine endoproteinase inhibitors, the reactive site 
of the carboxypeptidase inhibitor is also hydrolyzed (Hass and Ryan, 
1980b; Rees and Lipscomb, 1982). Unlike the carboxypeptidase A inhibitor, 
however, where the cleavage of Gly 39 (the C-terminal amino acid) goes 
essentially to completion, the equilibrium constant between the modified 
and virgin serine endoproteinase inhibitor species is near unity 
(Laskowski a~d Kato, 1980). For the cleaved species to retain inhibitory 
activity, the two fragments must be held together by disulphide bridges 
or non-covalent interactions. This behaviour contrasts with the 
carboxypeptidase A case: both PCI and. PCI* are equally effective 
inhibitors, even though Gly39 has been removed from the latter species. 
The differences in these two classes of proteinase inhibitors may 
reflect the fact that the loss of the peptides from a cleaved ser1ne 
endoproteinase inhibitor prevents a significant portion of the binding 
interactions with the correspondhtg protease (Rees and Lipscomb, 1982). 
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The protein inhibitors of proteinases others than serine 
endoproteinases still remain an understudied group, although their 
occurrence in plants is well documented. Inhibitors of sulfyhydryl 
proteinases have been isolated from pineapple stems (Reddy et al., 1975), 
potato tubers (Hoff et al. ,. 1972), corn (Abe~ al., 1980), Bauhinia 
seeds (Goldstein ~ al., 1973) ,and mung beans (Baumgartner and Chrispeels, 
1976). Inhibitors of acid proteinases were isolated from potatoes 
(Keilova and Tomasek, 1976) and Bauhinia seeds (Goldstein et al., 
1973). Metalocarboxypeptidase inhibitors were isolated from potato 
tubers (Ryan et al., 1974) and tomato fruits (Hass and Ryan, 1980).At 
--
the present there is no recorded example of a metaloendoproteinase 
inhibitor in plants. 
The inhibitors of serine endoproteinases are the best known 
group of class-specific reactive site inhibitors. Their mechanism of 
action is fairly well understood and the primary structures of many of 
them have been determined (Richardson, 1977, 1980, 1981; Croft, 1980; 
Ramshaw, 1982). Despite being a class of proteins whose primary 
structures vary from one another, they all appear to obey the same 
mechanism of interaction/inhibition of their relevant proteases (Eq. 1). 
The elucidation of this mechanism of action was achieved by chemical 
modification studies (Sealock and Laskowski, 1969; Leary and Laskowski, 
1973; Kowalski et al., 1974; Jering and Tschesche, 1976; Odani and 
Ikenaka, 1978), which helped to elucidate the role of the amino acids 
at the reactive site and their surroundings on 'the inhibition and also 
by both 'kinetic and X-ray. c~ystalographic analysis (Ruhlman et al., 
1973; Janin et al., 1974; Bolognasi et al., 1981; Ako ~ al., 1974; 
Gaier ~ al., 1981; Read et al., 1983). 
An-identification system for the am1no acids at the reactive 
site of .the serine endoproteinase inhibitors (Scherchter and Berger, 
1967) ~s given below: 
reactive site 
-P ~p -P 3 2 1 
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In the reaction of the inhibitor with the protease, the inhibitor behaves 
as a good substrate. A peptide bond on the surface of the inhibitor 
(the reactive site) where the P1 residue matches the specificity 
requirement of the protease, specifically interacts with the active 
site of the protease. Howeve~, due to the fact that the values of Kcat 
amd ~are much lower than the values for normal substrates, at low 
concentration of inhibitor and neutral pH the hydrolysis of the peptide 
bond is extremely slow and the system behaves as if it were a simple 
equilibrium between the enzyme on one hand and the complex on the 
other (Laskowski and Sealock, 1971; Laskowski and Kato, 1980; Read et 
al., 1983). It should be noted that the hydrolysis of the reactive 
site peptide bond does not go to completion. At neutral pH the 
equilibrium constant between virgin and modified inhibitor is near 
unity (Laskowski and Kato, 1980). The cleavage of the reactive site 
peptide bond creates a problem for the purification of inhibitors by 
affinity chromatography, as it may alter their electrophoretic mobilities, 
isoelectric points and, most importantly, creates difficulties during 
any subsequent sequencing of the inhibitor. However, this difficulty 
can be overcome by·using anhydrotrypsin or anhydrochymotrypsin as the 
column ligand. In these derivatives of trypsin and chymotrypsin the 
serine at the reactive site is converted to dehydroalanine by 
reactions which selectively remove water from the ser~ne R group . 
(Ako ~ al., 1974). Despite being catalytically inactive, 
anhydrotrypsin and anhydrochymotrypsin can still form stable complexes 
with their inhibitors (Ako et al., 1974; Yung and Trowbridge, 1980). 
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It was initially thought that the only reason why the modified 
inhibitor (with its reactive site peptide bond hydrolyzed) did not 
dissociate to give two peptide chains·was due to the fact that the 
reactive site was localised in a disulphide loop. However, it seems that 
the positioning of the reactive site in a peptide loop is not an 
essentiai requirement for the non-dissociation of the inhibitors, as 
inhibitors such as the yeast proteinase B inhibitor 2 (Maier et al., 
1979), the leech· (Hirudo medicinalis) trypsin inhibitor (Seemuller 
et al., 1980) and a lysine-rich protease inhibitor from barley 
(Svendsen and Jonassen, 1980) are devoid of intramolecular disulphide 
bridges and apparently obey the standard mechanism of inhibition, which 
suggests that strong non-covalent bonding can substitute for a disulphide 
bridge. Furthermore, it has been recently demonstrated that 
carboxymethylation of the two cysteines forming the only disulphide 
bridge in the potato inhibitor I had no effect on the inhibitory 
activity of this inhibitor (Plunkett and Ryan, 1980). Incidentally, the 
existence of these cysteine-free protease inhibitors, which also have 
an unusual the.rmal stability, also ind< cates that the resistance of 
most proteinase inhibitors to heat denaturation (Richardson, 1977; 
Laskowski and Kato, 1980; Ryan, 1981) is not dependent only on the tight 
packing of the molecules due to disulphide bonding. 
The number of proteinase inhibitors which have been isolated 
and partially characterized is enormous. This creates difficulties in 
making comparisons of the specificities, thermodynarm<c and kinetic 
parameters of the enzyme-inhibitor interactions. In order to facilitate 
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these comparisons, Laskowski and Kato (1980) proposed to assign each 
inhibitor to a family. The assignment of an inhibitor to a family was 
based primarily on amino acid sequence homology. As the proposed 
classification was concentrated on the serine endoproteinase inhibitors, 
a knowledge of the reactive ·site, details of the topological 
relationships between their disulphide bridges and evidence that the 
standard mechanism was obeyed, would be necessary before definitely 
assigning an inhibitor to a certain family. The inhibitor families, as 
proposed by Laskowski and Kato (1980) are presented in Table III. 
The assignment of an inhibitor fO a family (or otherwise 
to assign an inhibitor to a new family) is not always a straightforward 
task. Difficulties ar1se when a particular inhibitor has weak homology 
with inhibitors belonging to different families. The decision whether 
the homology is due to divergent or convergent evolution is a 
difficult one. It is thought that the inhibitors within a family are 
divergently related, while the families are apparently convergently 
related, but highly distant divergent relationshiPs cannot be discarded 
and this 1s 1n fact suspected for the Streptomyces subtilisin inhibitor 
family and the pancreatic secretory trypsin inhibitor (Kazal) family 
(Laskowski and Kato, 1980). Thus, the placement of an inhibitor within 
a family, or in other words, to decide to which others inhibitors a 
particular inhibitor related in terms of evolution, may depend not only 
on a knowledge of its primary structure. It is now suspected that 
three-dimensional structures of proteins change more slowly than amino ·· 
acid sequences during· evolution (Phillips~ al., 1983). In th~s 
context it 1s interesting to note that detailed crys.talographic studies 
of members of three inhibitor families revealed that their 
three-dimensional structures are strikingly different (Laskowski and 
TABLE III - Families of protein inhibitors that inhibit ser1ne 
endoproteinases and obey the standard mechanism, as 
proposed by Laskowski and Kato (1980). 
I. Bovine pancreatic trypsin inhibitor (Kunitz) family 
II. Pancreatic secretory trypsin inhibitor (Kazal) family 
III. Soybean trypsin inhibitor (Kunitz) family 
IV. Streptomyces sub.tilisin inhibitor family 
V. Soybean proteinase inhibitor (Bowman-Birk) family 
VI. Potato inhibitor I family 
VII. Potato inhibitor II f~mily 
VIII. Ascaris trypsin inhibitor fmaily 
IX. Other families 
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Kato, 1980; McPhallen et ~·, 1983). 
The number of inhibitor families originally proposed by 
Laskowski and Kato (1980) was recently added to by the creation of a 
new family to accomodate two small trypsin inhibitors from squash seeds 
(Wilusz et al., 1983). These are the smallest proteinase inhibitors 
so far known, being composed of 29 amino acids (molecular weight 3300) 
and seem to obey the standard mechanism. One may conclude that further 
families will have to be added as more sequence information becomes 
available (see Resuits and Discussion section). 
Just as the number of inhibitor. families is likely to 
increase 1n the future, so will the menbers of each of the existing 
families; the number of members of the potato inhibitor I family 
(Richardson, 1974; Richardson and Cossins, 1974) was recently expanded 
by the inclusion of two cysteine-free protease inhibitors from barley 
(Svendsen et al. ,1982) and a cysteine-free inhibitor from leech 
(Hirudo medicinalis) (Seemuller et al., 1980). The inclusion of the 
leech inhibitor in this family is particularly interesting as, besides 
being a cysteine-free inhibitor, it is also the first inhibitor of 
animal origin to be shown to have homology with a plant protease 
inhibitor (Figure 1). The inhibitors of the potato inhibitor I family 
also show a small degree of similarity with a cysteine-free protease 
A inhibitor 2 from yeast (Maier et al., 1979). This similarity ,howeyer, 
is not strong enough to suggest divergent evolution. 
Similarly, until recently the soybean trypsin inhibitor 
(Kunitz) family was composed of a single member. As sequence data 
became available for the inhibitors from seeds of Peltophorum 
africanum (Joubert, 1981), silktree (Albizzia julibrissin) (Odani 
1. 
2. 
1. 
2. 
1. 
2. 
ThriGlu Phe(Gly Ser Glu 
Lys!Glu PheiGlu Cys Lys 
LeuR* 
Gly~Leu 
PheiPro GluiVal Val\Gly\Lys 
Ile Gly Val TrpiPro GluiLeu Pro Thr Lys Ile Glu Lys 
Thr Val Asp 
Gln\Ala\Arg\Gltyr 
Leu Ala Lys Glu Ile 
Phe Thr * 
',Leu His Tyr Pro Gln Tyr IAsn Vall Tyr Phe \Leur ro Gl u Gly Se r Pro Val Th r Leu Asp Leu\ Arg\ Tyr IAsn ;\:rg Val Argl Val 
Gln Lys Leu Phe Gln Asn·Ser Leu Ile SeriAsn ValiH. Ile Leu L Asn Gly Ser Pro Val Thr M t Asp T Arg Cys IAsn Arg Val ArgiLeu 1s eu e yr 
Phe Tyr 
Phe Asp 
Pro Gly Thr Asn Val Val Asn His 
A!:tn ASP 
Ile Leu Gly Ser Val Val Glu * 
val\Prori· Val Gly 
Leu p Arg Val Gly 
Ile ro Val Leu Ala 
FIGURE 1 Comparison of the amino acid sequences of eglin (an elastase-cathepsin G inhibitor) from leech (Hirudo 
medicinalis) (1) (Seemuller et al., 1980) and· the polymorphous chymotrypsin inhibitor I from potatoes 
--
(2) (Richardson and Cossins, 1974). Identical residues are enclosed in boxes; (*) indicates gap. 
..... 
~ 
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et al., 1980), acacia (Acacia elata) (Kortt and Jernyn, 1981), Erythrina 
humana (Joubert, 1982), Acacia siberana (Joubert, 1983) and winged 
bean (Psophocarpus tetragonolobus) (Kortt ~ ~·· 1983), all of these 
inhibitors were seen to belong to this family. Apart from the winged 
bean inhibitor all of the others inhibit trypsin and chymotrypsin, while 
the soybean inhibitor inhibits only trypsin. The inhibitors from the 
silktree and acacia are both composed of subunits linked by disulphide 
bridges (Odani et al., 1980). 
Biological Role of Proteinase Inhibitors 
Despite the advances in the knowledge of the chemistry of the 
class-specific reactive site inhibitors, their possible biological role 
is still largely unknown, and at best, presumptive. Although their gross 
physiological function may be the prevention of unwanted proteolysis, a 
detailed physiological function is still not known. Possibly the problem 
lies in the fact that for most inhibitors so far studied, the true 
target enzyme or the enzyme that is most strongly inhibited is not 
known. As Il.askowski and Kato (1980) put it 11 they become proteins in 
search of a fun·ction, rather than proteins isolated to account for a 
previously discovered biological function. 11 
The possible role of proteinase inhibitors in heightening 
the fitness of plants against the attack of phytofagous animals is 
illustrated by the work of Professor Ryan1 s group (Green and Ryan, 1972; 
McFarland and Ryan, 1974; Walker-Simmons and Ryan, 1977; Graham and 
Ryan, 1981; Cleveland and Black, 1982; Plunkett et al., 1982) who 
--
showed that the wounding of tomato leaves or potato leaves leads to a 
great increase i~ the levels of a polysacharide hormone, proteinase 
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inhibitor inducing factor (PIIF), which in turn leads to a huge increase 
in the levels of serine and metalocarboxypeptidase inhibitors. It was 
also established that PIIF activity is generally distributed throughout 
the ~lant kingdom (McFarland and Ryan, 1974). Another piece of evidence 
for the role of proteinase inhibitors as protective agents, comes from 
the work of Gatehouse ~ ~.(1979,1980) and Gatehouse and Boulter (1983) 
who showed that the increased resistance of the seeds of the cultivar 
TVU 2027 of ViS?a unguiculata is due, at least in part, to elevated 
levels of trypsin inhibitors. This is the clearest example to date that 
the increased resistance of one seed variety over another toward insect 
attack may be due to elevated trypsin inhibitor content. Similar 
observations have been made before by Weiel and.Hapner (1976) who also 
suggested that varietal differences in the levels of proteinase 
inhibitors in barley plants, may possibly be related to their differential 
susceptibility to grasshopper (Camula pelucida) damage. Peng and Black 
(1976) also showed that the proteinase inhibitor activity of blight 
resistant varieties of tomato plants increased following infection by 
Phytophthora infestans 
The release into the external medium of proteinase inhibitors 
during the germination of seeds seems to be a general phenomenon, at 
least among legume seeds (Wilson, 1980). David et a1.(1977) and Wilson 
et al. (1982) hypothesized that the release of proteinase inhibitors 
--
during germination may play an important role in the establishment of 
a "normal" microbial complement in the rhizosphere of legumes and probably 
other plant families. Such an effect may. be both. due to the inhibition 
of pathogenic organisms and to the stimulation of beneficial symbionts. 
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The indications that protein inhibitors of proteinases 
together with lectins, tannins, lignin, cellulose and unassimilable 
starch, may play a role ~n plant defence are strong (Janzen, 1980, 
198la, 198lb). However, it seems that the relevance of each one of 
these compounds for a given plant is not absolute, but instead may vary 
according to the ability of a particular predator to bring about 
chemical or physical detoxification and there are many indications that 
protein inhibitors of proteinases are toxic for some organisms, but 
completely harmless for others. The rodent Liemys salvini can live 
with a sole diet of seeds of Enterolobium cyclocarpum, a mimosaceous 
legume that contains substantial amounts of proteinase.:inhibitors, but 
no lectins. This rodent is also able to live with a diet containing 
25% of soybean trypsin inhibitor, but will die if its diet contains 
only black bean (Phaseolus vulgaris) seeds which have proteinase 
inhibitors and a high content of lectins, but are without alkaloids 
or uncommon amino acids (Janzeri, 1981). Janzen et al (1977) also found 
that the southern cowpea weavils (Calosobruchus spp) could ingest 
trypsin inhibitors in concentrations of up to 5% of the diet without 
adverse effect. However, proteinase inhibitors from potatoes are 
lethal at this same concentration in the diet. Similarly, purified 
maize inhibitors at 2-5% in the diet have no effect on young com borer 
larvae (Steffens et al., 1978), but larval growth is impaired by 
soybean trypsin inhibitor. 
The inhibitory activities of most known proteinase inhibitors 
·-are primarily directed against the digestive proteinases found in 
animals and microorganisms and only a few are known that inhibit plant 
proteinases (Rich'ardson, 1977; Ryan, 1981). The proteinase inhibitors 
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that inhibit endogenous proteinases may have a regulatory 
or protective role(s) in controlling these proteinases before or during 
germination. Such inhibitors have been isolated from wheat (Preston and 
Kruger, 1976); barley (Mikola and Enari, 1970; Kirsi and Mikola, 1971); 
mung bean (Baumgartner and C~rispeels, 1976); corn (Reed and Penner, 
1978); scots pine (Pinus sylvestris) (Salmia and Mikola, 1980; Salmia, 
1981); buckwheat (Fagopyrum esculentum) (Belozerskii, 1982) and cashew 
nuts (Annacardium occidentalis) (Xavier-Filho and Ainouz, 1977). 
The inhibitors of endogenous proteinases which were more 
thoroughly studied, are those from barley (Kirsi and Mikola, 1971), mung 
bean (Baumgartner and Chrispeels, 1976; Chrispeels and Baumgartner, 
1978) and scots pine (Salmia and Mikola, 1980; Salmia, 1981). Precise 
knowledge of the subcellular compartmemtation of inhibitors and proteases 
1.s available only in the mung:. bean case, where the inhibitor is known 
to be localized in the cytosol, whereas the major mung bean protease 
is localized in the protein bodies. The function of the inhibitor seems 
to be to protect the cytoplasm from the very high and unspecific 
proteinase activity present in protein bodies. Although data on the 
intracellular localization of the proteases and inhibitors from scots 
pine and barley is not available, indirect evidence suggest a similar 
compartmentation and function as in mung bean (Mikola, 1983). On the other 
hand, the inhibitors from cowpea (Royer et al., 1974), rice (Horigushi 
and Kitagashi, 1971) and lettuce (Shain and Maier, 1968) are thought 
to regulate endogenous proteinases before germination. 
The large ·quantities of inhibitors present in seeds and in 
some cases their transitory presence in different organs in some plants 
may suggest a possible role as storage proteins (Ryan, 1973; Richardson, 
1977, 1980, 1981~. Carasco and Xavier-Filho (1981) found evidence for 
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a paralelism between the synthesis of reserve proteins and the synthesis 
of proteinase inhibitors in cowpea. The high cystine content of many 
inhibitors, makes them attractive as sulphur reserves for the developing 
seedling (Pui$tai, 1972). In some storage tissues inhibitors of serine 
endoproteinases decrease d~ring germinatron, being apparently utilized 
by the seed for growth (Xavier-Filho, 1973, 1974; Xavier-Filho and 
Negreiros, 1979; Baumgartner and Chrispeels, 1976; Freed and Ryan,l978). 
However- as yet it has not _been shown that this decrease corresponds to 
any specific biochemical or.physiological event. 
The findings discussed above, apparently indicate that, as 
a class of proteins, inhibitors of proteinases do not have a sole 
biological role and that, probably due to their peculiar properties 
they may, for example, double as a sulphur source for the germinating 
seed and as a protective agent against the attack of predators. In 
this connection, Adams and Rinne (1981) put forward the idea that the 
protein inhibitors of proteinases, together with lectins, (3 -amylases, 
urease and some proteinases, could be classified as "dispensable 
proteins" as opposed to the "undispensable proteins" such as glycolytic 
enzymes, ribosomal proteins and cytochromes. As some plants survive 
quite well without obvious examples of these "dispensable proteins" 
and also as their physiological function sometimes does not appear to 
be related to their intrinsic biochemical properties, these proteins 
may fulfill a non-specific role as part of the cellular protein 
complement and therefore could presumably be replaced by other proteins 
in other species. 
1.2. Protein Inhibitors of ~-Amylase 
Protein inhibitors of ~-amylase have been known ~o.occur 
in plants since Chrzasczs and Janick (1933,1934) described their 
presence in wheat seeds. Since then many more have been isolated from 
various plants sources (Table IV). As with the protein inhibitors of 
proteinases, they seem to be widespread throughout the plant kingdom. 
However, in contrast to more than thirty years of extensive researcn 
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on protein inhibitors of proteinases, ·until recently protein inhibitors 
of ~-amylase have received little attention. As with proteinase 
inhibitors, the main motivation for the study of ~-amylase inhibitors 
is their possibly deleterious effect on human and animal nutrition, as 
well as their potential use in clinical disorders such as obesity and 
diabetes mellitus. 
Plant protein inhibitors of c(-amylase have been reviewed 
Marshall (1975), Buonocore et al. (1977), Kassel (1978), Richardson 
(1980, 1981) and Whitaker (1981). A recent review by Warchalewski (1983) 
deals specifically with ~-amylase inhibitors from cereals. 
1.2.1. Occurrence and Distribution 
The protein inhibitors of <(-amylase appear to have been 
most extensively studied in the Leguminosae, Gramineae and Solanaceae, 
probably because of the large number of species in these families which 
form important food sources. The detection of oC.-amylase inhibitory 
activity is sometimes difficult because of the long time required for 
the formation of the enzyme-inhibitor complex (Marshall, 1975 ;Buonocore 
et al., 1977; Warchalewski, 1983) and also due to the high' endogenous 
Table IV - Prote,in inhibitors of. ((-amylase in plants· 
Inhibitor Source 
Avena ~ (oats) 
Cajanus cajan 
Canavalia ensiformis (jack bean) 
Cicer aretinium (chick pea) 
Colocasia antiquorum 
Colocasia esculenta (taro) 
Dioscorea alata (yam) 
Dolichos biflorus (horse gram) 
Dolichos lablab (field bean) 
Eleusine coracana (ragi) 
Hordeum vulgare (barley) 
Mangifera indica (mango) 
Penisetum typhoideum (pearl millet) 
Pisum ~ (garden pea) 
Phaseolus vulgaris (red kidney bean) 
!· vulgaris (white kidney bean) 
!· ~ (lima bean) 
!· coccineus (french bean) 
!· aborigenes (wild bean) 
Lens culinaris (lentils) 
~ cereale (rye) 
Setaria italica (setaria) 
Sorghum bicolor (Sorghu~) 
Triticum aestivum (wheat) 
Zea maiz· (maize) 
Part of Plant 
Seeds 
Seeds 
Seeds 
Seeds 
Tubers 
Tubers 
Tubers 
Seeds 
Seeds 
Seeds 
Seeds 
Fruit 
Seeds 
Seeds 
Seeds 
Seeds 
Seeds 
Seeds 
Seeds 
Seeds 
Seeds 
Seeds 
Seeds 
Seeds 
Seeds 
References 
Elliot and Leopold, 1953 
Shivaraj and Pattabiraman, 1976 
Jaffe ~ al., 1973 
Jaffe ~ .!!_., 1973 
Sharma·· and Pattabi'rama·n; i 98()' 
Rao ~ .!!·, 1967 
Sharma and Pattabiraman, 1982 
Jaffe ~ !!_., 1973 
Jaffe~ !'.!·, 1973 
Shivaraj and Pattabiraman, 1980 
Mundy et .!!_., 1983 
Mattoo and Modi, 1970 
Chandrasekher ~ !!.·, 1981 
Jaffe~ al., 1973 
Powers and Whitaker, 1977 
Marshall and Lauda, 1975 
Jaffe ~ al., 1973 
Jaffe ~ !!_., 1973 
Jaffe ~ .!!_., 1973 
Jaffe ~ al., 1973 
Granum, 1978 
Chandrasekher ~ !_!., 1981 
Chandrasekher ~ .!!_., 1981 
Buonocore ll··al., 1977 
Blanco-Labra and Iturbe-Chinas, 1980 
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amylase activity in some plants (Warchalewski, ·1983). These facts seems 
to be at least in part responsible for the initial failure to detect 
~ ~-amylase inhibitors in some p~lnts, such as soybean (Jaffe ~tal., 
1973), maize, barley and oats (Kneen and Sandstedt, 1946), horsegram 
and mothbean (Subbulakshmi et ~.,1976), and blackgram (Reddi and 
Salunkhe, 19SO). 
All of the protein inhibitors of ~-amylase so far studied 
were isolated from seeds, fruit and tubers (Marshall, 1975;Buonocore 
et al., 1977; Kassel, 1978; Warchalewski, 1983) but information on the 
distribution within these tissues is scanty, although at least in 
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cereals they are thought to be concentrated in the endosperm, associated 
with starch granules (Buonocore!!~·, 1977; Blanco-Labra and Iturbe-
Chinas, 1980; Mundy et ~·, 1983). As for their subcellular localization 
no information is available. 
1.2.2. Specificity and Mechanism of.Action 
The in vitro specificity of most protein inhibitors of 
~-amylase seems to be directed against ~-amylases other· than the 
endogenous ones present in the plants from which the inhibitors were 
extracted. A uniform specificity pattern among inhibitors from legumes 
and cereals does not exist, although inhibition of human pancreatic 
and salivary ~-amylase and ~-amylases from insects is commonly found 
(Table V). However it is not always clear whether this is due to the 
absolute specificity of the inhibitor or to analytical shortcomings, 
such as the non-fulfilment of optimal conditions of pH, ionic strength 
and temperature required by each ~-amylase in order for inhibition to 
be detected. Also the very slow rate of complex formation between the 
TABU! V • SpecUicltiea of ot-amylue inhibitora fr0111 phnta 
Inhibitor Source 
Phasoolus vulgado 
(red kidney bean) 
!!!!~ 
(maize) 
Phaseolua vulgaria 
(red kidney bean) 
Phaseolus vulgaris 
(white kidney bean) 
~vulgare 
(barley) 
Hordeum jlgare 
'""TbBrTey_ . 
Triticum aestivum 
(wheat·O :zB"'iniiib it or) 
Tricitum aestivum 
(wheat·0:5fiiihibitor) 
Sorghum~ 
(sorghWII) 
Dioscorea alata 
Colocasia antiguorum 
EleUsine coracana 
--rragn- ----
.-.-Amylue Teated 
Porcine Dancreaa (+),.human pancreu (+),human aaliva (+), 
Ten•brin molitor.(+), Bacilua subtili• (·), A•pergillus 
oryue (:5. barley(·), red kidney bean(·) 
Haiae (+), Bacilus subtilis (+), Tribolium castaneum (+), 
Sitophilus ·zeamaia ~zpertha dominica (+), rye(·) 
wheat(·), triticale(·), sorghum(·), human saliva(·), 
hoi pancreu (-), Aspergillus oryzae (·l.!!.ti!!!!, !.!!!!!i.!i!. (•) 
Tenebrio molitor (+), Tribolium castaneum (+), Tribolium 
~ (+), Anagasta khuniela (+). Sitophilus granarius 
(larvae) (+), Sitophilus granarius (adult) (·) . 
Hog pancreas (+), human saliva (+), human pancreas (+), 
Bacilus amyloliquifaciena (·), Bacilus subtilis (·),rye 
(-), Bacilus licheniformis.(-), Aspergillus oryzae (·) 
barley malt ( ·) 
Barley ( +) 
Halted barley '-amylase li ( +), germinated wheat ce -amylase 
II(+), malted barley ~-amylase 1 (·),germinated wheat 
oc. -amylaae I (-) 
Human saliva (+), Tenebrio molitor (+), rice weavel'.(+), 
yeallow meal worm ( +), confu~ur beetle (+), american 
coakroach (+), german coakroach (+), sawtoothed grain 
beetle (+),wheat(·), Asper!jllus o{!zae (·), Bacilua 
aubtilia (·)guinea pig(·), turkey -) 
Rice weavil (+),yellow mealworm (+), confused flor beetle 
(+), german coakroach (+), american coakroach (+), 
ecwtoothed grain beetle (+),human aaliva (-), guinea pig 
(-), chicken paacreaa (·) 
Humaa uliva (+),hog pancreas(-), Bacilus !.!!!!!i!i!. (-), 
Aspergl"llus oryzae (-) 
Human saliva (+), human pancreas (·), bovine pancreas (-) 
Humaa saliva(+), human pancreas (+), porc~ne pancreas (•), 
bovine pancreas (·) 
Human saliva (+),human pancreas (+),porcine pancreas (+), 
~~(·),Aspergillus oryzae (·) 
Human aaliva (+), human pancreas (+), hog pancreas (+), 
~~(-),Aspergillus oryzae (-) 
Human ji.ancreas -(+f; ·human saliva C•i, hog pancreae (+), 
~ aubtilis (-) 
(+)- indicate• positive inhibition 
(·)· 1Ddicate1 negative inhibition 
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cl.-amylase inhibitor and the a:..-,amylase (from 5 minutes to 2 hours) is 
a factor which, if overlooked, may produce misleading results (Marshall, 
1975; Buonocore et al., 1977). Thus it may not be accidental that 
reports of the inhibition of plant ~-amylases by endogenous inhibitors 
have only recently started to appear (Warchalewski, 1977; MacGregor_et 
al., 1983; Mundy et al., 1983; Blanco-Labra and Iturbe-Chinas, 1981). 
The reaction between the different ~-amylases and their 
inhibitors involves the formation of an enzyme-inhibitor complex, where 
the catalytic activity of the enzyme towards substrates such as starch 
and amylose, is completely abolished. The formation of a stable 
enzyme-inhibitor complex has been demonstrated in several cases (Shivaraj 
and Pattabiraman, 1981; Powers and Whitaker, 1977; Marshall and Lauda, 
1975; Sharma and Pattabiraman, 1982). However, detailed information 
about the mechanism of complex formation is scarce. The possibility 
exists that the formation of the complex may be triggered by the 
recognition by the ~-amylase of a carbohydrate moiety in the inhibitor 
(Buonocore et al., 1981), but strong evidence for this has not yet 
been presented.·· 
Unfortunately considerable uncertainty exists in the 
literature concerning the kinetics of inhibition and also over the 
assay conditions used to measure it. Furthermore, the determination of 
the value of kinetic parameters such as the inhibition constant (K.), 
l. 
have been based on models constructed for the analysis of interactions 
between proteinases and their inhibitors (Green and Work, 1953; Bieth, 
1974, 1980), which in all cases are of a ·'Competitive mture (Laskowski md 
Kato, 1980), while competitive inhibition as yet has not been 
demonstrated for any inhibitor/ <>e -amylase system. On the contrar.y, ,most 
inhibitors of ~-amylase seem to inhibit ~-amylase in a non-competitive 
way, although uncompetitive inhibition has been claimed for some 
inhibitors (Buonocore~ al., 1977). However the fact that inhibitors 
from cereals (Mundy et al., 1983), tubers (Chandra~ekher ~ al., 
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1981) and legumes (Marshall, 1975) do bind to amylase in the absence 
of substrate and furthermore the demonstration of an enzyme-inhibitor-
substrate ternary complex in cereals (Mundy~ al., 1983), and legumes 
(Whitaker, 1981), indicates that a non-competitive mode of inhibition 
may be prevalent among protein inhibitors of ~-amylase. Also adding 
to this the fact that the rate of complex formation is very slow 
(Marshall, 1975; Buonocore~~·, 1977; Warchalewski, 1983) one may 
speculate that the active site of the ~-amylase is not affected by the 
inhibitor, but the binding of the inhibitor to the ~-amylase triggers 
a slow conformational change in the ~-amylase active site so that it 
does not form the enzyme-substrate complex at its normal rate and, 
once formed, the enzyme-substrate complex does not decompose at normal 
rates to yield products. 
As some ~-amylase inhibitors have different specificities 
towards human salivary and pancreatic ~-amylase (Table V), they are 
being used for differential isoenzyme assays 1n human serum and ur1ne 
(O'Donnel et al., 1977). 
1.2.2. Structure 
The well characterized ~-amylase inhibitors from plants 
are proteins commonly found to contain carbohydrate moieties (Marshall, 
1975; Buonocore et_al., 1977; Richardson, 1980, 1981). Their molecular 
weights range from 12000 to 60000. The inhibitors with molecular 
weight above 12000 generally give rise to subunits of 12000 molecular 
weight under dissociating conditions. (Powers and. Whitaker, 1977; 
Marshall, 1975; Buonocore et al., 1977; Granum, 1978; Granum and 
Whitaker , 19 77) . 
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The carbohydrate content of protein inhibitors of ~-amylase 
varies from 0.9% in the wheat inhibitors (Silano ~ al., 1975; Buoncore 
et al., 1981) to 64% in the yam ~-amylase inhibitor (Sharma and 
Pattabiraman, 1982). The high carbohydrate content of some inhibitors 
is ·thought to be responsible for the difficulties in ascertaining the 
molecular weight by molecular exclusion chromatography as their elution 
from the column tends to be delayed by interactions between their 
carbohydrate moiety and·the column gel (Shivaraj and Pattabiraman, 
1981). 
The endosperm ?f wheat seeds is known to contain- a number 
of closely related protein inhibitors of ~-amylase. Three of these 
inhibitors are well characterized: the 0.53, 0.28 and 0.19 inhibitors, 
named after their electrophorectic mobilities in polyacrylamide gels. 
The 0.53 and 0.19 inhibitors have molecular weights around 24000, but 
under dissociating conditions are separated into two subunits of 
aproximately 12000 molecular weight. The two subunits which form the 
0.53 inhibitor are identical (Maeda et al., 1983) and the two subunits 
which form the 0.19 inhibitor also seem to be identical (Petrucci et 
al., 1978). The 0. 28 inhibitor has a molecular weight of 13400. The 
sequences of the 24 N-terminal residues in the 0.19 (Redman, 1976) 
and 0.28 (Petrucci~ al., 1978) inhibitors show that nine out of the 
24 N-terminal residues. occupy identical.positions. Further evidence 
for the structural homology between the wheat~-amylase inhibitors was 
provided by the complete.amino acid sequencesof the 0.28 inhibitor 
(Richardson and Kashlan, 1981; Kashlan and Richardson, 1981) and the 
0.53 inhibitor (Maeda et al., 1983) which showed that these two 
inhibitors are highly homologous (Figure 2). The sequence of the 0.53 
inhibitor is notable in having an odd number (9) of cysteine residues 
and in having phenylalanine and histidine, residues which were thought 
to be absent in the wheat inhibitors (Richardson and Kashlan, 1981; 
Kashlan and Richardson, 1981; Buonocore et al., 1977). Recently 
-- --
Richardson (personnal communication), has shown that the homology of 
the 0.19 inhibitor and the 0.53 and 0.28 inhibitors is not restricted 
to theN-terminal residues, but extends throughout the whole sequence. 
Also recently, Aschauer ~ ~- (1981) have reported the sequence of an 
~-amylase inhibitor from Streptomyces tendae (strain 4158). This 
inhibitor of molecular weight 7900 has no structural homology with the 
wheat 0.28 and 0.53 inhibitors. 
The amino acid composition of the red kidney bean~-amylase 
inhibitor (Powers and Whitaker, 1977) 1s quite different from that of 
the ~-amylase inhibitors from cereals, especially with respect to 
aspartic acid, threonine, serine, proline, methionine, isoleucine, 
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tryptophan and arginine. Also notable is the very low content d cysteine 
residues and the absence of proline. 
1.2.4. Biological Role 
It was believed for some time that the~-amylase enzymes 
from higher plants were not inhibited by. the ~-amylase inhibitors found 
in the same tissues and therefore the inhibitors would not be involved 
in the control of starch metabolism in plants. However reports on the ( 
isolation of~-amylase inhibitors from wheat (Warchalewski; 1977), 
maize (Blanco-Labra and Iturbe-Chinas, 1981) and barley (Mundy et al., 
sniProlAla-Thr-Gly-Tyr-Ly:tVallSertAla~eu-Thr Gly-Cys-Arg\Ala-Met-Val~Lys~ 
Tyr Pro Gly-Gln-Ala-Phe-Gl Val Pro Ala Leu-Pro Gly-Cys-Arg Pro-Leu-Leu Lys 
0.28.1 Ser-Gly-Pro-Trp1Ser-TrprCys 
0.53.1 Ser-Gly-Pro-Trp1 * -MetrCys 
0.28.1 Leu-Gln-CysjVal 
0.53.1 Leu~Gln-Cys~sn 
Gly-Ser-Gln-Val-Pro-Glu-Ala-Val-Leu-Arg-Asp-Cys-Cys-Gln-Gln-Leu-Ala-Asp-IlerAsn-AsntGlul 
Gly-Ser-Gln-Val-Pro-Glu-Ala-Val-Leu-Arg-Asp-Cys-Cys-Gln-Gln-Leu-Ala-Asp-Ile * -Ser Glu 
0.28-r Trp1Cys Arg-Cys•Gly As:tLeulSer Ser·Met-Leu Arg-Ala-Val-Ala-GlnfGlui:eu 
0.53. Trp Pro Arg-Cys-Gly Al -Leu-Tyr Ser-Met-Leu Asp~Ser~Met-Tyr-Lys Glu-His 
Gly,..Val 
Gly-Val 
~----~ 
§ § Arg * - * - * Giy Ser Gly-Gln-Ala Gly 
Cys-Arg7LystGlu-ValtMet1Lys-Leu-Thr-Ala-Ala-SerrVal-Pro-GlutVal-Cys 
..__ _ __, 
0.28. Lys-Glu-Val-LeutPro!Gly 
0. 53. Thr~Gly~Ala .. Phe .-Pro Serrys .. ArgtArgfGluc-Val tV~liLys:Leu~ThnAla,:Ala,Serple:Thr~AlatVal ':'Cys 
0.28.111•·~* -Pro-Asn~Pro Ser-Gly-Asp Arg~AlatGly Val•Cys Tyr-Gly!Asp~T+pHAla-Tyr,Pro•Asp•Val · 
0!53. Ile- alooVal .. Asp~Ala Ser .. Gly~Asp Gly Ala Tyr Val-Cys * -Lys-Asp Val~Tyr-Pro-Asp~Ala .. Ala 
Lys-Vatro-1 
Arg-Leu Pro-
Figure 2 - Comparison of the amino acid sequences of 0.28 (Kashlan and Richardson, 1981) and 0.53 (Maeda et al 
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1983) ~-amylase inhibitors from wheat. Homologous positions are enclosed in brackets. (*) indicates 
gap. 
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1983; Weselake ~ al., 1983) which inhibit ~-amylases from these 
plants, show that an active in vivo role for these substances cannot 
be ruled out. The maize inhibitor is especially interesting as it seems 
to behighly specific for an ~-amylase produced during germination and is 
also active against ~-amylases from insects which are known to attack 
stor~d maize grain. The maize inhibitor is inactive towards ~-amylases 
from wheat, barley, rye, Triticale, sorghum and also those from 
Bacillus subtilis and Aspergillus oryzae (Blanco-Labra and Iturbe-Chinas, 
1981). These authors speculate that the inhibitor may help to prevent 
the biochemical events of starch breakdown which have been associated 
with the pre-harvest sprouting in cereals. The inhibitor isolated from 
barley (Mundy et al., 1983) apparently has a passive function during 
--
germination, but these authors speculate that this inhibitor plays 
a regulatory role during devel~?pment of the seed by inhibiting 
endogenous ~-amylase activity during starch granule synthesis and also 
may help to delay degradation caused by premature sprouting. Although 
the ~-amylase inhibitor isolated from barley by Weselake et al. (1983) 
has not yet been characterized sufficiently to allow a comparison with 
the ~-amylase/subtilisin inhibitor isolated from barley by Mundy~t~l. 
(1983) and other ()(-amylase inhibitors, it seems to inhibit specifically 
mal ted barley at -amylase II, and germinated wheat o:~amylase II, having 
no in-~ibitory activity towards mal ted barley ~-amylase I and germinated 
wheat ~-amylase I .. The effect of this inhibitor on animal oc-amylase iS 
not known. As the barley (Mundy et al., 1983) and maize (Balnco-Labra 
and Iturbe-Chinas',· 1981) c(-amylase inhibitors are also active against 
insect d: -amylases, they may double as regulatory proteins and 
protective agents against see~. predation. Although interesting, these 
results have to-be viewed with caution as the possibility exists that 
there are factors in plants which prevent the in v1vo inhibitor/~­
amylase association. 
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While in general inhibitors of c( -amylase constitute a 
significant portion of the protein content of many cereals, legumes and 
tubers (Marshall, 1975; Buonocore~ al., 1977; Whitaker, 1981), their 
mobilisation during plant growth has not been the subject of much 
study. Preliminary studies on the inhibitors from Colocasia antiquorum 
tubers by Sharma and Pattabiraman (1980) have shown that the total~­
amylase inhibitor activity decreases during plant growth. In wheat the 
inhibitor content also decreases after germination begins (Sandstedt 
and Beckford, 1946; Pace et al., 1978). 
With few exceptions the protein inhibitors of cx:-amylase are 
active against ~-amylases from insects and microorganisms (Table V),and 
thus to assign to them a role of protecting seeds and tubers against 
the attack of insects and microorganisms 1s tempting. If they can be 
proved to be effective in this way, they would constitute an excellent 
index for the selection of varieties of plants resistant to pests. 
Unfortunately most of the studies on the inhibition of insect and 
microorganisms ex: -amylases by protein inhibitors of c.{-amylase from 
plants are restricted to the in vitro action of these inhibitors 
(Buonocore ~ al., 1980; Powers and Culberston, 1982; Orland et al., 
1983) so that accurate assessement of the in vivo effects of the 
inhibitors cannot be made. However, Applebaum (1964) has shown that if 
wheat «-amylase inhibitors are incorporated· into the semi-synthetic 
diet of Tenebrio molitor larvae, the larval growth is impaired. These 
results are supported by Yetter et al. (1979) who showed a correlation 
between the in vivo res is"tance of the "seeds to the insect and the 
extent of in. vitro inhibition of the insect larval a-amylase by the 
:.! 
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inhibitor extracted from the same seeds. 
The uncertainty in relation to the in ~ effect of ~­
amylase inhibitors on insects and microorganisms, is paralleled by the 
uncertainty concerning their role in human and animal nutrition. As 
many inhibitors are inactivated in vitro by pepsin (Saunders and Lang, 
1973; Petrucci et ~·, 1978; Chandrasekher et ~·, 1981), it is thought 
that they would affect salivary ~-amylase in vivo but not pancreatic 
~-amylase. However, the intake of purified ~-amylase inhibitors from 
wheat by rats, humans, dogs and cats, results in a reduction of the 
rate of appearence of glucose in the blood (Marshall, 1975). Also, 
Marshall (1975) reported that rats which were fed with a diet containing 
wheat inhibitors which had been inactivated by autoclaving grew at a 
rate 15-20% faster than did rats fed on an untreated diet. ·Lang ~ ~· 
(1974) showed that when rats were fed on a casein/starch diet in the 
presence and absence of purified ~-amylase ·inhibitor reduction of 
growth rate and increased faecal starch levels were caused by the 
presence of inhibitors, and the magnitude of these changes was 
dependent on the inhibitor dosage. On the other hand, Shainkin and Birk 
(1970) and Savaiano et al. (1977) showed that rats have. a normal growth 
after consuming massive quantities of red kidney bean ~-amylase inhibitor 
which is without any detectable trypsin inhibitor or hemaglutinin 
activity. 
The pharmacological and clinical significance of the cC -amylase 
inhibitors have been under s.tudy for some time (Puls et al., 1980; 
Berchtold and Kieselbach, 1980; Frerichs~ al., 1973; Silane, 1978; 
Puls and Keup, 1973). However the effectiveness of ~-amylase inhibitors 
in the control of clinical disorders associated with carbohydrate 
metabolism is still controversial. This controversy is highlighted by 
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a recent report by Carlson et al. (1983) who claim that an ~-amylase 
inhibitor preparation from kidney bean with potent inhibitory activity 
~vitro, which was being sold in the United States as an aid 1n 
controlling obesity, has no effect on starch degradation in humans. 
The main purpose of the present study was to determine the 
complete primary structures of the bifunctional trypsin/ ~-amylase 
and the ~-amylase inhibitors present in the seeds of ragi (Indian finger 
millet, Eleusine coracana Gaertn.) (Shivaraj and Pattabiraman, 1980, 1981). 
The trypsin/~-amylase inhibitor, at the time, was the first protein to 
be shown to have inhibitory activity against two completely unrelated 
classes of hydrolytic enzymes. It was thought that the determination 
of its primary structure would give important clues to unravelling the 
possible evolutionary relationship between inhibitors of~-amylase and 
inhibitors of proteolytic enzymes. Furthermore it was hoped that a 
comparison of the primary structure of the trypsin/ ~-amylase inhibitor 
with the primary structure of the ~-amylase inhibitor would g1ve some 
indications of the structural features of the ~-amylase inhibitor which 
are responsible for the interaction with the ~-amylases. Finally, a 
minor part of this work is dedicated to the sequencing of the protease 
inhibitor P-I from the Tracy cultivar of soybean (Glycine~). 
2. MATERIALS AND METHODS 
2 .1. Materials 
2.1.1. Biological Materials 
Seeds of ragi (Indian finger millet, Eleusine coracana, 
Gaertn.) were obtained as a generous gift from the Tropical Products 
Institute, Culham, Oxford. 
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Ragi is a cereal crop of substantial economical importance 
(Hill, 1937; Johnston, 1958). Both upland and irrigated forms are grown 
mainly in Asia and Africa, where they sometimes constitute the staple 
diet of many people. In India it ~s one of the major crops, particularly 
during the rainy season. Ragi flour is used for soup, bread ,puddings 
and cakes, and also a fermented beverage is made from the grain (Hill, 
1937; Johnston, 1958; Shivaraj and Pattabiraman, 1976). 
2. 1. 2. Chemicals and Reagents 
The following products were obtained from Sigma Chemical 
Company Ltd., Poole, Dorset: Trypsin (E.C. 3.4.21.4) Type XI, from 
porcine pancreas; at-amylase (E. C. 3.2.1.1.) Type I-A from hog pancreas; 
Cytochrome C, Type III, from horse heart; 3,5,-dinitrosalieylic acid; 
p-nitrophenol-p'-guanidino-benzoate; soluble starch; ~-N-benzoyl~DL­
arginine-p-nitroanilide-HCl (BAPNA). 
The following products were obtained from British Drug House 
(BDH) Ltd., Pool~, Dorset: Acrylamide; NN' -methyle.nebisacrylamide; · 
coomassie brilliant blue and iodoacetic acid. 
The following products were obtained from Worthington 
Biochemical Corporation, New Jersey, U.S.A.: Trypsin-TPCK treated 
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(E.C. 3.4.21.4); ~-chymotrypsin (E.C. 3.4.21.1) and Staphylococcus aureus 
(Strain V-8) protease.(E.C. 3.4.21.19). 
Thermolysin (E.C. ·3.4.24.4) was obtained from Daiwa Kasei 
K.K., Osaka, Japan. 
Proline-Specific endoproteinase (E.C. 3.4.21.26) was obtained 
from Seikagaku Kogyo Company Ltd., Tokyo, Japan. 
Pyridine (Sequanal grade) and trifluoracetic acid (Sequanal 
grade) were obtained from Rathburn Chemicals Ltd~, Walkerburn, 
Peebleshire. 
Guanidine hydrochloride (Sequanal grade) was obtained from 
Pierce, Rockford, Illinois, U.S.A. 
Ninhydrin (indantrione hydrate) and cyanogen bromide (CNBr) 
were obtained from Koch-Light Laboratories Ltd., Colnbrook, Bucks. 
Arginyl-arginine was obtained from Cyclochemical Corporation, 
Los Angeles, U.S.A. 
Phenylisothiocyanate (PITC) was obtained from Rathburn 
Chemicals Ltd., Walkerburn, Peebleshire. 
4-NN-Dimethylaminobenzene-4-isothiocyanate (DABITC) was 
kindly supplied by Mr. John Gilroy and prepared as described by Chang 
~ al. (1976) and Chang (1977), and also obtained from Fluka AG Chemische 
Fabrik, Buchs, Switzerland. 
Ampholine carrier ampholytes (pH 2-11) were obtained from 
Serva, Heidelberg, West Germany. 
Polyamide sheets were obtained from Cheng Chin Company Ltd., 
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Taipei, Taiwan. 
Sephadex. G-10 and Sephadex G-50 were obtained from Pharmacia 
Fine Chemicals AB, Upsala, Sweden. 
Biogel P-2, Biogel P-4 and Biogel P-6 were obtained from Bio-
Rad Laboratories Ltd., London. 
CM-52 cellulose was obtained from Whatman Biochemicals Ltd., 
Maidstone, Kent. 
Buffer components and reagents, except as noted, were 
obtained from British Drug Houses Ltd. and were of analytical grade when 
necessary. Tris "Trizma'·base" was obtained from Sigma Chemical Company 
Ltd., Poole, Dorset. 
2.2. Methods 
2.2.1. Purification of the Trypsin/ ~-Amylase and ~-Amylase Inhibitors 
from Ragi (Indian Finger Millet, Eleusine coracana Gartn .. ) 
The purification of both inhibitors was carried out 
essentially as described by Shivaraj and Pattabiraman (1980, 1981). One 
Kg of ragi seeds were _ground in a mill using a O.lmm sieve. The flour 
was homogeneized with 2 L of 0.15M NaCl and after stirring for 30 
minutes, the slurry was centrifuged at .2000 x g for 30 min in a MSE 4L 
centrifuge. The residue was reextracted with 1 L of 0.15M NaCl, stirred 
·for 30 minutes and the slurry centrifuged. _Solid ammonium sulphate was 
slowly added with stirring to the combined supernatants to bring the 
saturation to 55% (w/v). After standing overnight at 4° C, the solution 
was centrifuged at 5000g.for 30 minutes. The precipitate obtained was 
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dissolved in 250 ml of 2mM acetate buffer pH 5.0 containing 75mM Nael 
and the solution dialysed against 20 volumes of the same buffer. The 
dialysed solution was centrifuged at 5000g for 30 minutes. The clear 
supernatant was designated as the ammonium sulphate fraction (ASF). 
The ASF was subjected to chromatography on a column (1.4 
x 20 em) of eM-cellulose equilibrated with 2mM acetate buffer pH 5.0 
containing 75mM Nael. The column was eluted successsively with the 
equilibrating buffer, 20 mM acetate buffer 0.15M Nael, and 20mM 
acetate buffer, 0.30M Nael pH 5.0. Fractions of 10 ml were collected 
at a flow rate of 30 ml/h. The elution profiles were followed by 
measurement of the absorbance at 280nm and by !assaying for the trypsin 
and ~-amylase inhibitory activity of each fraction. The fractions eluted 
with the second elution buffer (20mM acetate buffer, 0.15M Nael, pH 
5.0) contained- the trypsin/ c( -amylase inhibitory activity (Fraction 
1) and the fractions eluted with the third buffer (20mM acetate buffer, 
0.30M Nael, pH 5.0) contained the ~-amylase inhibitory activity 
(Fraction 2). 
After dialysis overnight against fifty volumes ·of 2mM acetate 
buffer, 75mM Nael, pH 5.0, Fraction 1 was concentrated by chromatography 
on a column of eM-cellulose (1.0 x 8.0 ·em) equilibrated with the dialysis 
buffer. The initial column effluent was discarded and then the column 
was washed witn 150 ml of the equilibrating buffer. The column bound 
proteins were eluted with O.lM phosphate buffer, 0.15M.Nael, pH 6.9 
and 5 ml fractions were collected at a flow rate of 30 ml/hour. The 
concentrated inhibitor solution obtained was subjected to chromatography 
on a column (2.6 x 90cm) of Sephadex G-50. Elution was performed using 
the same buffer at a flow. rate of 20 ml/h and 5 ml fractions were 
collected. The fractions with trypsin/ c:( -amylase inhibitory activity 
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were pooled and designated as Sephadex G-50 Fraction 1. 
Similarly after dialysis against fifty volumes of O.lM 
phosphate buffer, 0.15M NaCl, pH 6.9, Fraction 2 was subjected to 
chromatography on a Sephadex G-50 column,(2.6 x 90cm), using the dialysis 
buffer as eluent. The fractions with «-amylase inhibitory activity were 
pooled and designated as Sephadex G-50 Fraction 2. 
Both fractions were recromatographed on a column ( 1.0 x 
6.0 em) of eM-cellulose. The fractions were dialysed against 2mM 
acetate buffer, 75mM NaCl, pH 5.0 and applied to the column previously 
equilibrated with the dialysis buffer. The effluents were discarded and 
the columns eluted with the dialysis buffer. The effluents were 
discarded and the columns eluted with a linear gradient system formed 
between 100 ml of the equilibrium buffer and 100 ml of 2mM acetate 
buffer, 0.3M NaCl, pH 5.0. Fractions of 4 ml were collected at a flow 
rate of 20ml/h. When the Sephadex G-50 Fraction 1 was subjected to 
this process the fractions shown to contain trypsin and 4-amylase 
inhibitory activity were pooled and designated as the trypsin/« -amylase 
inhibitor. Similarly the fractions with ~-amylase inhibitory activity 
obtained from processing the Sephadex G-50 Fraction 2 were pooled and 
designated as the ~-amylase inhibitor. 
The homogeneity of both inhibitors was checked by subjecting 
them to SDS-polyacrylamide gel electrophoresis, isoelectric focusing 
and N-Terminal analysis by the dansyl-chloride method and by the DABITC/ 
PITC double coupling method. 
2.2.2. Purification of the Protease Inhibitor PI-I hom the Tracy 
Cultivar of Soybean (Glycine max L. Merr) 
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The protease inhibitor PI-I from the Tracy cultivar of 
soybean, purified as described by David et l!!_. (1977) was obtained as a 
gift from Dr .. D. Foard (Department of Botany and Plant Pathology, Purdue 
University, West Lafayette, Indiana 47907,. U.S.A.) 
2.2.3; Enzyme and Inhibitor Assays 
2.2.3.1. ~-Amylase Inhibitor Assay 
~-Amylase inhibitor activity was determined by the method 
of Bernfeld (1955). 
·assay mixture - 0.5 ml oe-amylase (1.25 pg/ml 1.n O.OSM acetate buffer 
pH 7.0) 
0.5 ml starch s0lution (1% w/v 1.n ~20) 
·1.0 ml inhibitor solution ( in O.OSM acetate buffer, 
pH 7.0) 
2.0 ml 
·After incubation of the enzyme and inhibitor at 30°C for 25 minutes, the 
assay was started by the addition of the substrate. After 10 minutes the 
assay was terminated by the addition of 2.0 ml of dinitrosalicylate 
solution (prepared by dissolving lg of dinitrosalicylic acid in 20 ml 
NaOH and 50 ml H20; 30 g of potassium tartrate (Rochelle Salt) was added 
and the solution volume made up to lOO.ml). The mixture was then heated 
for 10 minutes in a boiling water bath and 10 ml of water was added to 
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the solution and after cooling, the absorption at 530 n.m \vas measured . 
. In every assay controls were established in order to determine the maximun 
and minimum digestion of starch under the experimental conditions, by 
incubating the enzyme solution only with starch and by incubating the 
inhibitor solution.with the starch solution. 
2.2.3.2. Trypsin Inhibitor Assay 
Trypsin inhibitory activity was determined by measuring. the 
inhibition of the hy<i:"olysis of BAPNA by trypsin as proposed by Erlanger 
et al.. (1961). 
assay mixture - 0.5 ml trypsin (0.3 mg/ml in 2.5 x 10- 3M HCl) 
0.5 ml inhibitor solution (in 0.05M Tris-HCl pH 8.~) 
2.0 ml BAPNA (1.25 x 10-3M in 0.05M Tris -HCl pH 8.2) 
3:0 ml 
After incubating the enzyme and inhibitor for 5 minutes at 37° Ct the 
substrate was added. After 10 minutes the reaction was stopped by the 
addition of 0.5ml 30% acetic acid. The absorption of the solution was 
measured at 410nm. 
2.2.3o3. Trypsin Active_Site Titration 
The concentration of active trypsin in the different solutions' 
used for assay of trypsin activity was determined by active site titration 
of trypsin by p-nitrophenol-p 1 -guanidii1D-henzoate (NPGB), by the method. 
of Chase arid Shaw (1970). In these experiment·s a double beam recording 
spectrophotometer \-las used in order to <illm-1 the. nonenzymatic 
breakdown of NPGB to be automatically subtracted by adding an equal 
amount of the compound· to the reference cuvette .. 
Titration procedure - Sodium veronal buffer O.lM, pH 8. 3 was 
pipetted into the reference cuvette and the enzyme sample and buffer 
were pipetted into the sample cuvette to a volume of l.Oml. The 
cuvettes were placed in the spectrophotometer and the instrument· (set 
at 410nm) zeroed. The cuvettes were then removed from the instrument 
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and 5 pl of ·NPGB solution was quickly added to the. sample cuvette, the. 
solutions mixed and the cuvette replaced, and the instrument turned on. 
The concentration of active enzyme was then calculated from the ·increase 
in optical density thus determined and the molar coefficient of 
p-nitrophenol at this pH and wavelength. 
2.2.4. Isoelectric Focusing 
Isoelectric focusing experiments· were carried out as described. 
by Wrigley (1976). Samples for isoelectric focusing were prepared by 
dissolving the lyophylized material in distilled \-later at a concentration 
of 2mg/ml. Cytochrome C (pi 10.65) was used as a marker. Prior to loading, 
the gels were pre-run.at aproximately 260V for 10 minutes to stabilise 
the pH gradient. The inhibitor samples were loaded centrally and the 
cytochrome C marker was loaded at both poles. The gel was run at 
aproximately 15\.J until the two marker samples had merged. together. and 
become focused; this took approximately 2 hours. Phosphoric acid O.lM 
pH 1.5 formed the anode~ whilst ethylenediamine formed the cathode. 
All attempts to stain the inhibitors after isoelectric focusing by 
using coomassie brilliant blue failed. Nevertheless prolonged immersion 
of the gels in 17.5% trichloroaceti'c acid, made the .precipitation 
bands in the gels visible. 
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2.2.5. SDS-Polyacrylamide Gel Electrophoresis 
The SDS-polyacrylamide gel electrophoresis experiments 
were carried out as described by Laemli 0970), and were used to assess 
the homogeneity of inhibitor preparations and also to determine the 
apparent molecular weight of proteins. 17% acrylamide gels were used. 
-Separating~ formulation: 
22.5 ml Tris-HCl pH 8.8 
34.5 ml acrylamide stock (30% acrylamide - o.~35% bis-acrylamide 
p.l\ 
1. 5 ml ammoniumAsulphate (15mg/ml) 
20 J.ll TEMED. 
Stacking ~ formulation: 
2.5 ml Tris-HCl pH 6.8 
2.0 ml acrylamide stock (30% acrylamide - 0.344% bis-acrylamide) 
14.8 ml distiled w~ter 
r,.~~. . 
0.5 ml ammonium~ulphate (15 mg/ml) 
20 ).ll TEMED 
Lyophylized samples for electrophoresis were dissolved ~n 0.2M Tris-HCl 
containing 2% SDS and 10 % sucrose. Prior to electrophoresis bromophenol 
blue was added as a ma~ker. Electrophoresis was initially carried out· 
.at 15 rnA/gel and subsequently as 25mA/gel for 6-7 hours. After 
electrbphoresi~ the total length of the gel and the distance of migration 
of the bromophenol blue marker were measured. The gel was then stained 
overnight with 0. 25% coomassie brilliant blue in methanol/ acetic acid 
and destained using a 5% methanol, 7% acetic acid mixture ~n water. 
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2;2.6. ~rotein Sequenc~ Determination 
2. 2. 6.1. Reduction and.S-'Carb9~methylation 
The reduction ano S-carboxymethylation of the inhibitors was 
. . 
carried out using a modification of the method proposed by Crestfield 
et al. (1963). The protein (10-30mg) was dissolved in 2 ml of 6M 
guanidine hydrochloride, 1M Tris-HCl, pH 8.5. 10-30 pl of 2-mercaptoethanol 
was added and the mixture left standing, under a constant stream of 
nitrogen for 3 hours at room temperature (18-20° C). Then 100-300 ul of 
iodoacetic acid (0.268g/ml in 1M NaOH) was added and the solution kept 
in the dark for 15 minutes under a nitrogen stream. The reduced and 
S-carboxymethylated protein was recovered by gel filtration (in the dark) 
of the solution on a column (30 x 1.5cm) of Sephadex G-10, equilibrated 
·in· 50nM pyridine acetate buffer, pH 5. 4. The eluted protein was 
subsequently freeze-dried. 
2.2.6.2. Chemical Cleavage with Cyanogen Bromide (CNBr) 
CNBr cleavage of the inhibitors was carried out by the 
method of Steers et al. (1965). The reduced and carboxymethylated protein 
was dissolved in 1.0 ml of 70% (v/v) formic acid and a;.l 20 fold molar 
excess of CNBr was added and the solution kept in the dark for 24 hours 
at room temperature and under a nitrogen_ stream. After this period the 
solution \vas diluted 10_-fold with distilled \~Tater and the reaction 
terminated by lyophilisation. 
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2.2.6.3. Enzymatic Hydrolysis 
2.2.6o3.1. Trypsin (E.C. 3o4.21.4) 
The protein or peptide was dissolved in a minimal volume of 
0 .2M N-ethylmorpholine buffer, pH 8. 5 and trypsin (TPCK- treated) was 
added to give a 2% (w/\-1) enzyme/substrate rat:io. After incubation for 
2 hours at 37° C, the reaction was stopped by lyophilisation. 
Specificity-- Trypsin catalyses the hydrolysis of peptide bonds 
involving the carboxyl group of lysine and arginine, 
except where the following residue is proline. Trypsin has lm-1 exopeptidase 
activity, especially aminopeptidase, and adjacent lysine or arginine 
residues usually provide alternative points of cleavage, with low 
yields of free lysine or arginine (Allen, 1981). Even when pure trypsin 
is used some chymotryptic activity can usually be detected (Inagami 
apd Sturtvant, 1960). 
2.2.6.3.2. Chymotrypsin (E.C. 3.4o21.1) 
The conditions of digestion were the same as those used 
with trypsin. 
Specificity - Chymotrypsin cleaves peptides and proteins at the carboxyl 
side of tryptophan, phenylalanine·, tyrosine, leucine and 
methionine, with occasional cleavage at other sites (e.g. histidine, 
asparagine). If the following residue is proline cleavage does not 
occui (Allen, 1981). 
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2.2.6.3~3. Thermolysin (~ 3.4.24.4) 
The conditions of digestion were the same as those used with 
trypsin ,except that the buffer contained 5mM CaC1 2 . 
S12_ecificity - Thermolysin catalyses the hydrolysis of peptide bonds 
involving the amino group of the hydrophobic amino acids 
leucine, isoleucine, methionine, phenylalanine, tryptophan, and valine. 
Other sites, at the amino side of alanine, tyrosine and threonine 
may also be cleaved (Matsubara, 1965). 
2.2.6.3.4. Staphylococcus aureus (Strain V-8) Protease 
The protein or peptide was dissolved 1n a minimal volume 
of O. 1M Na-phosphate buffer pH 7. 8 and incubated for 16 hours at 37° C. 
The reaction was stopped by lyophilisation. (Drapeau, 1977). 
Specificity - If the digestion is performed in 50-lOOmM Na-Phosphate 
buffer pH 7. 8 the V-8 protease specifically cleaves on 
the carboxyl side of glutamyl and aspartyl peptide bonds. The. rate of 
digestion is low if glutamic acid or aspartic acid are within three 
residues from either the N- or C-terminus of a peptide containing lysine 
or arginine and Glu-Pro and Asp-Pro peptide bonds are not cleaved 
(Austen and Smith, 1976; Croft, 1980). If the buffer is changed to 
either NH4Hco3 (pH 7.8) or ammonium acetate (pH 4.0), cleavage only 
occurs at glutamyl residues. 
. . 
2.2~6.3.5. Proline-Specific Endoproteinase (E.C. 3.4.21.26) 
The protein or peptide '"as dissolved in a minimal volume of 
O.lM Na-phosphate buffer, pH 7.0 and the enzyme was added to give a 2% 
Cwhv) enzyme/substrate ratio. After incubation for 1-2 hours at 370 C 
thereaction was stopped by lyophilisation (Yoshimoto.~ al., 1980). · 
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Specificity - The proline-specific endoproteinase specifically cleaves 
Pro~X and occasionally Ala-X peptide bonds (Yoshimoto 
et al.' 1980) .. 
2. 2. 6. 4. Purification of Protein and Peptide Mixtures 
The purification of protein and peptide mixtures produced 
by enzymatic or chemical digestion was performed either by molecular 
exclusion chromatography, or by high voltage paper electrophoresis or 
by reverse-phase high performance liquid chromatography (RP-HPLC) or 
by a combination of these methods, as indicated. 
2. 6.4. 1. ·Molecular Exclusion Chromatography 
The hydrolysates were dissolved in the column eluent, as 
indicated, and applied to columns (0.8 x 190 em) of Sephadex G-50, 
Biogel P-4 or Biogel P-6. The elution was performed at the flow rates 
indicated and 1.4ml fractions were collected. The detection of peptides 
in the fractions was done either by measuring the optical density of 
the fractions at 280 and/or 230 nm, or by removing small samples 
(10~30 pl) for N-terminal and semi~quantitative amino acid analysis 
using the dansyl-chloride method (see below). 
2.2.6.4.2. High-Voltage Paper Electrophoresis 
The separation of peptide mixtures by high voltage paper 
electrophoresis \vas done as described by Thompson et al. ( 1970)) at pH 
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6.5 (pyridine-acetic acid-water, 25:10:225 by volume) or at pH 1.9 
(acetic acid-formic acid-water, 4:1:45 by volume) on a water-cooled 
flat-plate apparatus (107 x l5cm; The Locarte Co., London). Separation 
was achieved on \fuatman paper Cl07 x 15 em) using a voltage. of 9 KV to 
give a current of 50-50 mA at 7 p.s.i. pressure for 120-150 minutes 
for the electrophoresis at pH 6.9 and by using a voltage of 9 KV to 
give a current of 30-50 rnA for 60-120 minutes at 7 p.s.i. pressure for 
the electrophore3is at pH 1.9 
The peptides were located using the cadmiuro ninhydrin 
reagent ( cadmium acetate 100 mg, lOml water, 5 ml glacial acetic acid, 
100 ml acetone). A 1% (w/v) solution of ninhydrin in this solution was 
prepared, just before it was required (Heilman et al., 19.57). 10% 
strips of the electrophoresis paper (guide-strips) were dipped 1n the 
cadmium ninhydrin reagent and dried at 105° C for 2-5 minutes. Some 
electrophoresis guide strips were also passed through freshly prepared 
E~ich reagent (2% w/v) 4-dimethylaminobenzaldehyde in 20% HCl 1n 
acetone (v/v). The pink ninhydrin spots became colorless and a purple 
colour appeared indicating a positive reaction with tryptophan. 
. . . 
At pH 1. 9 peptide mobilities were measured from 
1-dimethylamino-naphtalene-5-sulfonic acid and expressed relative to the 
distance of the dansyl-arginine standard. At pH 6.5 they were measured 
from a true neutral point determined as 4/11 of the distance from the 
standard dansyl-arginylarginine to the 1-dimethylaminonaphtalene-5-
sulfonic ac.id. 
Peptides were eluted \-lith . 20% (v/v) aqueous pyridine into 
scre\-7-cap tubes (1 x Scm). The samples ,.,ere freeze-dried in~ over. 
soiid NaOH. 
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2. 2 o6.4. 3. Reverse-Phase High Performance Liquid Chromatography (RP-HPLC) 
RP-HPLC was performed in a Varian model 5000 HPLC fitted 
with a C-18 p-bondapak column (0.5 x 25cm) (from HPLC Technology Ltd., 
Hacclesfield, Cheshire) and using a linear gradient of 0 to 70% 
acetonitrile in 0.1% (v/v) trifluoracetic acid (Mahoney and Richardson,. 
1980). Mixtures of peptides were injected in 100 )ll of 0.1% trifluoracetic 
acid (TFA) or in the case of mixtures which were insoluble in this 
sol vent in ·100 pl of 6M guanidine hydrochloride in 0.1% TFA. The 
presence of peptides in the eluting solvent was detected by measuring 
the absorbance at 214 nm. The peaks of absorbance at 214 nm were 
collected manually and lyophi lise d. 
2.2.6.5. Amino Acid Analysis 
2.2.6.5.1. Semi-Quantitative Amino Acid Com12osition of Pe-ptides 
Purified samples (30- 50 nM) of peptides-were dried~~ 
over solid NaOH in Durham tubes, 50 ul of 6M HCl was added and the tube5 
sealed with an oxygen .flame, and hydrolysed for 18 hours at 105° C. 
The acid was removed by drying in ~ over solid NaOH and the free 
amino acids ,.,ere labelled by the dansyl-chloride method of Gray and 
Hartley (1963) and the dansyl-amino acids identified as described in 
Section J2•r;. 
2.2.6.5.2. Quantitative Amino Acid. Composition of Proteins and Peptides 
Samples of protein (0.2 - 0.5mg) or peptides (0.05-0.25 · 
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pmole) were. hydrolysed with 5. 7 M HCl at 10S° C in evacuated pyrex 
tubes for 20-72 h. After hydrolysis the samples were dried in~ 
over solid NaOH and stored at -20° C until analysis. 
The amino acid composition of the samples was determined 
us1.ng either ·a Locarte amino acid analyser, or, alternatively,. in a 
Varian SOOO High Performance Liquid Chromafograph fitted with a 
Micropak Hydroly s~te Amino Acid (AA) column ( 4mm x 15cm) in the sodium 
form, a post-colunm orthophtlalaldehyde reactor system, and a Fluorichrom. 
. . 
detector. The buffer system used was the Phix PicoBuffer System II 
(Pierce.Chemical Co., Rockford, Saint Louis, U.S.A.), and the post-
colunm reaction system was as described in the operators manual (Varian 
Associates, 1981) .. 
2.2.6.6. N-Terminal Analysis of Protein and Peptides 
The N-tern~nal analysis of peptides and proteins was 
performed using the dansyl-ch lor ide method (Gray and Hartley, 1963; 
Gray, 1972). A sample of the peptide or protein ( z..lOnmol) was 
dissolved in 50% aqueous pyridine and transfered to a durham tube 
(30mm x 6mm, A. Gallenkamp Ltd., London) and dried in vacuo over solid 
----
NaOH. 10 ,ul of 0.2M NaHC03 was added and the solution dried again in 
vacuo over solid NaOH. 10 pl of a solution containing water and dansyl-
chloride (Smg/ml acetone) in equal proportion was added, the tube 
sealed with parafilm and incubated for SO minutes at 4S2 C. The 
dansylated protein or peptide \oJas dried in vacuo over solid NaOH. SO 
ul of 6M HCl \oJas then added and the tube sealed using an oxygen flame 
and incubated for 18 hours at 105° C. After incubation the tube was 
broken open and the acid removed in vacuo over solid NaOH. The residue 
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was dissolved in 10 pl of 20% (v/v) aqueous pyridine and the dansyl 
amino acid was ·identified by thin layer chromatography (TLC), in the 
solvent systems described by Ramshaw et al (1970). The 10 pl solution 
was spotted on both sides of a polyamide sheet (15 x 15cm), 80% of the 
sample on the experimental side and 20% on the standard side, and dried 
under a hot-air draught. 1 pl of a chromatography marker solution 
containing 0 .lmg/ml in 95% ethanol of the following amino acids; 
dansyl-proline, · dansyl-isoleucine, dansyl-phenylal~nine, dansyl-
glutamic acid, dansyl-glycine, dansyl-serine and dansyl-arginine was 
applied to the standard side of the sheet. Frames of the type described 
by Smith (1958) were used to support up to five polyamide sheets for 
simultaneous separation. The solvents used to separate the amino acid 
derivatives were: 
Solvent A - 1.5% (v/v) formic acid 
Solvent B - Toluene-acetic acid, 9:1 (v/v) 
Solvent C- Butylacetate-methanol-acetic acid, 30:20:1 (v/v/v) 
The dansyl derivatives were identified by running the sheets 
in Solvent A for 45 minutes and after drying under a hot air draught, 
were ·.run at right angles in relation to the first running with Solvent 
B for 45 minutes. After being dried the sheets were examined in a U.V. 
light (350nm) and the results recorded (Figure3 ). The sheets were 
then run in Solvent C in the same direction as Solvent B, for 35 
minutes, dried and examined under U. V. light (350 nm) and the results 
recorded (Figure 4). The co-chromatography of unknown samples with 
kno\vn standards was used to help in the identification of close pairs 
of derivatives. 
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Figure 3 - Two dimensional separation of dansyl-amino acids on a polyamide 
sheet (Ramshaw ~ al., 1970). The solvents used for 
chromatographic separation are given in the text. Development was by 
solvent A in the first dimension and solvent B in the second dimension. 
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Figure 4 Two dimensional separation of dansyl-amino acids on a polyamide 
sheet (Ramshaw et al., 1970). The solvent used for 
chromatographic separation are given in the text. Development was by 
solvent A in the first dimension and solvent B followed by solvent C in 
the second dimension. 
2.2.6.7. C-Terminal Analysis Using Carboxneptidase A 
10 ul of carboxypeptidase A suspension (lOmg/100 pl) 
diisopropyl-phosphofluoridate treated was washed twice with 2 ml of 
distilled water and 100 ul of 0. 2M NaHC03 was added to the suspension 
which was then placed in an ice bath and O.lM NaOH was added to just 
dissolve the enzyme. After the enzyme was dissolved, O.lN HCl was 
added to neutralise the solution and the volume was made up to 1. 5 ml 
with 0.2M N-ethylmorpholine-HCl buffer pH 8.5 • 
Samples of the protein or peptide to be digested were 
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dried in a durham tube in vacuo over solid NaOH. 20 p1 of the 
carboxypeptidase A solution was added and the tube sealed with 
parafilm. The incubation was carried out for varying times (30 m~n. to 
4 hours at 37~ C) and the liberated amino acids were determined as 
their dansyl derivatives (see Section 2.2.6.6.). 
2.2.6.8. Manual Sequencing Methods 
2.2.6.8.1. "Dansyl-Edman" Method 
This method is a var,iation of the phenylisothiocyanate 
(iiTC) degrad~tion procedure introduced and developed by Edman (1950, 
1953, 1956; Ilse and Edman, 1963; Edman and Begg, 1967). In the 
"dansyl-Edman method the newly released N-Terminal residue at each 
cycle is identified as its dansyl derivative. 
The peptide (0 .1 - 0. 5 nmol) was dissolved m 150 p1 of 
20% aqueous pyridine. Then 150 ul of a 5% solution of re-distilled 
phenylisothiocyanate (PITC) was added and the tube flushed with 
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oxygen~free nitrogen and capped. The samples were allmv-ed to react 
at 45° C for 1 hour. Excess reagent and the volatile reaction by-
products \vere then removed by drying in ~ over solid NaOH. When 
the samples \vere completely dry, 200 pl of anhydrous TFA was added, 
the tube sealed with parafilm and incubated at 45° C for 30 min. The 
TFA was removed 1n vacuo over solid NaOH. The residue was dissolved 
----
in 200 ul of distilled water and extracted twice with O.Sml of butyl 
acetate, and then dried in vacuo over solid NaOH. The residue was 
dissolved in 150 pl of 20% aqueous pyridine. 5-10% of this material was 
removed and a new degradation cycle was initiated with the remaining materi• 
The material removed was utilised to identify the newly revealed N-terminal 
amino acid as descr~bed in Section 2. 2. 6. 6. 
2.2.6.8.2. DABITC-PITC Double Coupling Method (Chang et al., 1978) 
Samples of the peptide or protein (5 - 10 nmol) were placed 
1n a glass tube (0.5 x 3.0cm) fitted with a ground glass stopper and 
dissolved in 80 pl of 50% (v/v) aqueous pyridine. 40 pl of the 
4-NN-dimethylaminobenzene-~-isothiocyanate (DABITC) solution (2.82 
mg/ml pyridine) was added; the tube flushed with nitrogen, the 
contents mixed by agitation on a whirlmixer and incubated at 52°C 
for 50 minutes. 10 pl of PITC was then added, the mixture flushed 
again with nitrogen and incubated at 52° C for 30 minutes. The excess 
of reagents and by-products were removed by extracting the mixture 
three times with a 2:1 (v/v) solution of heptane/ethyl acetate. The 
. organic phase was separated in each case by centrifugation, removed 
by pipette and discarded. The aqueous phase was dried down in ~ 
over solid NaOH. The extraction of the 4-NN-dimethylaminobenzene-4 1 -
thiazolinone-amino acid (DABTZ-amino acid) was done by adding to the 
residue 50 pl of water and 200 pl of butyl acetate. After m1x1ng on a 
whirlmixer for three. seconds, the contents were centrifuged for 30 
seconds at lOOOg. The upper butyl acetate layer was removed with a 
pipette and the peptide in the aqueous phase was dried down 1n ~ 
over solid NaOH and subjected to the next degradation cycle. 
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The butyl acetate extract was dried down in ~ over solid 
NaOH and the residue was dissolved in 20 pl of water and 40 ).11 acetic 
acid saturated with HCl (or alternatively with SO ul of 50% aqueous 
TFA). Conversion of the thiazolinones of the amino acids into the 
thiohydantoins was carried out in the 52° C heating block for SO 
minutes, or by heating at 80° C for 1o minutes.when the SO% aqueous 
TFA was used. The sample was dried in vacuo over solid NaOH and 
redissolved in a suitable volume (5 - 30pl) of 95% (v/v) ethanol. 
The identif{cation of the 4-NN-dimethylaminobenzene-4 1 -
thiohydantoin-amino acid (DABTH-amino acid) was done by thin layer 
chromatography (TLC). The synthetic marker 4-NN-dimethylaminobenzene-
4' -thiocarbamyl (DABTC)-diethylamine was used as a marker and spotted 
in the same position as the ethanol extract. The first dimensional 
separation was done using an acetic acidh11ater (2: 1, .v/v) solution 
and the second dimension separation with a toluene/n-hexane/acetic 
acid solution (2:1:1, v/v/v). After TLC the dried sheets were exposed 
to HCl vapo~rs which led to the temporary formation of the characteristic 
colours of the DABTH-amino acids. The DABTH amino acids were identified 
by comparing the position of the coloured spots (blue, red or purple) 
with the blue marker (Figure 5). 
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Figure 5 - Two-dimensional separation of DABTH-amino acids on a polyamide 
sheet (Chang~ al., 1978). The solvents used for chromatographic 
separation are given in the text. The colours (after exposure to HCl 
vapours) are represented by solid areas (red), dotted areas (blue) and 
hatched areas (purple). (e) is the blue synthetic marker DABTC-diethylamine. 
(U) is a blue coloured thiourea formed by the coupling of PITC with 
hydrolyzed DABITC. The DABTH derivatives of the amino acids are denoted 
.by the single letter code. TA ~ DABTH-dehydrothreonine; g 4 , go and go , 
products formed by -elimination of DABTH-serine; Tx, product formed 
after 13 -elimination of DABTH-threonine; K1, c(. -DABTH- e.-DABTC-lysine; 
K2- 6. -PTH- e: -DABTC-lysine; K3 , ~A-DABTH- e: -:PTC-lysine. Other blue spots 
are sometimes visible, due to incomplete conversion to DABTH deri~atives, 
particularly with the glycine derivative. 
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2.2"6.9. Nomenclature of Peptides 
In the summarising data (Figures H, S'if, and '3) and in the 
text and tables, each peptide is characterized by its or1g1n (i.e. from 
digestion with CNBr (CN), trypsin (T), chymotrypsin (Ch), Thermolysin 
(Th), Staphylococcus aureus (Strain V-8) protease (V), proline-
sp-ecific endoproteinase (P) ~.·catalytic cleavage with trypsin (CC) ) 
and by its elution order from gel filtration and/or reverse phase 
columns. For example, ThS-7 means a thermolysin peptide obtained by 
the separation of peak 5 (from gel filtration of the thermolysin 
digest of the relevant protein), by RP-HPLC; the number 7 indicates 
the order of elution of the peptide from the reverse phase column. 
Also, CN-Ch4 means a chymotryptic peptide obtained by the sub-digestion 
of a CNBr peptide with chymotrypsin; the number 4 indicates the order 
of elution of the peptide from the reverse-phase column. 
2. 2. 6.10 - Identification of the Reactive (Trypsin Inhibitory) Site 
of the Trypsin/ ~-Amylase Inhibitor (Ozawa and ·Laskowski, 
1966; Richardson, 1974) 
The native inhibitor was dissolved in 0.2M acetic acid 
containing O.OSM CaCl •. Trypsin was added to give a 2% (w/w) solution. 
After adjusting to pH 2.5 with HCl the solution was incubated for 20 
hours at 37'! C. The reaction was stopped by lyophilisation. After 
reduction and S-carboxymethylation the fragments produced by catalytic 
. cleavage were separated by RP-HPLC. The position of the reactive site 
1n the primary structure of the inhibitor was deduced from the analysis 
of the N-terminal sequence of each fragment by the DABITC-PITC double 
coupling method (see Section 2.2.6.8.2.). 
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2.2.7. Sequence Comearisons 
The alignment of am~no acid sequences was performed us~ng 
a computer program developed from Gotch's algorithm (Gotch, 1982) for· 
aligning biological sequences (proteins and nucleic acids). Gotch 
derived his algorithm· from Waterman's algorithm (Waterman~ al., 
19 76). In order to do so he made some simplifying assumptions, which 
were already used in practice by users applying Waterman's algorithm 
(Smith !:..!. al., 1981; Kanchisa, 1982). These simplifications allowed 
him to perform some algebraicmanipulations of the equations used by 
Waterman et .§!!. 0976) which eventually reduced the order of the 
algorithm's complexity.· 
The "best" alignment of two sequences is the one with the 
smallest distance measure (DM), according to·a given set of parameters. 
The distance measure is defined in such a way that the greater its 
value the less the number of matching residues~ The insertion of gaps 
and their s~ze also increase the distance measure . 
. The functions are used in order to evaluate the distance 
measure: 
a) ...: The function d(a,b) represents the contribution of two aligned 
residues to the distance measure. It can be interpreted as a 
penalty for a mismatch. So d(a,b) ~s equal to zero (no penalty) 
if a=b and ~s equal to c ::> 0 otherwise; and 
b) - the function w(k) defines the penalty for a gap where k 
represents the size or length of the gap. The function is defined 
by Gotoh (1982) as w(k) = u xk + v, where u~O and v~O. This 
means that v is the initial cost or penalty for introducing a 
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gap and u 1.s the increment to that penalty for each gap size 
unit. 
The distance measure is now defined as the sum of the 
functions d applied to all aligned residues plus the sum of the function 
w applied to all gaps. Thus the value of the distance measur.e of a 
certain alignment depends on the values given to the.three parameters 
c, u and v. The definitions .of the functions d and w also imply that 
the greater the value of u in relation to the value of c the harder 
becomes the insertion of a gap. Additional difficulty might also be 
given by a gre~ter value for v .. Then defining these values the user 
... 
must.keep in rriin,d_ the likelihood or not of the occurrence of gaps. 
The alignment program ~perates in two maJor steps.·During 
the first the "best" alignment is determined according to Gotoh' s 
algorithm. At. the second one the statistical significance of the 
al_ignment' s 'similarity is determined. In order to determine the 
significance 'of the alignment, both bio~ogical sequences are shuffled 
100 times (the residues of each sequence are r.andomly rearranged) and 
, I , -
for each shu.ffle the smallest dist·ance ~easure is determined for the 
same parameters c,. u and v as used be fore. The mean ( JA) and the 
., 
· standa.rd deviation (c:r) are derived from those 100 minimum distance 
measures of the randomly rearranged biological sequences can be 
described by a norm~l distribution with mean (fA.) and standard. deviation 
( o). At a next step the distance measure (x) of the or.iginally 
unshuffled sequences is derived in terms of standard deviations units 
( z = ( J-t. -x) / u). An alignment is said to be significant if z -;: 3. 0 . 
This means that the probability of the alignment occurring by chance is 
less than 0.135 x 10 -z according to Table 35 in Dayhoff 0979). 
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2.2.8. Prediction of Secondary Structure 
The prediction . of the secondary structure:: of the 
inhibitors was performed by tpe computerized method.of Robson (Garnier 
et !!!.·, 1978). This is the most widely utilised method for predictions 
of protein secondary structure from the amino acid sequence (Kabsch 
and Sander, ·1983) and has.· the advantage over the also popular method· 
of Chou and Fasman (1974, 1978, 1979), as it is presented as an 
algorithm-·and not , as in the Chou and Fasman predictive model, as a 
set of rules (some of them qualitative rather than quantitative). 
Thus, in the Robson's method unambiguous and objective predictions are 
. guaranteed. 
The· choice of the directional method of Robson was also made 
on consideration of the fact that it also ha5 a higher rate of 
predictive success than the method of Chou and Fasman.·Kabsch and 
Sander (1983) have demonstrated that one may expect a success rate 
of about 50% with the Chou and Fasman method and 55 to 56% with the 
Robson's method. A similar conclusion was reached by Busetta and 
Hospital (1982). 
The Robson method allows for a four state prediction, in which 
each residue is unambiguously assigned to one conformational state of 
a. -helix (H), extended chain (E), reverse turn (T) or random coil (C). 
A complete account of the theory which justifies the formal correcteness 
of the method as \.Jell as an analysis of its accuracy, can be found 1.n 
Robson (1974), Robson and Suzuki (1976) and Garnier et. al. (1978). An 
outline of the method 1.s given below (Garnier et !!!.·, 1978). 
The method was built on the consideration that the prediction 
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f S ( h f . . 1 f 1. • tb . . d . h ) o . t e con orroat1.ona state o tlle J res~ ue 1.n t e sequence , 
J 
depends not only on the type of one or several residues, but on the 
whole sequence. Thus the roost general statement concerning the 
th information for the conformation of the j residue is thus 
which reads as the "information which the residue at the first, second 
and so on up to the last residue carry about the conformation of the 
jth residue". As the model allm-1s for the prediction of four 
conformational states H ( c< -helix), E (extended chain), T (reverse 
turn) and C (random coil), the predictive procedure leads to four 
values for information associated with each residue (R): 
I (S. 
J 
H· 
' 
Rl' R2' Rlast) 
I (S. E· Rl, Rz, Rlast) J ,
I (S. 
J 
: T; Rl' R2, Rlast) 
I (S. 
J 
Whichever of these values is highest defines the conformational state 
predicted. Each of these four information values may be estimated by 
inspection of the amino acid sequence. The actual procedure for carrying 
out this inspection and assigning the values depends on how i(Sj; R1 , 
R2 , •.. Rlast) is expanded. In their studies Garnier et al. (1978) 
have shown that the effect of one resid.ue type on the conformation of 
residues up to eight residues distant plays a predominant role, while 
choosing shorter separation distances neglects significant information. 
The equation belm-1 was then proposed as a simple aproximation: 
I (S. ;R .. L 
J J+ro 
(Equation 1) 
6i 
~n which terms in the. expansion containing more than one R. parameter 
J 
have been neglected and interactions between residues separated by more 
than eight positions ~n the amino acid sequence are neglected. 
The measure of I (S. ;R .. ) represents the information which 
. . J J+m 
the type of residue at j+m carries about the conformational state of 
the j th residue. Since there are 20 types of residue R and four 
conformational states, there are 20 x 4 differents parameters for each 
separation m. Since -8 $ m ~ 8, including m=O; there are effectively 
17 separations. If m is negative, the information concerns a residue 
on theN-terminal side of R .. If m is positive, the information 
J 
concerns a residue on the C-terminal side of R .. If m is zero, the 
J 
information is I ( S. ;R.), which is the information the residue carries 
. J J . 
about its own conformation. There ~s thus a total of 20 x 4 x 17 
parameters, which were .calculated by the authors. The calculation of 
these .parameters was based on the statistical (information theory) 
.analysis of 25 proteins of known sequence and conformation. 
The prediction of the conformational state of each j 
residue thus' involves the evaluation of equation 1 for each conformational 
state, and then choosing the conformation with the hightest information 
content. 
It was also shown that the predictions may be greatly 
improved by introducing different decision constants for all four 
states. The values of each decision constant, which have to be 
subtracted from the information measure at each residue, \vere 
established by tracing the highest percentage of correctly predicted 
residues for the four conformations by varying the decision constant. 
These studies showed that the higher the content of a given 
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conformation, the more negative the value of the optimal value of· 
the decision constant. The value of the optimal decision constant was 
calculated as the average of the optimal decision constant of the 
proteins having an ~-helix content less than 20% ,between 20foand SO% and 
over 507.. The optimization of the predictive model through the use of 
decision constants requires the prior measurement of secondary 
structure contents (e. g. through circular dichroism). When these data 
are not available the choice of the decision constants can still be 
made from a preliminary prediction with all decision constants equal 
to zero .. 
Finally, the optimized predictive model when applied to 
26 proteins of known conformation, led to 66.1% on average of the 
residues observed as ~-helix being correctly predicted as helix, 55.2% 
as e~tended chain, 42.1% as reverse turn but only 28.6% as coil. 
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3. RESULTS AND DISCUSSION 
3.1. Purification of the Trypsin/ ~-Amylase and d-Amylase Inhibitors 
The trypsin/ c(-amylase and c(-amylase inhibitors from ragi 
seeds were purified as described by Shivaraj and Pattabiraman (1980, 
1981). Both inhibitors were obtained in a pure state, with yields of 
25 and 17 mg per 500 g of ragi flour, for the trypsin/c(-amylase and 
~-amylase inhibitor, respectively . These yields were almost the 
same as the ones obtained by Shivaraj and Pattabiraman (1980,1981). 
The homogeneity of both inhibitors was ascertained by SDS-polyacrylamide 
gel electrophoresis, isoelectric focusing and by N-terminal analysis 
by the dansyl-chloride and by the DABITC-PITC double coupling method, 
which in every case confirmed their homogeneity. 
From the SDS-polyacrylamide gel electrophoresis (SDS-PAGE) 
experiments the molecular weights of the inhibitors were estimated 
to be 13400 for the trypsin/ cJ. -amylase inhibitor and 10200 for the 
( f u;111llir 5' a..) 
~-amylase inhibitorA These values are in good agreement with the 
values calculated when the amino acid sequences of both inhibitors 
were determined. Previously Shivaraj and Pattabiraman (1981) had 
estimated the molecular weight of the trypsin/ d:.. -amylase inhibitor as 
14300 and the ~-amylase inhibitor as 16500. 
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3.2. The Complete Amino Acid Sequence of the Trypsin/ ()(-Amylase Inhibitor 
from Seeds of Ragi (Indian Finger Millet, Eleusine coracana Gaertn.) 
3.2.1. Amino~ Analysis 
The results of the amino acid analysis of the trypsin/~ -amylase 
inhibitor from ragi are shown in Table VI. The results obtained are 1n very 
good agreement with the composition of amino acids calculated from the 
sequence (Figure 35) with the only exceptions beign the values for Asp,Met, 
Tyr and Val. It is possible that some part of the high value obtained for 
Asp in the analysis was contributed by the Cys residues which were not 
completely resolved by the column system employed. The low values for Met 
and Tyr were thought to be due to partial destruction of these amino acids 
during hydrolysis. The slightly low value for Val could be due to the-·high 
resistance to acid hydrolysis of peptide bonds involving this amino acid. 
It should be noted that the amino acid composition of the 
ragi inhibitor reported here shows strong similarity to the very recently 
published data on the composition of another trypsin/ tf. -amylase inhibitor 
from the same tissue by Manjunath et al (1983) except for the values of 
Lys, Ser, Cys and Leu. 
3.2.2. N-Terminal Analysis 
The N-terminal analysis of the reduced and carboxymethylated 
protein was carried out by the DABITC-PITC double coupling method. The 
sequence obtained is given below: 
Ser-Val-_lli-TI!.!:.-~-~-Ile-!2£-Q.!y-fu-..!._k-Pro-His-~-~-~-Asp 
The identities of Ile 7 and Ile 12 were ascertained by compar1son with 
peptides Th3-7 an'd Th3-8. 
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Table VI - The amino acid composition of the trypsin/~-amylase inhibitor 
from seeds of ragi (Indian finger millet, Eleusine coracana 
Gaertn. ). 
Amino Acid Analysis Sequence 
Asp 6.59 5 
Thr 6.15 6 
Ser 6.59 6 
Glu 12.23 13 
Gly 12.02 12 
Ala 11.02 11 
Val 8.38 9 
Met 1.62 3 
Ile 5.00 5 
Leu 11.70 12 
Tyr 1. 26 2 
Phe 1. 89 2 
Lys 3.02 2.5 
His 2.89 3 
Arg 9. 98 10 
Trp ND 1 
Cys ND 10 
Pro ·ND 9.5 
ND= Not determined. 
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3.2.3. C-Terminal Analysis 
All attempts to identify the C-terminal residues of t;he native and 
reduced and carboxymethylated trypsin/ ~-amylase inhibitor by the -use of 
carboxypeptidase A were unsuccessful. The reasons for this became apparent 
when the C-terminal peptides (Th5-6, Ch3-6, CN-Ch3 and CN-T7) were 
identified and their analysis revealed that the C-terminal sequence was 
Gly-Glu. Both of these amino acids are only released very slowly by 
carboxypeptidase A (Allen, 1981). 
3.2.4. Cyanogen Bromide (CNBr) Digestion 
20 mg of the reduced and carboxymethylated protein were 
subjected to CNBr cleavage , under the conditions described in 
Section 2.2.6.2. The fragments obtained were purified by RP-HPLC, 
separating aproximately 1 mg at each run (Figure 6). Although cross-
contamination among some peptides was observed, all peaks collected 
could at least be partially sequenced. These cross-contaminations are 
attributed to the existence of microheterogeneity within some peptides 
thus altering their elution time and to the incomplete reduction and/ 
or carboxymethylation of the protein. The sequence of the peptides 
obtained, together with their elution time and position in the 
sequence are given in Table VII. 
Peptide CN-1 (positions 1· to 10) 
The identity of Ile 7 was ascertained by comparison with peptide Th3-7 
(see below) and by semi-quantitative amino acid analysis by the dansyl-
chloride method. 
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Figure 6 - RP-HPLC separation of peptides obtained by the treatment of the 
trypsin/ ~-amylase inhibitor from ragi seeds (Indian finger 
finger millet, Eleusine coracana Gaertn.) with CNBr. Separation was 
performed on a u-Bondapak column (0. 5 x 2.5cm) with a linear gradient of 
20 
60 
80 
0-70% acetonitrile (v/v) in 0.1% (v/v) trifluoracetic acid at a flow rate of 
.1.0 ml/min. Fractions correspondj,.g to peptides which were fully or partially 
fl..l O/ 
sequenced are numbe.red. Dotted line indicate 11 concentrationAacetonitrile. 
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~VII - Peptides obtained by the cleavage of the trypsin/ G£-amylase 
inhibitor from seeds of ragi (Indian finger millet, Eleusine 
coracana Gaertn.) with CNBr. 
Peptide no. Elution 
and Position Time in Sequence 
Sequence . 
CN-1 ( 1-10) 43 
CN-2 ( 23-40) 46 
Arg-Leu-Ala-Thr-Gln-Glu-HSE 
CN-3 (11-22) 49 
Trp 
CN-4 ( 23-40) 53 
Arg-Leu-Ala-Thr-9ln-Glu-HSE 
CN-5 (11-22) 58,' 
Trp 
CN-6 (11-22) 60 
Trp 
CN-7 (11-22) 61 Ala-.!.!!:,-Pro-His-Asn-~-~-AsE_-~-~-Arg 
Trp 
CN-8 (41-64) 64 Lys-~-Ar~-~-~-Ar~-Q!!!,-~-~-fu-Ile 
Pro-Ala-Tyr-Cys-Arg-Cys-Glu-Ala-Val-Arg-Ile 
Leu-HSE 
CN-9 (41-64) 65 ~-~-Arg-f¥.!-~-Arg-.Q!!!-Leu-Glu-Ala-Ile 
Pro-Ala-Tyr-Cys~Arg-Cys-Glu-Ala-Val-Arg-Ile 
Leu-HSE 
CN-10 (41-64) 67 1Y_!-~-Ar~-~-~-Ars-~-~-~-&-.!.!!:, 
K!2-Ala-Tyr-Cys-Arg-Cys-Glu-Ala-Val-Arg-Ile 
Leu-HSE 
CN-11 (41-64) 69 Lys-Le.u-Ari-~-f¥.!-Arg-~-~-Glu-!!,!-Ile 
Pro-Ala-Tyr-Cys-Arg-Cys-Glu-Ala-Val-Arg-Ile 
Leu-HSE 
Table VII (cont.) 
Peptide no. 
and Position 
in Sequence 
CN-12 1 (41;.64) 
CN-13 (65-122) 
CN-14 (65-122) 
CN-15 (65-122) 
Elution 
Time 
71 
76 
84 
86 
69 
Sequence 
~-~-Arg-~-fi.!-Ar,g_-G1n-~-Glu-&-lli_­
Pro-Ala-Tyr-Cys-Arg-Cys-Glu-Ala-V~l-Arg-Ile-
Leu-HSE 
Ser . · Asp-Glv-Val-Val-Thr- -Ser-Gly-G1n-H1s•Glu-
-- ~------Pro--------
Gly-Arg-Leu-Leu-Gln-Asp-Leu-Pro-Gly-Cys-Pro-
Arg-Gln-Val-Gln-Arg-Ala-Phe-Ala-Pro-Lys-Leu-
Val-Thr-Glu-Val-Glu-Cys-Asn-Leu-Ala-Thr-Ile-
His-Gly-Gly-Pro-Phe-Cys-Leu-Ser-Leu-Leu-Gly-
Ala-G1y-G1u 
A~n-G1v-Val-Val-Thr- 5er_Ser;.Glv-Gln-His-Glu-~ .:=...=...t...--- Pro- .:=...=...t...---
G ly-Arg-Leu- Leu-Gln-Asp-Leu- Pro- Gly- Cys-P-ro-
Arg-Gln-Val-G1n-Arg-Ala-Phe-Ala-Pro-Lys-Leu-
Va1-Thr-Glu-Val-Glu-Cys-Asn-Leu-Ala-Thr-Ile-
His-Gly-Gly-Pro-Phe-Cys-Leu-Ser-Leu-Leu-G1y-
Ala-G1y-Glu 
Asp-G1v-Val-Val-Thr- 5er_Ser-Glv-Gln-His-Glu-
.::...;zL - - - Pro - .::...;zL - - --
Gly-Arg-Leu-Leu-Gln-Asp-Leu-Pro-Gly-Cys-Pro 
Arg-Gln-Val-G1n-Arg-Ala-Phe-Ala-Pro-Lys-Leu-
Val-Thr-Glu-Val-Glu-Cys-Asn-Leu-Ala-Thr-Ile-
His-Gly-Gly-Pro-Phe-Cys-Leu-Ser-Leu-Leu-Gly-
Ala-Gly-Glu 
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Peptides CN-3, CN-5, CN-6 and CN-7 (positions 11 to 22) 
Ala-Ile-Pro-His- Asn- Pro-Leu- Asp- Se r-~-Arg-Trp 
The identity of Ile 12 was ascertained by subjecting the peptides to 
one cycle of degradation by the "Dansyl-Edman" method. The multiplicity 
of these peptides was thought to be due to the incomplete reduction and/ 
19 
or carboxymethylation of Cys • 
Peptide CN-2 (positions 23-40) 
Tyr-Val- Ser-Th r- Arg-Th r-~-Qly_-Val-Qb:_-Pro-Arg- Leu- Ala-Tit r-Gln-
Glu-HSE 
Peptide CN-4 (positions 23-40) 
Glu-HSE 
Peptides CN-2 and CN-4 arose as a result of the anomalous 
. 22 
cleavage of the Trp -Tyr peptide bond by the CNBr treatment. These 
peptides were separated in approximately equal amounts (Figure 6). 
They differ only at positions 25, 26 and 28. Confirmation of the 
significant level of heterogeneity in these positions was obtained 
from the analysis of other relevant peptides obtained from the 
digestion of the inhibitor with different proteolytic enzymes (see 
below). 
Pe12tides ~' CN-9, CN-10, :9!:1.!. and 9:!:..!:1 (positions 41-64) 
~-Ala::-Arg-Cys-~-Arg-Gln-Leu-~-Ala-Ile-Pro-Ala-Tyr-Cys-Arg-Cys-
Glu-Ala-Val-Arg-Ile-Leu-HSE 
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As for peptides CN-3, CN-5, CN-6 and CN-7, the above peptides provide 
further examples of different elution times for the same peptide. As 
no indication of microheterogeneity was detected, this phenomenon is 
probably due to the incomplete reduction and/or carboxymethylation. 
of Cys 44 and Cys 45 , and also probably due to the presence of 
homoserine or homoserine lactone as the C-terminal residue. 
Peptides CN-13, CN-14 and CN-15 (positions 65 to 122) 
Aqn-Glv-Val-Val-Thr-Pro_Ser-Gly-Gln-His-Glu-Gly-Arg-Leu-Leu-Gln-Asp-
.:..:.=.J:.. .::::..=..t.... -- -- -- Ser ~- --~ --
Leu-Pro-Gly-Cys-Pro-Arg-Gln-Val~Gln-Arg-Ala-Phe-Ala-Pro-Lys-Leu-Val-
Thr-Glu-Val-Glu-Cys-Asn-Leu-Ala-Thr-Ile-His-Gly-Gly-Pro-Phe-Cys-Leu-
Ser-Leu-Leu-Gly-Ala-Gly-Glu 
As peptides CN-13, CN-14 and CN-15 were easily isolated from the CNBr 
digestion of the trypsin/ o::-amylase inhibitor by RP-HPLC, their sub-
digestion with proteolytic enzymes (see below) was used as a 
convenient means of establishing many important overlappings in the 
sequence and also to confirm the amino acid(s) residue(s) which 
occupy positions where heterogeneity was suspected. When ref~~ng 
to these peptides the term CNBr C-terminal fragment and the 
abbreviation CN is collectively applied to them. 
The treatment of the inhibitor with CNBr led to cleavages 
at the three methionine residues in the molecule (Met 10 ,Met40 , and 
64 Met ~). Also cleavage occurred at the only tryptophan residue in the 
molecule. Although the cleavage of Trp-X peptide bonds by CNBr has 
been reported earlier (Blumenthal et ~·, 1975; Ozols and Gerard, 
1977; Kashlan and Richardson, 1981), it is not known whether this 
cleavage was caused by the CNBr itself or was a result of prolonged 
incubation in 70% formic acid. It l.S possible that the cleavage 
may have occurred due to the high concentration of CNBr used in the 
digestion of the inhibitor, as such conditions are known to favour 
cleavage at Trp-X peptide bonds (Han ~ al., 1983). 
The sequencmg of the CNBr fragments provided evidence 
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for heterogeneity at positions 25, 26 and 28 and the variant forms were 
isolated separately. Apparently both forms are present in. equal proportion. 
Heterogeneity was also detected at position 70, but in this case, the 
variant forms were not isolated separately; this may be due to the 
poor resolution of large peptides under the RP-HPLC conditions here 
utilized. The heterogeneities at positions 25, 26, 28 and 70 were 
later confirmed by the analysis of peptides arising from the cleavage 
of the inhibitor with different proteolytic enzymes. 
3.2.5. Thermolysin Digestion 
The thermolysin digestion of a 25 mg sample. of the reduced 
and carboxymethylated protein was performed as described in Section 
2.2.6.3.3. The fragments produced were separated by gel filtration 
on a Biogel P-4 column, equilibrated in 0.05M pyridine-acetate 
buffer, pH 5.4 (Figure 7). Further purification was achieved by 
subjecting each of the peaks from the Biogel P-4 column to RP-HPLC. 
The HPLC chromatograms of the separation of peaks 1, 3, 4 and 5 are 
shown in Figures 8, 9, 10, and 11, respectively The peptides present 
in peaks Th2, Th6 and Th7 were not resolved by RP-HPLC. The sequences, 
elution times and position in the sequence of each of the peptides 
purified are presented in Table VIII. 
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Figure 7 - Chromatography of the products of the digestion by thermolysin 
of the trypsin/ ~-amylase inhibitor from seeds of ragi 
(Indian finger millet, Eleusine coracana Gaertn.) on a Biogel P-4 column 
(0.8 x 190cm) in O.OSM pyridine acetate buffer, pH 5.4 (flow rate 6 
ml/h., fraction size 1.4 ml). 
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Figure 8 - RP-HPLC separation of fraction Th-1 from the thermolysin 
digestion of the trypsin/ c( -amylase inhibitor from seeds of 
ragi (Indian finger millet, Eleusine coracana Gaertn.) on a C-18 p-
Bondapak column (0.5 x 25cm) with a linear gradient of 70% (v/v) 
acetonitrile in 0.1% (v/v) trifluoracetic acid at a flow rate of 1.0 
ml/min. Fractions which were fully or partially sequenced are numbered. 
Dotted line indicates concentration of acetonitrile.· 
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Figure 9 - RP-HPLC separation of fraction Th-3 from the thermolysin 
digestion of the trypsin/ d.. -amylase inhibitor from seeds of 
ragi (Indian finger millet, Eleusine coracana Gaertn.) on a C-18 u-
Bondapak column (0.5 x 25cm) with a linear gradient of 70% (v/v) 
acetonitrile in 0.1% (v/v) trifluoracetic acid at a flow rate of 
1.0 ml/min. Fractions which were fully or partially sequenced are 
numbered. Dotted line indicateJ concentration of acetonitrile. 
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Figure 10 - RP-HPLC separation of fraction Th-4 from thermolysin digestion 
of the trypsin/ ~-amylase inhibitor from ragi seeds (Indian 
finger millet, Eleosine coracana Gaertn.) on a C-18 p-Bondapak column 
(0.5 x 25cm) with a linear gradient of 70% (v/v) acetonitrile in 0.1% 
(v/v) trifluoracetic acid at a flow rate of 1.0 ml/min. Fractions. 
corresponding to peptides which were fully or partially sequenced are 
numbered. Dotted line indicates concentration of acetonitrile. 
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Figure ll - RP-HPLC separation of fraction Th-s from the thermolysin 
digestion of the trypsin/ 0.. -amylase inhibitor from seeds of 
rag1 (Indian finger millet, Eleusine coracana Gaertn.) on a C-18 u-
Bondapak column (0.5 x 25cm) with a linear gradient of 70% (v/v) 
acetonitrile in 0.1% trifluoracetic acid at a flow rate of 0.1% ml/min. 
Fractions which were fully or partially sequenced are numbered. Dotted 
line indicatet concentration of acetonitrile. 
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Table VIII - Peptides obtained by the cleavage of the trypsin/<>~. -amylase 
inhibitor from seeds of ragi (Indian finger millet, 
Eleusine coracana Gaertn.) with thermolysin. 
Peptide no. Elution 
and Position Time in Sequence ' 
Sequence 
Thl-1 (67-77) 23 
ThL-2 (67-77) 28 
Thl 3 (6u- l1) 34 
Thl-4 . (67-78) 36 
Leu 
Thl-5 (63-69) 42 Leu-Met- Asp-Qlz-.Y&-M -.Th.!:. 
Thl-6 (79-88) 43 Leu-~-Asp-Leu-Pro-Q!y-~-Pro-Ar_&-Gln_ 
Thl-7 ( 78- 88) so Leu-~~~-AsE-~-Pro-Gly-~-~-Ar,g_-Gln 
Thl-8 (48-58) 54 ~-ill:2,-~-.!._k-!!.2,-fu-Tyr-~-Al'g-Cy~·Glu 
Th3-l (24-27) 8 Val-lli-~-Ar,g_-Thr 
Th3-2 ( 70-77) 14 Ser-~-Q.U.-~-fu-lli-Gly-Arg 
Th3-3 (42-47) 22 fu- Arg-ill-~-Arg- Gln 
Th3-4 (98-104) 30 Y&-Thr-fu-Y&·Glu-~-~ 
Th3-S (11-16) 33 Ala-Ile-Pro-His-Asn-Pro 
--.-----
Th3-6 (97-104) 40 Leu-Y!!_-!h!,-~-.Y&-~-.£ll-Asn 
Th3-7 ( 1-9) 41 ~-Val-Q!y-Ih!.-~-~-Ile-K!.2.-Gly 
Th3-8 (10-16) 43 Met-Al a-.!.1!;,-!!.2,-His -~-Pro 
Th3-9 (S0-58") 48 !!_!-~-~-fu-Tyr-~-Arg-~-Glu 
Th3-10 (48-58) 54 ~-~~Ala-lli·K!.2.·fu-Tyr-Cys-Ar_&·.fll-Glu 
Th4-1 (36-40) Ala-Thr-Gln-Glu-Met-Lys 
-----
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Table VIII - (Cont.) 
Peptide no. Elution 
and Position 
·Time ' Sequence in Sequence 
Th4-2 :: 89-9 2)- 8 Val-~-Arg-~ 
Th4-3 (35- 39) 19 · Leu-Ala-Thr-Gln-Glu 
-----
Th4-4 (9 3-9 6) 22 ~-Ala-~-Lys 
Th4-5 (62-66) ~ 37 Ile-~-~-As£-Qh 
Th4-6 (31-35) 41 .Y&-Q!x-~-Arg 
Th4.-7 (108-114) 43 Ile-His-QJL-Q!z,-Pro-~-~ 
Th5-l ( 105-107) '16 <Leu--Ala-Thr 
-~-
Th5-2 (60-61) 22 Val-Arg 
Th5-3 (23-30) 28 Tyr-M-~-!h!,-Arg_-~-Gly 
Th5-4 (54-58) 29 Tyr-.2-Arg-~-Glu 
Th5-5 (60-63) 32 .Y&-Ar~-.!,k-~ 
Th5-6 ( 118-122) 35 ~-Gli-~-Q.!l,-Glu 
Th5-7 (17-22) 45 ~-Asp-~-.2-Ar~-Trp 
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Peptide Th3-7 (positions 1 to 9) 
The identity of Ile 7 was ascertained by semi~quantitative amino acid 
analysis by the dansyl-chloride method. 
Peptide Th3-8 (positions 10-16) 
Met-Ala-Ile-Pro-His-Asn-Pro 
--- --- --- --- --- ---
The identity of Ile 12 was ascertained by semi-quantitative amino acid 
analysis by the dansyl-chloride method and by subjecting the peptide 
to two cycles of degradation by the "Dansyl-E-dman" method. 
Peptide ThS-7 (positions 17-21) 
Leu-Asp-Ser-~-Aq~-Trp 
Th "d ' f L 17 . db N . 1 1 . f h e 1 ent1ty o eu was ascerta1ne y -term1na ana ys1s o t e 
peptide by the dansyl-chloride method and through semi-quantitative 
amino acid analysis by the dansyl-chloride method. 
Peptide Th3-S (positions 11 to 16) 
Ala-Ile-Pro-His-Asn-Pro 
The identity of Ile 12 was ascertained by subjecting the peptide to 
one cycle of degradation by the "Dansyl-Edman" method and by semi-
quantitative amino acid analysis by the dansyl-chloride method. 
Peptide ThS-3 (positions 23-30) 
Tyr-~- Se r-:!:b.E- Arg-Th r-~ -Gly 
50000 ~ 
33000 -~·;,~· 
19000 
12400 
12000 
"' 
B A 
.... 
0 ·, 
Figure ~ - SDS-polyacrylamide gel electrophoresis of the bifunctional 
trypsin/d-a.mylase inhibitor (A) and theti-am:ylase inhibitor 
(B) from seeds of ragi (Indian finger millet, Eleusine coracana Gaertn.) 
in 1~/o gel (see text for details). The 12000, 19000, 33000 and 50000 
vicilin subunits and cytocbromec (12400) were used as molecular weight 
markers. 
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Peptide Th3-1 (positions 24-27) 
Peptides ThS-3 and Th3-l. confirm the heterogeneity at positions 
25 and 26, as showed earlier by the CNBr peptides CN-2 and CN-4. 
Peptide Th4-6 (positions 31-34 
Peptide Th4-3 (positions 35-39) 
Leu-Ala-Thr-Gln-Glu 
35 The identity of Leu was ascertained by N-terminal analysis by the 
dansyl-chloride method, and by semi-quantitative amino acid analysis 
by the dansyl-chloride method. 
Peptide ~ (positions 36-41) 
Peptide Th3-3 (positions 42-47) 
Ala-Arg-~-~-Arg-Gln 
Peptides Thl-8 and Th3-10 (positions 48-58) 
. d . . f L 48 d 11 Sl . d b b. t. th The 1 ent1ties o eu an e were ascerta1ne y su JeC 1ng ese 
peptides to three cycles of degradad.on by the "Dansyl-Edman" method, 
and by N-terminal analysis by the dansyl-chloride method. 
Peptide Th3-9 (positions S0-58) 
Ala-I le-Pro-Ala-Tyr-~-Arg-~-Glu 
82 
51 . 
The identity of Ile was ascertained by semi-quantitative amino acid 
analysis by the dansyl-chloride method and by subjecting the peptide to 
one cycle of degradation by the "Dansyl-Edman" methqd. 
Peptide Th5-4 (positions 54-58) 
Peptide Th5-2 (positions 60-61) 
Peptide Th5-5 (positions 60-63) 
. . . f 11 62 d L 63 t . d b . t. t t. The ~dent~t~es o e an eu were ascer a~ne y seml-quan ~ a 1ve 
peptide to three cycles of degradation by the "Dansyl-Edman" method 
and by comparison with peptides Th4-5, Thl-5 and Ch3-1. 
Peptide Th4-5 (positions 62-66) 
Ile-~-~-As£-.§br. 
. d . . f I 1 6 2 d L 6 3· . d b . t . . The ~ ent~t1es o e an eu were ascerta~ne y seml-quan 1tat1ve 
amino acid analysis by the dansyl-chloride method and by N-terminal 
analysis by the dansyl-chloride method. 
Peptide 1h!:2 (positions 63-69) 
. . f 63 . d b . 1 1 . b The 1dent~ty o Leu was ascerta1ne y N-term1na ana ys1s y the 
dansyl-chloride method and by semi-quantitative amino acid analysis 
by the dansyl-chloride methode 
Peptide Thl-3 (positions 64-77) 
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Peptides Thl-1 and Thl-4 (positions 67-78) 
Val-Val-Thr-~-~-~-Gln-His-~-~-Ar~-Leu 
Peptide Thl-1 is a shorter version of Thl-4, lacking the C-terminal 
78 78 . 
Leu . The identity of Leu was ascertained by semi-quantitative amino 
acid analysis by tme dansyl-chloride method and by comparison with 
peptide Thl-6. 
Peptide Thl-2 (positions 67-77) 
Peptide Thl-2 differs from Thl-1 only in having a proline at residue 
70 instead of serine, and thus provid~ evidence for heterogeneity 
at this position, which have been previously detected in the analysis 
· of peptides· CN-13, CN-14 and CN-15. As would be expected, these 
two peptides have different elution times (Figure 9). Further 
evidence for heterogeneity at position 70 will be given later. 
Peptide Th3-2 (positions 70-77) 
This peptide which arose from the cleavage of the peptide bond 
69 Thr -Ser, provides confirmation of the ability of thermolysin to 
specifically cleave this peptide bond, as established be fore by 
Emmers et al. 0966). 
Peptide Thl-7 (positions 78-88) 
Th . d . . f 7 8 79 d 82 . e 1 ent1t1es o Leu , Leu an Leu were ascerta1ned by sem1-
quantitative amino acid analysis by the dansyl-chloride method and 
by subjecting the peptide to four cycles of degradation by the 
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"Dansyl-Edman" method. 
Peptide Thl-6 (positions 79 to 88) 
. . f 79 d L 82 . b b . . The 1dent1ty o Leu an eu were ascerta1ned y su ]ect1ng the 
peptide to three cycles of degradation by the "Dansyl-Edman" method 
and by semi-quantitative amino acid analysis by the dansyl-chloride 
method. 
Peptide Th4-2 (positions 89-92) 
Peptide Th4-4 (positions 93-96) 
Peptide Th3-6 (positions Th3-6) 
Leu-Val-Thr-Glu-Val-Glu-~-Asn 
97 The identity of Leu was ascertained by N-terminal analysis by the 
dansyl-chloride method. 
Peptide Th3-4 (positions 98-104) 
Peptide Th5-1 (positions 105-107) 
Leu-Ala-Thr 
-----
105 The identity of Leu was ascertained by N-terminal analysis by the 
dansyl-chloride method. 
Peptide Th4-7 (positions 108-114) 
85 
108 The identity of Ile was ascertained by N-terminal ·analysis by the 
dansyl-chloride method. 
69 Apart the cleavage of the peptide bond Thr -Ser, the other 
peptide bonds cleaved by the treatment of the ragi trypsin/~ -amylase 
inhibitor with thermolysin were consistent with those previously 
reported ( Matsubara, 19?0; Allen, 1981). Cleavage at the amino 
side of serine residues has been previously reported (Emmens et. al., 
1966) who found the peptide bond Thr99 -ser in pike whale ribonuclease 
to be cleaved by thermolysin. However, as it will be showed later in 
the sequence of the ragi <(-amylase inhibitor, thermolysin seems to be 
able to cleave other X-Ser and not only Thr-Ser peptide bonds. 
3.2.6. Chymotrypsin Digestion 
20 mg of the reduced and carboxymethylated inhibitor was 
used for the chymotrypsin digestion of the inhibitor. The fragments 
were separated on a Biegel P-4 column, equilibrated and eluted with 
0.05M pyridine-acetate buffer, pH 5.4 . The fractions pooled (Figure 
12) were subjected to RP-HPLC. The HPLC chromatograms of fractions 
Chl,Ch2,Ch3,Ch4,Ch5,Ch6,Ch7 and Ch8 are shown in Figures 13,14,15,16,17,18, 
19 and 20. A list of the peptides obtained, together with their elution times 
and positions in sequence is given in Table IX. 
Peptide Ch2-8 (positions 1-14) 
h ' d ' . f I 1 7 12 ' T e 1 ent1t1es o e and Ile were ascerta1ned by semi-quantitative 
amino acid analysis by the dansyl-chloride method and by comparison 
with peptides Th3-7 and Th3-8. The cleavage of the peptide bond 
lO 1 . h' 'd 1 ' 'd Ch3 5 ·(s V 1 Met -A a 1n t 1s pept1 e a so gave r1se to pept1 es - er- a -
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Figure g - Chromatography of the products of the digestion by chymotrypsin of the trypsin/~ -amylase inhibitor 
from seeds of ragi (Indian finger millet, Eleusine coracana Gaertn.) on a Biogel P-4 column (0.8 x 
190c.m) in O.OSM pyridine acetate buffer, pH 5.4 (flow rate 6 ml/h., fraction size 1.4 ml). 
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Figure 13 - RP-HPLC separation of fraction Ch-1 from the chymotrypsin 
digestion of the trypsin/ P..-amylase· inhibitor from the seeds 
of ragi (Indian finger millet, Eleusine coracana Gaertn.) on a C-18 u-
Bondapak colunm (0.5 x 25cm)· with a linear gradient of 70% (v/v) 
acetonitrile. in .0.1% .trifluoracetic acid at a flow .. rat·e of 1.0 ml/~in. 
Fractions which were fully or partially sequenced are numbered. Dotted 
line indicates concentration of acetonitrile. 
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Figure 14 - RP-HPLC separation of fraction Ch-2 from the chymotrypsin 
-
digestion of the trypsin/ «.-amylase inhibitor from seeds of 
ragi (Indian finger millet, Eleusine coracana Gaertn.) on a C-18 p-
Bondapak column (0.5 x 25cm) with a linear gradient of 70% (v/v) 
acetonitrile in 0.1% (v/v) trifluoracetic acid at a flow rate of 1.0 
ml/min. Fractions which were fully or partially sequenced are numbered. 
Dotted line indicates concentration of acetonitrile. 
89 
1.5 20 
s 
~ 
..;t 
...-4 
N 
... 
~ 
... H 
... 
... 
p::: 
~ 
~ 
~ 1. 0 r-~ 
0 
2 4 
3 40 
H 
s 
~ 
f%J (.) 
< 
tl.l 
~ N 
60 
5 
7 
.5 
6 
80 
~~ VJ ~ ~ \~~L 
20 40 60 80 
TIME (min) 
Figure 15 - RP-HPLC separation of fraction Ch-3 from the chymotrypsin 
digestion of the trypsin/ ~-amylase inhibitor from ragi 
seeds (Indian finger millet,.Eleusine coracana Gaertn.) on a C-18 Jl-
Bondapak column (0.5 x 25cm) with a linear gradient of 70% (v/v) 
acetonitrile in 0.1% (v/v) trifluoracetic acid at a flow rate of 1.0 
ml/.min. Fractions which were fully or partially sequenced are numbered. 
Dotted line indicates concentration of acetonitrile. 
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Figure 16 - RP-HPLC separation of fraction Ch-4 from the chymotrypsin 
digestion ·of the trypsin/ ~-amylase inhibitor from ragi 
seeds (Indian finger millet, Eleusine coracana Gaertn.) on a C-18 p-
Bondapak column (0.5 x 25cm) with a linear gradient of 70% (v/v) 
acetonitrile in 0.1% (v/v) trifluoracetic acid at a flow rate of 1.0 
ml/min. Fractions which were fully or partially seuqenced are numbered. 
Dotted line indicat~ concentration of acetonitrile. 
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Figure 17 - RP-HPLC separation of fraction Ch-5 from the chymotrypsin 
digestion of the trypsin/<( -amylase inhibitor from ragi 
seeds (Indian finger millet, Eleusine coracana Gaertn.) on a C-18 p-
Bondapak colunm (0,.5 x 25cm) with a linear gradient of 70% (v/v) 
acetonitrile in 0.1% (v/v) trifluoracetic acid at a flow rate of 1.0 
ml/min. Fractions which were fully or partially sequenced are numbered. 
Dotted line indicate5concentration of acetonitrile. 
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Figure 18 - RP-HPLC separation of fraction Ch-6 from the chymotrypsin 
digestion of the trypsin/ d.. ·amylase inhibitor from ragi 
seeds (Indian finger millet, Eleusine coracana Gaertn.) on a C-18 p-
Bondapak column (0.5 x 25cm) with a linear gradient of 70% (v/v) 
acetonitrile in 0~1% (v/v) trifluo~acetic acid at a flow rate of 1.0 
ml/min. Fractions which were fully or partially seuqenced are numbered. 
Dotted line indicates concentration of acetonitrile. 
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Figure 19 - RP-HPLC separation of fraction Ch-7 from the chymotrypsin 
digestion of the trypsin/ ~-amylase inhibitor from ragi 
seeds (Indian finger millet, Eleusine coracana Gaertn.) on a C-18 p-
Bondapak column (0.5 x 25cm) with a linear gradient of 70% (v/v) 
acetonitrile in 0.1% (v/v) trifluoracetic acid at a flow rate of 1.0 
ml/min. Fractions which were fully or partially sequenced are numbered. 
Dotted line indicates concentration of acetonitrile. 
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Figure 20 - RP-HPLC separation of fraction CH-8 from the chymotrypsin 
digestion of the trypsin/ ol-amylase inhibitor from ragi 
seeds (Indian finger millet, Eleusine coracana Gaertn.) on a C-18 p-
Bondapak column (0.5 x 25cm) with a linear gradient of 70% (v/v) 
acetonitrile in 0.1% (v/v) trifluoracetic acid at a flow rate of 1.0 
ml/min. Fractions which were fully or partially sequenced are numbered. 
Dotted line indicates concentration of acetonitrile. 
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Table IX - Peptides obtained by the digestion with chymotrypsin, of the 
trypsin/ ~-amylase inhibitor from seeds of ragi (Indian finger 
millet, Eleusine coracana Gaertn.) 
Peptide No. 
and Position 
in Sequence 
Chl-1 
Ch2-1 
Ch2-2 
Ch2-3 
Ch2-4 
Ch2-5 
Ch2-6 
Ch2-7 
Ch2-8 
Ch3-l 
Ch3-2 
Ch3-3 
(94~122) 
(80-93) 
(80-93) 
(79-93) 
(29-40) 
(55-63) 
(55-63) 
(24-40) 
(1-14) 
(70-18) 
(41-48) 
(24-35) 
Elution 
77 
38 
41 
47 
49 
51 
53 
55 
58 
29 
33 
34 
· Sequence 
Ala-~-~-Leu-Val-Thr-~-~-~-EI!-Asn­
~-~ -.'!E,::-.!J..!-!!!!.-£!l_-Gl_l-~-Phe- Cys-Leu-
Ser-Leu-Leu-Gly-Ala-Gly-Glu 
Arg-Ala-Phe 
Arg-Ala-Phe 
Gln-Arg-Ala-Phe 
~-Q!y-Val-Ql.!-~-Ar ,g,-~-,&!-!!!.!:-G ln -Q12.-
Met 
~-Ar~-~-lli-fu-Y!l-Arg-Ile-Leu 
~-Ar,g,-m-Glu-fu-Val-Arg-_!.k-Leu 
.Y!!.-~-:!:h.!:-Ar _g-.Th.E-~ -Qh-.Y!!_-Q.!y-IE£-Arg-
Leu-Ala-Thr-Gln-Glu-Met 
----
Ile-Pro-His 
LJ:s-fu-Arg-~-~-Arg-Gln-Leu 
Val-Ala-Lvs-Arg-Ala-Cys-Gly-Val-Gly-Pro-Arg-__ ;;;;;.a.,;;;.. ______ _ 
Leu 
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Table IX - (Cont.) 
Peptide No. Elution 
and Position Time Sequence 1n Sequence 
Ch3-4 (11-17) 47 Ala- Ile-Pro-His -Asn-Pro-Leu 
Ch3-5 (1-10) 53 Ser-.Y!!.-QU.-1.}:!£-~-~-Ile-~-lli-Met 
Ch3-6 ( 114-122) 54 ~-~-~-~-~-Q.!y-fu-Gly-Glu 
Ch3-7 ( 11-23) 61 ~-,lli-~-His-~-Pro-~-Asp-~-~-Arfl.-
Tr.£_-Tyr 
Ch4-1 (35-41) 33 Leu-fu-lh.!,-.Q!.!!,-G1u-Me t-Lys 
Ch4-2 (42-48) 35 fu-Arg-~-~-Arg-G1n-Leu 
Ch4-3 (23-35 ) 39 Tyr-~-~-.:!h.!:-Arg-.'!h!:-~-lli-.Y!!,!-.-fu-Pro-
Ar~-Leu 
Ch4-4 (49-54) 42 ~-A!!-.!_k-!2£-fu-Tvr 
Ch5-1 (27-35) 26 Arg-~-2-fu_-.Y!!.- G1y-~-Arg-Le~ 
ChS-2 ( 11-14) 28 A1a-Ile-Pro-His 
-----
ChS-3 ( 64- 78) 44 ~-Asp-lli-.Y.!!_-Y!!_-I!l!:- Ser-~-G1y-G1n-His-
~-£!1_- Arg-Leu 
Ch6-1 (24-28) 10 Va1-Ser-Thr-Arg-~ 
Ch6-2 (114-117) 14 SE-~-Ser-Leu 
Ch£- 3 (91-97) 29 Arg-A1a-~-_lli-.E!2_-~-Leu 
Ch6-4 (18-23) 41 Asp-~-~-Arg-TrE_-Tyr 
Ch6-5 (15:-22) 55 Asn-.E!2_-~-Asp-Ser-~-Arg-Trp 
Ch7-1 ( 110-113) 35 G1y-Q!y_-Pro-Phe 
Ch8-1 <18-23) 41 Asp- Ser-~-Arg-Trp-Tyr 
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Gly-Thr-Ser-Cys-Ile-Pro-Gly-Met) and ChS-2 (Ala~Ile-Pro-His). 
Peptide Ch3-7 (positions 11-23) 
The sequencing of this peptide by the DABITC/PITC double coupling 
method Went Unt1. 1 Trp22 Tyr23 1 d b . . h . d was p ace y compar1son w1t pept1 es 
Ch6-4 and Ch8-l and also by semi-quantitative amino acid analysis by 
the dansyl-chloride method. The cleavage of the peptide bond 
17 Leu -Asp in Ch3-7 also gave rise to peptides Ch3-4 (Ala-Ile-Pro-His-
Asn-Pro-Leu) and Ch6-4 and Ch8-l (~sp-Ser-Cys-Arg-Trp-Tyr). The 
treatment of peptides Ch3-7, Ch6-4 and Ch8-1 with the Erlich reagent, 
confirmed the presence of tryptophan in it. 
Peptide Ch6-S (positions 15-22) 
Asn-~-Leu.:.Asp-Ser-~-Arg-Trp 
The identity of Leu17 was ascertained by semi-quantitative am1no acid 
analysis by the dansyl-chloride method and by subjecting the peptide 
to two- cycles of degradation by the "Dansyl-Edman" method. The 
presence of tryptophan in this peptide was confirmed by the Erllich 
reaction. 
Peptide Ch4-3 (positions 23-35) 
·Peptide Ch2-7 (positions 24-40) 
The cleavege of the peptide bond Thr28-cys gave rise to peptides Ch6-1 
(Val-Ser-Thr-Arg-Thr) and Ch2-4 (Cys-Gly-Val-Gly-Pro-Arg-Leu-Ala-Thr-
Gln-Glu-Met). The identity of Leu35 was ascertained by semi-quantitative 
amino acid analysis by the dansyl-chloride method and by comparison 
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with peptides Th4-3 and Ch4-l. 
Peptide Ch3-3 (positions 24-35) 
Peptide Ch5-l (positions 27-35) 
Peptides Ch2-7, Ch3-3 and Ch5-l once more provide 
·confirmation for the·heterogeneity at positions 25 (Ser/Ala), 26 
(Lys/Thr) and 28 (Thr/Ala), which have been indicated before by 
peptides CN-13, CN-14, CN-15, Thl-1 and Thl-2. 
Peptide Ch4-l (positions 35-41) 
~-fu- .:!1!.!-Qb:t. -G lu-~-Lys 
35 The identity of Leu was ascertained by N-terrninal analysis by the 
dansyl-chloride method. 
Peptide ~ (positions 41-48) 
Lys- Ala- Arg-~- Cy_s- Arg-Gln- Leu 
Peptide Ch4-2 (positions 42-48 
Ala-Arg-~-~-Arg-Gln-Leu 
Pertide Ch4-4 (positions 49-54) 
Glu-fu- I le-Pro- Ala-Tyr 
'd . f 1 51 . db . . . . 'd The 1 ent1ty o I e was ascerta1ne y sem1-quant1tat1ve am1no ac1 
analysis and by comparison with peptides Thl-8 and Th3-10. 
Peptides Ch2-5 and Ch2-6 (positions 55-63) 
The identity of Ile62 and Leu63 was ascertained by comparison with peptides 
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Thl-5 and Th4-S, and by the specificity of chymotrypsin. 
Peptide ChS-3 (positions 64-78) 
Peptide Ch3-l (positions 70-78) 
Peptide Ch2-3 (positions 79-93) 
~-Gln-As£-:-~-Pro-~-~-~-Arg.:QlE,-~-Gln-Arg-Ala-Phe 
Th . d . . f L 79 d L 82 . d b . . . e 1 en~1t1es o eu an eu were ascerta1ne y sem1-quant1tat1ve 
am1no acid analysis by the dansyl-chloride method, by N-terminal 
analysis by the dansyl-chloride method and by comparison with peptides 
Thl-6. 
Peptide Ch2-l and Ch2-2 (positions 80-93) 
. d . .f 82 . d b . . . . 'd The 1 ent1ty o Leu was ascerta1ne . y sem1-quant1tat1ve am1no ac1 
analysis by the dansyl-chloride method. 
Peptide Ch6-3 (positions 91-97) 
Arg-~-~-lli-~-~-Leu 
Peptide Ch6-3 arose from an anomalous chymotryptic cleavage at the 
. b 90 Th . . f 97 . d b pept1de ond Gln -Arg. e 1dent1ty o Leu was ascerta1ne y 
semi-quantitative amino acid analysis by the dansyl-chloride method. 
Pe£tide Chl-1 (positions 94-122) 
Gly-Gly-Pro-~-Cys-Leu-Ser-Leu-Leu-Gly-Ala-Gly-Glu 
. . 97 lOS 108 114 116 L 117 The 1dent1ty of Leu , Leu ,Ile ,Leu ,Leu and eu , were 
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ascertained by compar~son with peptides Th3-6, Th5-l, Th4-7 and 
Ch3-6. 
Peptide Ch7-l (positions 110-113) 
Peptide Ch6-2 (positions 114-117) 
~-~-Ser-Leu 
115 117 . The identities of Leu and Leu were ascerta~ned by semi-quantitative 
amino acid analysis by the dansyl-chloride method. 
Peptide Ch3-6 (positions 114-122) 
. . . f L 115 117 d L 118 . d b . The ~dent~t~es o eu ,Leu an eu were ascerta~ne y sem~-
quantitative amino acid analysis by the dansyl-chloride method and by 
subjecting the peptide to four cycles of degradation by the "Dansyl-
Edman" method. 
3.2.7. Sub-Digestion of Peptides CN-13, CN-14 and CN-15 with Chymotrypsin 
During the analysis of the peptides obtained from the 
hydrolysis of the ragi trypsin/ tt. -amylase inhibitor with chymotrypsin 
no confirmation of the previously observed heterogeneity at position 70 
(Pro/Ser) was obtained. In an attempt to find this confirmation, the 
C-terminal CNBr fragment (CN-13, CN-14 and CN-15, Figure 6) was 
subdigested with chymotrypsin. The fragments were purified directly 
by RP-HPLC (Figure 21). As can be seen ~n Table X, no peptides were 
found which could confirm the findings of the analysis of the 
thermolysin fragments. Instead, evidence was found for a 
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Figure ~ - RP-HPLC separation of peptides obtained by the digestion with 
chymotrypsin of the CNBr C-terminal peptide of ~~e trypsin/ 
~-~my1ase inhibitor from seeds of ragi (Indian finger millet, Eleusine 
coracana Gaertn.). The peptides were separated on a c~l8 p-Bondapak 
column (0.5 x 25cm) with a linear gradient of 70% (v/v) acetonitrile in 
0.1% (v/v) trifluoracetic acid at a flow rate of l.O.ml/min. Fractions 
corresponding to peptides which were fully or partially sequenced are 
numbered. Dotted line indicatesconcentration of acetonitrile. 
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Table X- Peptides obtained by the digestion.by chy~otrypsin of the 
CNBr· C-terminal fragment of the trypsin/ .c -amylase inhibitor 
from seeds of ragi (Indian finger millet, Eleusine coracana Gaertn.) 
Peptide No. Elution 
and Position Time in Sequence 
CN-Chl ( 114-115) 16 
CN-Ch2 (65-69) 22 
CN-Ch3 (119-122) 
CN-Ch4 (80-93) 38 
CN-ChS (70-79) 41 
CN-Ch6. (80-931 42 
CN-Ch7 ( 80-9 3) 43 
CN-Ch8 (108-113) 44 
CN-Ch9 (106-113) 47 
CN-ChlO ( 114-122) 51 
CN-Ch11 (94-105.) 65 
CN-Ch12 (94-105) 68 
CN-Chl3 (94-105) 69 
CN-Chl4 (94-105) 71 
Sequence 
Arg-Ala-Phe 
Arg-Ala-Phe 
Arg-Ala-Phe 
I le-~-.£!r ~-f!.2.-Phe 
~-~-~-~-Val-Thr-Glu-Val-Glu-~-Asn-Leu 
&!!-Pro-Lys -Leu-Val-Th r-Glu-.Y!l-Glu-~-Asn-Leu 
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microheterogeneity at position 83. Two peptides (CN-Ch4 and CN-Ch6) 
were sequenced and differ from one another only at position 83 (alanine 
in CN-Ch4 and proline in CN-Ch6). 
The treatment of the inhibitor and its C-terminal CNBr 
fragment with chymotrypsin led to the expected cleavages at the 
carboxyl side of tyrosine, phenylalanine, methionine and leucine. 
Also observed were cleavages at threonine, glutamine, and histidine 
residues. Such cleavages at threonine, glutamine and histidine residues 
have often been observed previously (Croft, 1980). In addition 
some hydrolysis of the Arg-X and Lys-X peptide bonds was observed. 
34 41 . (e.g. Arg -Leu and Lys -Ala), wh1ch was probably due to the 
contamination of the chymotrypsin preparation utilised by trypsin. 
These "anomalous" cleavages illustrate the difficulty in predicting 
accurately the sites of chymotrypsin cleavage, since it depends 
upon factors outside the immediate environment of the bond cleaved 
(Kaspar, 1970). 
3.2.8. Staphylococcus aureus (Strain V-8) Protease Digestion 
10 mg of the reduced and carboxymethylated ragi trypsin/ 
~-amylase inhibitor was digested with the V-8 protease, under 
the conditions described in Section 2.2.6.3.4. The fragments were 
separated on a Biogel P-4 column, equilibrated with 0.05M pyridine-
acetate buffer, pH 5.4 . The peptides eluted from the column were 
monitored by measurement of theabsorbance of each tube collected at 
280nm (Figure 22). Further purification was achieved by applying 
each peak from the Biogel column to RP-HPLC. The chromatograms of 
the RP-HPLC separation of peaks 2,3,4,5,6, and 7 are shown 1n 
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Figures 23, 24, 25, 26, 27 and 28. The sequences, elution time and 
positions in the sequence of the peptides obtained are presented 
in Table XI. 
Peptide V2-l (positions l-3:1t) 
~-Val-~-!hE-Ser-~-~-~-Q!l-Met-Ala-Ile-Pro-His-Asn-Pro-
Leu-Asp-Ser-Cys-Arg-Trp-Tyr-Val-Ser-Thr-Arg-Thr-Cys-Gly-Val-Gly-
Pro-Arg 
The identity of lle 7 was ascertained by compar1son with peptide Th3-7. 
Peptide ~ (positions 35-39) 
Leu-Ala-Thr-Gln-Glu 
------
Peptide V5-l arose from an anomalous cleavage at the peptide bond 
34 
· d · f L 35 . d b N . 1 1 . Arg -Leu. The 1 ent1ty o eu was ascerta1ne y -term1na ana ys1s 
· by the dansyl-chloride method. 
Peptide VS-4 (positions 40-46) 
Met-~-~-Ar~-~-~-Arg~Gln-Leu-Glu 
Peptide V4-l (positions S0-58) 
The identity of Ile 51 was ascertained by semi-quantitative amino acid 
analysis by the dansyl-chloride method and by comparison with peptides 
Thl-6 and Th3-10. 
Peptide ~ (positions 59-65) 
&-M-Arg-lli-Leu- Met- Asp 
The identities of Ile62 and Leu63 were ascertained by co~arison with 
peptides Th4-S and Thl-5. 
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Figure 23 - RP-HPLC separation of fraction V-2 from the Staphylococcus 
aureus (strain V-8) protease di~estion of the trypsin/ oC.-
amylase inhibitor from ragi seeds (Indian finger millet, Eleusine 
coracana Gaertn.) on a C-18 p-Bondapak column (0.5 x 2Scm) with a 
linear gradient of 70% (v/v) acetonitrile in 0.1% (v/v) trifluoracetic 
acid at a flow rate of 1.0 ml/min. Fractions which were fully or 
partially sequenced are numbered. Dotted line indicates concentration 
of ace toni tri le. 
e 
~ 
""'" 
..-1 
N 
~ 
~ 
gj 
0 
t/) 
~ 
. 75 
.so 
.25 
.. 
.. 
.. 
20 
.. 
.. 
...... 
. ..... 
........ 
.. .. 
1 .... 
... .. 
40 60 
TIME (min) 
... .... 
.. 
.. 
.. 
.. 
.. 
.. 
80 
107 
60 
80 
Figure 24 - RP-HPLC separation of fraction V-3 from the Staphylococcus 
aureus (strain V-8) protease digestion of the trypsin/«.-
amylase inhibitor from ragi seeds (Indian finger mit let, Eleusine 
coracana Gaertn.) on a C-18 u•Bondapak column (0.5 x 25cm) with a 
linear gradient of 70% (v/v) acetonitrile in 0.1% (v/v) trifluoracetic 
acid at a flow rate of 1.0 ml/min. Fractions which were fully or 
partially sequenced are numbered. Dotted line indicates concentration 
of acetonitrile. 
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Figure 25 - RP-HPLC separation of fraction V-4 from the Staphylococcus 
aureus (strain V-8) protease digestion of the trypsin/«.-
amylase inhibitor from ragi seeds (Indian finger millet, Eleusine 
coracana Gaertn.) on a C-18 p-Bondapak colurrm (0.5 x 25 em) with a 
linear gradient of 70% (v/v) acetonitrile in 0.1% (v/v) trifluoracetic 
acid at a flow rate of l.o ml/min. Fractions which were fully or 
partially sequenced are numbered. Dotted line indicates concentration 
of a·cetoni trile. 
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Figure 26 - RP-HPLC separation of fraction V-5 from the Staphylococcus 
aureus (strain V-8) protease digestion of the trypsin/ ~-
amylase inhibitor from ragi seeds (Indian finger millet, Eleusine 
coracana Gaertn.) on a C-18 ~-Bondapak column (0.5 x 25cm) with a 
linear gradient of 70% (v/v) acetonitrile in 0.1% (v/v) trifluoracetic 
acid at a flow rate of 1.0 ml/min. Fractions which were fully or 
partially sequenced are numbered. Dotted line indicates concentration 
of acetonitrile. 
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Figure 27 - RP-HPLC separation of fraction V-6 from the Staphylococcus 
aureus (strain V-8) protease digestion of the trypsin/~-
amylase inhibitor from ragi seeds (Indian finger millet, Eleusine coracana 
Gaertn.) on a C-18 p-Bondapak column (0.5 x 25 em) with a linear 
gradient of 70% (v/v) acetonitrile in 0.1% trifluoracetic acid at a 
flow rate of 1.0 ml/min. Fractions which were fully or partially sequenced 
are numbered. Dotted line indicates concentration of acetonitrile. 
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Figure 28 - RP-HPLC separation of fraction V-7 from the Staphylococcus 
aureus (strain V-8) protease digestion of the trypsinl~­
amylase inhibitor from ragi seeds (Indian finger millet, Eleusine coracana 
Gaertn.) on a C-18 p-Bondapak column (0.25 x 2Scm) with a linear 
gradient of 70% (v/v) acetonitrile in 0.1% (v/v) trifluoracetic acid 
at a flow rate of 1. 0 ml/min. Fractions which were fully or partially 
sequenced are numbered. Dotted line indicates concentration of 
acetonitrile. 
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Table XI - Peptides obtained by the digestion of the trypsin/ ct -amylase 
inhibitor from the seeds of ragi (Indian finger millet, 
Eleusine coracana Gaertn.) with the Staphylococcus aureus (strain V-8) 
protease. 
Peptide No. 
and Position 
in Sequence 
V2-l (1- 34) 
V3:...L (82-100.) 
V4-l (50-58) 
V5-l (35-39) 
V5-2 (66-75) 
V5-3 (66-75) 
V5-4 (40-49) 
V6-l (66-75) 
V6-2 (76- 81) 
V7-l (59-65) 
Elution 
Time 
71 
59 
44 
22 
28 
32 
39 
28 
38 
51 
Sequence 
Ile-Pro-His-Asn-Pro-His-Asn-Pro-Leu-Asp-Ser-
Cys-Arg-Trp-Tyr-Val-Ser-Thr-Arg-Thr-Cys-Gly-
Pro-Arg 
~-Ala-Q!x.-.2-~-Arg-Gln-.Y2l-Gln-Arg-Ala-
Phe~Ala-Pro-Lys-Leu-Val-Thr-Glu 
Ala-~-.!2£-~-Tyr-~-Ar_g-~-Glu 
Leu-Ala-Thr-Gln-Glu 
-----
Gly-Val-M-Thr- Ser- Ser-Q!x,-Gln-His-Glu 
Glx_-~-.Y.!!, -:!'E.!:-!!:£- Se r-£!z_-.Qltl-His- Glu 
Met-~-,&-Ar g-~-.fi!.-Arg-Gln-Leu-Glu 
Q!z_-.Y.!!_-.Y.!!.-Thr-~-~-&-~-His-Glu 
Gly-Arg;.~-Leu-~-Aso 
Ala-Val-Arg-Ile-~-~-Asp 
.-.J--
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Peptides V5-2 ~ V6-1 (positions 66-75) 
Gly-Val-Val-Thr-Ser-Ser-Q!r:-Ql!!-His-Glu 
Peptide V5-3 (positions 66-75) 
Peptides V5-2, V6-l and V5-3 provide evidence for 
heterogeneity as position 70, as evidenced before with peptides CN-13, 
CN-14, CN-15, Thl-1 and Thl-2. As would be expected, peptides V5-2 and 
V5-3 have different elution times (Figure 26, Table XI). 
Peptide V6-2 (positions 76-81) 
T . d . . f 7 8 d 1 79 . d b . . . he ~ ent~t~es o Leu an eu were ascerta~ne y sem~-quant~tat~ve 
amino acid analysis by the dansyl-chloride method. 
Peptide ~ (positions 82-100) 
Leu-~-~-~-P~o-Arg-~-~-Gln-Arg-Ala-Phe-Ala-Pro-Lys-Leu-
Val-Thr-Glu 
Peptide V3-1 provides additional evidence for heterogeneity at position 
83.This position is occupied by proline in peptides Thl-6, Thl-7, Ch2-3 
and by alanine in peptides CN-Ch4 and V3-l. 
3.2.9. Sub-Digestion of Peptide CN-Tll with Staphylococcus aureus 
(Strain V-8) Protease 
On examination of the results obtained from the digestion 
of the whole protein with the V-8 protease, it was apparent that some 
peptides expected to be derived from the C-terminal region of the 
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protein were not recovered. In order to obtain them, peptide CN-Tll 
obtained from the digestion of the C-terminal CNBr fragment (CN-13, 
CN-14 and CN-15 - see Figure 6 and Table VII) with trypsin (see 
Section 3.2.11.1 and Figure 31), was sub-digested with V-8 protease. 
The resulting fragments were separated through RP-HPLC (Figure 29). 
The sequences, elution times and positions in the sequence of the 
peptides obtained are shown in Table XII. 
Peptide CN-Tll-V2 (positions 97-100) 
Leu-Val-Thr-Glu 
-----
The identity of Leu97 was ascertained by N-terminal analysis by the 
dansyl-chloride method. 
Pe£tide CN-Tll-V1 (positions 101-102) 
Val-Glu 
~
Peptide CN-T11-V4 (positions 103-122) 
~-~-~-Ala-.!.b!-Ile-His-~-~-~-~-2-Leu-Ser-Leu-Leu-
Gly-A1a-Gly-G1u 
Peptides CN-T11-V3 and.CN-T11-V5 (positions 101-122) 
Leu-Leu-Gly-Ala-Gly-Glu 
. 33 
Apart from the cleavage of the bond Arg -Leu, the enzyme 
specificities observed were consistent with those previously reported 
(Allen, 1981). Cleavage at argjnyl residues by the V-8 protease has 
been previously reported by Richardson et al. (1978) in the ox 
phospholipase A2. 
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Figure 29 - RP-HPLC separation of peptides obtained by the digestion 
·of the peptide CN-T11 (see Figure 31, Table XIV) with 
Staphylococcus aureus (~train V-8) protease. The peptides were separated 
on a C-18 p-Bondapak column (0.5 x 25cm) with a linear gradient of 70% 
(v/v) acetonitrile in 0.1% (v/v) trifluoracetic acid at a flow rate of 
1.0 ml/min. Fractions which were fully or partially sequenced are 
numbered. Dotted line indicates concentration of acetonitrile. 
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Table XII - Peptides obtained by the digestion of peptide CN-T11 with 
Staphylococcus aureus (strain V-8) protease· 
Peptide No. 
and Position 
in Sequence 
CN-T-V2 (97-100) 
CN-T-V3 (101-122) 
CN-T-V1 ( 101-102.) 
CN-T-V4 (103-122) 
CN-T-VS (101)122) 
Elution 
Time 
24 
65 
6 
71 
74 
Sequence 
Leu-Va1-Thr-Gl u 
Pto-Phe-~-Leu-Ser-Leu-Leu-Gly-Ala-Gly-Glu 
Val-Gfu 
Cys-Leu-Ser-Leu-Leu-Gly-Ala-Gly-Glu 
~-G1u-.2-~-Leu-fu-Thr-Ile-His-Qh-Q.!I.-
Pro-~-~-Leu-Ser-Leu-Leu-Gly-Ala-Gly-Glu 
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3.2.10. Proline-Specific Endoproteinase Digestion of the~ C-Terminal 
Fragment 
1 mg of pooled fragments· CN-13, CN-14 and CN-15 (see Figure 
6, Table VII) was sub-digested with proline-specific endoproteinase, 
under the conditions described in Section 2.2.6 .3.5. The peptides 
produced were separated by RP-HPLC (Figure 30). The sequences, elution 
times and positions in the sequence of the peptides obtained are 
presented in Table XIII. 
Peptide ~ (positions 65-76) 
Peptide CN-Pl3 (positions 77-83) 
Th . d . . f 78 79 82 . . . e ~ ent~t~es o Leu :Leu ,Leu were ascerta~ned by sem~-quant~tative 
amino acid analysis by the dansyl-chloride method and by comparison 
with peptides Thl-6 and Thl-7. Peptides CN-PlO (Gln-Asp-Leu-Pro) and 
CN-P7 (Leu-Gln-Asp-Leu-Pro) were products of the cleavage of the 
78 79 peptide bonds Leu -Leu and Leu -Gln in peptide CN-Pl3. 
Peptide CN-Pl (positions 84-86) 
Peptide CN-P2 (positions 87-92) 
Peptide CN-Pl2 (positions 96-107) 
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' Figure 30 - RP-HPLC separation of peptides obtained by the digestion of 
the CNBr C-terminal ·peptide of tbe trypsin/ :111:: -amylase 
inhibitor from seeds of ragi (Indian finger millett, Eleusine coracana 
Gaertn. )with proline specific endoproteinase on a C-18 p-Bondapak 
column (0:5 x 25cm) with a linear gradient of 70% (v/v) acetonitrile 
·in 0;.1% (v/v) trifluoracetic acid at a flow rate of 1.0 ml/min. Fractions 
corresponding to peptides which were fully or partially sequenced are 
numbered. Dotted line indicatesconcentration of acetonitrile. 
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Table XIII- Peptides obtained by the cleavage wi"th proline specific 
:) . endoproteinase of the CNBr C-terminal fragment. 
Peptide No. Elution 
and Pos1tion Time in Sequence 
Sequence 
CN-Pl (84- 86 11 
CN-P2 (87-92) 12 
CN-P3 (98-102) 15 
CN-P4 (96-99) 28 
CN-P5 (65-76). 30 
Gly 
CN-P6 (93-95) 32 Phe-Ala-Pro 
CN-P7 (80-83) 34 
CN-P8 (100-107) 39 
CN-P9 (99-106) 41 .:!:b.E-Glu-Val-~-~-Asn-Leu-Ala-Thr 
CN-P10 (79-83) 43 
CN-P 11 ( 113- 116) 45 
CN-P12 (96-107) 53 
CN-P13 (77-83) 57 
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Th . d . . f L 97 d L 105 . . . . e 1 ent1t1es o eu an eu were ascerta1ned by sem1-quant1tat1ve 
am1no acid analysis by the dansyl-chloride method and by comparison 
with peptides Th3-6 and Th4-ll. Peptides CN-P4 (Lys-Leu-Val-Thr), 
CN-P8· (Glu-Val-Glu-Cys-Asn-Leu-Ala-Thr) and CN-~9 (Thr-Glu-Val-Glu-
Cys-Asn-Leu-Ala-Thr) were products of the cleavage of the peptide 
bonds Thr99-Glu and Val 98-Thr. 
Peptide CN-P3 (positions 108-112) 
108 The identity of Ile was ascertained by N-terminal analysis by the 
dansyl-chloride method, and by semi-quantitative amino acid analysis 
by the dansyl-chloride method. 
Peptide CN-Pl1 (positions 113-116) 
The identity of Leu 115 was ascertained by semi-quantitative am1no 
acid analysis by the dansyl-chloride method. 
The specificity of the proline-specific endoproteinase was 
not as expected (Yoshimoto et al., 1980) in that in addition to cleavage 
of Pro-X and Ala-X peptide bonds, "anomalous" cleavages of Gly-X, Thr-X, 
Ile-X and Leu-X peptide bonds were also observed (Table XIII). 
3.2.11. TrXPsin Digestion 
3.2.1.1. Trypsin Digestion of the C-Terminal CNBr Fragment 
Fragments CN-13, CN-14 and CN-15 from the CNBr cleavage of 
the inhibitor (see Figure 6 and Table VI!J , were pooled and subjected 
I 
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to digestion with trypsin under the conditions described·in Section 
2.2.6.3.1. The resulting fragments were separated by RP-HPLC (Figure 
31). In Table XIV the sequences, elution times and positions in the 
sequence of the peptides obtained are presented. . 
Peptide CN-TS (positions 47-56) 
. d . . f L 48 d Il Sl . d b . . h The 1 ent1ty o eu an e were ascerta1ne y compar1son w1t 
peptides Thl-8 and Th3-10 and by subjecting the peptide to four 
cycles of degradation by the "Dansyl-Edman" method. 
Peptide CN-Tl (positions 57-61) 
Peptides CN-TS and CN-T1 indicated that the CNBr C-terminal 
fragment used for this digest was contaminated with the fragments 
CN-8, CN-9, CN-10, CN-11 and CN-12 (which correspond to residues 
41 to 64), or alternatively, indicates that the cleavage by CNBr of 
the peptide bond Met 64-Asp was not complete, and thus in the preparation 
used for the digestion, in addition to the CNBr C-termina1 fragment 
(residues 65 to 122) there was an additional peptide corresponding 
to positions 41 to 122. 
Peptide CN-T2 (positions 65 to 77) 
Peptide CN-T4 (positions 78-87) 
The identities of 78 79 82 Leu , Leu and Leu were ascertained by sem1-
quantitative amino acid analysis by the dansyl-ch1oride method. 
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Figure 31 - RP-HPLC separation of the peptides obtained by the digestion 
of the CNBr C-terminal fragment of the trypsin/ «-amylase 
inhibitor from seeds of ragi (Indian finger millet, Eleusine coracana 
Gaertn.) with trypsin. The peptides were separated on a C-18p-Bondapak 
column (0.5 x 25cm) with a linear gradient of 70% (v/v) acetonitrile 
in 0.1% (v/v) trifluoracetic acid at a flow rate o·f 1.0 ml/min. 
Fractions corresponding to peptides which were fully or partially 
sequenced are numbered. Dotted line indicate~concentration of acetonitrile. 
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Table XIV - Pepti~es obtained by the digestion by. trypsin of the CNBr 
C-terminal fragment of the trypsin/~ -amylase inhibitor 
from·seeds of ragi (Indian finger millet, Eleusine coracana Gaertn.) 
Peptide No. 
and Position 
in Seguence 
CN-T1 
CN-T2 
CN-T3 
CN-T4 
CN-T5 
CN-T6 
CN-T7 
CN-T8 
CN-T9 
CN-TlO 
CN-Tll 
CN-T12 
(57-61) 
(75-77) 
(92-96) 
(78-87) 
(47-56) 
(78-91) 
( 114-122) 
(97-113) 
(97-113) 
(97-122) 
(97-122) 
(97-122) 
Elution 
Time 
22 
27 
30 
40 
50 
52 
54 
67 
73 
76 
78 
81 
Sequence 
Q.!z_-Arg 
Ala-~-!1!-~-Lvs 
~-~-~-Asp-~-Pro-.Qlx-~-.!I£-Ar:g 
~-Leu-~-_lli-..!,k-Pro-Ala-Tyr-~-Ar:g 
~-Leu-~-Asl?-~-~-g_!z-~-Pro-Arg-£!E_-
Arg 
Cys_~-Ser-~-~-.Q.!z.-Ala-.Q1y-G1u 
~-Val-~-~-Va1-Glu-~-Asn-~-Ala-Thr-
Ile-His-Gly-Gly-Pro-Phe ,. 
~-.Y.2.!,- Th r-~-.Y!!.!_- G lu-~.:.~-Leu-Ala-.!!!.!:-
~-His-Gly-Gly-Pro-Phe 
Leu-.Y_&-I!.t.!.-Q!!!-.Y21.-~-~-~-~-Ala-Thr-
Ile-His-Gly-Gly-Pro-Phe-Cys-Leu-Ser-Leu-Leu-
Gly-Ala-Gly-Glu 
Ile-His-Gly-Gly-Pro-Phe-Cys-Leu-Ser-Leu-Leu-
Gly-Ala-Gly-Glu 
Ile-His-Gly-Gly-Pro-Phe-Cys-Asn-Leu-Ala-Thr-
Ile-His-Gly-Gly-Pro-Phe-Cys-Leu-Ser-Leu-Leu 
Gly-Ala-Gly-Glu 
124 
Peptide CN-T6 (positions 78-91) 
Th . d . f L 78 79 82 . d b . e 1 ent1ty o . eu , Leu and Leu were ascerta1ne y sem1-
quantitative amino acid analysis by the dansyl-chloride method. 
Peptide CN-T3 (positions 92-96) 
Peptides CN-T8 ~ CN-T9 (positions 97-114) 
Leu-Val-Thr-~-Val-Glu-~-Asn-~-Ala-Thr-Ile-His-Gly-Gly-Pro-Phe 
The identity of Leu97 was ascertained by N-terminal analysis by the 
106 109 dansyl-chloride method, and the identity of Leu and Ile were 
ascertained by comparison with peptides th3-6, ThS-1 and Th4-7. 
Peptides CN-TlO, CN-Tll and CN-Tl2 _(positions 97 to 122) 
~-Val-Thr-Glu-Val-Glu-~-Asn-~-~-~-Ile-His-Gly-Gly-Pro-Phe-
Cys-Leu-Ser-Leu-Leu-Gly-Ala-Gly-Glu 
Peptide CN-Tll was sub-digested with Staphylococcus aureus (Strain V-8) 
protease. The results of this sub-digestion were described in 
Secti.on 3. 2. 9. 
Peptide CN-T7 (Positions 114-122) 
Th "d t"t" fL llS L 117 dL 118 . db e 1 en 1 1es o eu , eu an eu were ascerta1ne y semi-
quantitative amino acid analysis by the dansyl-chloride method. 
Peptide CN-T7 arose as the result of an anomalous tryptic 
cleavage at the peptide bond Phe 113-cys. However, as the height of 
the peak indicates (Figure 31) this cleavage seems to have been only 
partial . 
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3.2.1.2., Trypsin Digestion of Catalytic Cleavage Fragment 1 
In order to obtain a better overlapping between positions 
21 .to 34, the catalytic cleavage fragment 1 (CC1), which was shown to· 
be the N-terminal fragment (see Table XVI) was subjected to hydrolysis 
with trypsin, under the conditions described in Section 2.2.6.3.1. 
The way in which this fragment was obtained is fully described 1n 
Section 3.2.12. The fragments obtained were directly separated by 
RP-HPLC (Figure 32). Table XV shows the sequences, elution times and 
positions in the sequence of the peptides obtained. 
Peptides CC1-T3 and CC1-T4 (positions 1-21) 
Asp-Ser-Cys-Arg 
7 12 The ide~tities of Ile and Ile were ascertained by comparison with 
peptides Th3-7 and Th3-8. The identity of Leu 17 was ascertained by 
comparison with peptide ThS-8. 
Peptide CC1-T2 (positions 22-27) 
Pe£tide CC1-T1 (positions 28-34) 
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Fi~re 32 - RP-HPLC separation of peptides obtained by the digestion 
of catalytic cleavage fragment 1 (CCI) with trypsin .. The 
separation was performed on a C-18 u-Bondapak column (0.5 x 25cm) with 
a linear gradient of 70% (v/v) acetonitrile in 0.1% (v/v) trifluoracetic 
acid at a flow rate of 1.0 ml/min. Fractions which were fully or partially 
sequenced are numbered. Dotted line indicates concentration of acetonitrile. 
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Table XV - Peptides. obtained by the cleavage with trypsin of the 
catalytic cleavage fragment 1 (CCl) of the trypsin/ ((-
amylase inhibitor from seeds of ragi (Indian finger millet, Eleusine 
coracana Gae.rtn. ) 
Peptide No. Elution 
and Posit ion Time in Sequence 
Sequence 
CCl-T 1 (28-34) 30 
CC1-T2 (22-27) 45 
CC1-T3 (1-21) 59 
11!-~-His-~-~-Leu-Asp-Ser-Cys-Arg 
CC1-T4 (1-21) 62 
~-Pro-His-~-Pro-Leu-Asp-Ser-Cys-Arg 
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3.2.12. Identification of the Reactive (Trypsin Inhibitory) Sites of 
!E!;_ Trypsin/ ~~~:-Amylase Inhibitor ~ Ragi (Eleusine coracana 
Gaertn.) 
The identification of the reactive (trypsin inhibitory) 
sites of the ragi trypsin/ ((.-amylase inhibitor was performed by 
incubating 5 mg of the native inhibitor with a catalytic amount of 
trypsin (50 ~g) (Ozawa and Laskowski, 1966; Richardson, 1974) for 20 
hours at pH 2.5 The separation of the resulting fragments by RP-HPLC 
(Figure 33) was preceded by the reduction and carboxymethylation of 
the modified inhibitor. Each fragment collected was subjected to 8 
sequencing cycles by the DABITC-PITC double coupling method (Table 
XVI) and the position in the sequence of each of them was unambiguously 
determined. 
The three fragments obtained, which were identified as 
1-34, 35-91 and 92-122, suggest the existence of two reactive sites 1n 
34 
the inhibitor molecule, both having arg1n1ne at position P1 : Arg -Leu 
91 f" d" h . . ( ) . 1 d and Arg -Ala. The 1n 1ng t at the react1ve s1te s 1nvo ve an 
. 
Arg-peptide bond is in agreement with earlier studies by Shivaraj and 
Pattabiraman (1981), which showed that the chemical modification of 
arginine residues by treating the inhibitor with cyclohexane-1,2-dione 
34 led to the almost complete loss of inhibitory activity. The Arg -Leu 
bond corresponds exactly to the position of the reactive site in the 
homologous barley trypsin inhibitor (Odani et al.,l983a) (Figure35) 
In addition both peptide bonds (Arg34-Leu and Arg91-Ala) appear to 
obey the proposed tentative rules for reactive sites (Laskowski and 
Kato, 1980L 
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Figure 33 - RP-HPLC separation of peptides obtained by the cleavage of 
the native trypsin/ ~-amylase inhibitor with trypsin (see 
text for details) on a C-18 u-Bondapak column (.OS x 2Scm) with a 
linear gradient of 70% (v/v) acetonitrile in 0.1% (v/v) trifluoracetic 
acid at a flow rate of 1.0 ml/min.The N-terminal sequence of the peptides 
obtained is given in Table XVI. Dotted line indicates concentration of 
acetonitrile. 
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Table XVI - Peptides obtained by the catalytic cleavage of thr trypsin/ 
ol-amylase inhibitor from ragi seeds (Indian finger millet, 
Eleusine coracana Gaertn.) with trypsin. 
Peptide No. Elution 
and Position Time Sequence in Seguence 
CC-1 (1- 34) 72 Ser Val-Gly-Thr-Ser-Cys-Ile-Pro~ ... 
CC-2 (92-122) 83 Ala-Phe-Ala-Pro-Lys-Leu-Va1-Thr- ••. 
CC-3 (92-122) 87 A1a-Phe-A1a-Pro-Lys-Leu-Va1-Thr- ... 
CC-4 (35-91) 90 Leu-A1a-Thr-G1n-G1u~Met-Lys-Ala- ... 
CC-5 (35-91) 92 Leu-Ala-Thr-G1n-Glu-Met-Lys-A1a- ... 
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Based on the elution of the enzyme-inhibitor complex from 
a Biegel P-200 column, Shivaraj and Pattabiraman (1981) suggested the 
formation of a 1·: 1 molar complex between the trypsin/~ -amylase inhibitor 
and trypsin. Also, based on the same sort of experiment, they suggested 
that the inhibitor can bind simultaneously to trypsin and ~-amylase, 
thus implying that the ~-amylase inhibitory site is independent of 
the trypsin inhibitory site. Following the determination of the 
existence of two reactive (trypsin inhibitory) sites in the rag1 
trypsin/ t1. -amylase inhibitor, attempts were made to determine 
through kine·tic experiments, the molar ratio of the inhibitor/trypsin 
complex. As shown in Figure 34, the suggestion of Shivaraj and 
Pattabiraman (1981) of a 1:1 molar complex is confirmed. 
The formation of a 1:1 molar complex between the trypsin/ 
d.-amylase inhibitor and trypsin is in apparent contradiction with the 
possible existence of two reactive (trypsin inhibitory) sites 1n the 
inhibitor molecule, as it would be expected that each inhibitory site 
would bind, simultaneously and independently, to one molecule of 
trypsin. The existence of more than one reactive site in the same 
inhibitor molecule is quite common among protein inhibitors of 
proteinases (Richardson, 1977, 1980, 1981; Laskow$ki and Kato, 1980; 
Ryan, 1981), and in all cases so far studied each reactive site can 
bind independently and simultaneously, to the enzyme they inhibit. 
Thus, the ragi trypsin/~ -amylase inhibitor seems to be the first 
example of an inhibitor with two distinct but overlapping reactive 
sites, where possibly steric hindrance prevents association with two 
molecules of trypsin. 
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Figure 34 - Inhibition of trypsin by ragi trypsin/~ -amylase inhibitor. 
A fixed amount of bovine trypsin .was mixed with increasing 
amounts of the inhibitor, and the residual trypsin activity was 
measured using BAPNA as substrate (see text for details). 
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The complete amino acid sequence of the ragi trypsin/ cc -
amylase inhibitor is shown in Figure 35. The protein consists· of 122 
amino acids which corresponds to a molecular weight of 13300, which 1s 
1n good agreement with the molecular weight calculated from SDS-
polyacrylamide gel electrophoresis. The sequence presented in Figure 
35 is also in good agreement with the amino acid composition of the 
inhibitor (see Table VI). 
The inhibitor was also shown to be heterogeneous at positions 
25, 26, 28, 70 and 83. In most cases the variantforms were isolated 
and sequenced separately, thanks to the resolving power of the RP-HPLC 
system utilised, which is very sensitive to slight changes in the 
hydrophobicity character of the peptides being separated; the only 
exceptions were the large peptides with minor (single) changes (e.g. 
CN-13, CN-14 and CN-15) where such peptides were not resolvedoRegarding 
the heterogeneities detected in the sequence of the ragi trypsin/ d. -
amylase inhibitor,~is worth noting that the replacements Ala/Ser, Ala/ 
Thr and Pro/ Ala are the most frequently observed amino acid,:replacements 
in proteins (Doolitle, 1979). 
All the amino acids in the sequence were unambiguously 
identifiedo As it is difficult t~ identify leucine and isoleucine by 
the DABITC-PITC double coupling method alone, these residues were also 
identified by semi-quantitative amino acid analysis, by N-terminal 
analysis or by subjecting the relevant peptide to a few degradative 
cycles of the "Dansyl-Edman" method, or to a combination of these three 
methods. The spe-cificity of cleavage by chymotrypsin was also helpful 
in confirming the identity of certain leucine residues. Also the 
identification of aspartic acid/asparagine and glutamic acid/glutamine 
residues was unambiguous. Although during the DABITC-PITC double 
Figure 35 The complete amino acid sequence of the bifunctional trypsin/ ~-amylase inhibitor. 
T = tryptic pep tides, C = chymotryptic pep tides, Th "' thermolysin pep tides·; .· 
V "' Staphylococcus aureus (strain V-8) peptides, CN "' peptides resulting from 
digestion with CNBr, CC = catalytic cleavage peptides. ( ) peptide sequenced by 
the DABITC-PITC double coupling method and/or the dansyl-Edman method; (:-- -) 
regions of peptides which were not sequenced or gave unsatisfactory results. 
10 20 30 40 50 60 
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I LE ·LEU-MET ·ASP-GL Y·VAL -IAL· THR-~·SER·GLY·GLN·HIS· GW·GL Y·ARG ·LEU·LEU-GLN·ASP·LEU -~ ·GLY ·CYS·PRO- ARG· GLN- VAL ·GLN·ARG·ALA· PHE·ALA·PRO ·L YS·LEU·VAL • THR·GLU·VAL·GLU·CYS·ASN·LEU·ALA·THR ·I LE ·HIS·GLY-GL Y·PRO·PHE·CYS·LEU-SER·LEU·LEU·GLY·ALA·GLY·GLU 
Th 1-3 Th 1-7 Th4·2 Th 4-4 Th 3-6 ThS-1 Th 4-7 Th 5-6 
Th3-4 
Th 4-5 Th1-1 Th1-2 Th1-4 Th 1-6 
Th 1-5 Th 3-2 Ch 6-3 Ch7-1 Ch 3-6 
Ch 5-3 Ch 2-3 Ch6-2 
Ch 3-1 Ch 2-1 Ch 2-2 Ch 1-1 
VS-2, VS-3, V6 -1 V6-2 V3-1 -
CN T4 CN-TB CN·T9 --- ---+ CN-Ch10 
CN-Ch2 Ct.I-ChS CN-Ch4 CN-Ch6 CN -Ch7 CN-Ch11 CN-Ch12 CN-Ch13 CN-Ch14---+ CN-Ch9 -• CN·T7 
CN-T2 CN- T6 CN- P12 - .. CN -ChB -.. 'eN-Chi CN- Ch3 
CN-T10 CN-T11 CN·T12 
CN ·PS CN-P7 Ct.I-P1 CN-P2 CN-P6 CN-P3 CN·P11 
CN-P13 CN·T3 CN -P9 
CN-P10 CN-P4 CN·PB 
CN-T-V2 CN-T-V3 CN·T·VS ---- ----+ 
err-vi CN-T-V4 ---------+ 
- -- ... ------------------
CN-13, CN-14, CN-15 
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coupling method it LS known that deamidation of asparagine and glutamine 
residues can occur (Chang et al., 1978) this deamidation is only partial 
and the intensity of the spots corresponding to asparagine and glutamine 
residues on the TLC sheet are more conspicuous than the one of the 
deamidated forms. Another.indirect confirmation ot the correct 
assignement of aspartic acid, asparagine, glutamic acid and glutamine 
residues, was provided by the fragments obtained from the hydrolysis 
of the inhibitor with the StaEhylococcus aureus (strain V-8) protease: 
All of the peptide bonds involving aspartic acid and glutamic acid 
18 
were cleaved, with the exception of Asp -Ser. The failure of the V-8 
protease to cleave this peptide bond can be explained by the short 
time of incubation, as Glu-X peptide bonds are more readily cleaved 
than the Asp-X ones (Croft, 1981). 
The many digestions and sub-digestion of the protein 
described above, although in some cases providing repetitive and 
redundant data, has assured that the fragments sequenced were correctly 
aligned. A further confirmation of the validity of the alignment 
shown in Figure 35 may be drawn from a comparison of the primary 
structures of the ragi trypsin/ ~-amylase inhibitor and the barley 
trypsin inhibitor (Odani ~ al., 1983a), a closely homologous protein 
(Figure 36). 
3.2.13. Sequence Comparison 
The search for proteins structurally related to the ragL 
trypsin/~ -amylase inhibitor was conducted using the computer program 
described in- Section 2.2. 7. The value of the parameters d, u and v, 
as well as the distance measure and z (see Section 2.2. 7. for 
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definitions) for each alignment are given 1n the legend of the :, 
relevant figures. 
The alignment of the am1no acid sequences of the ragi 
trypsin/ 1$. -amylase inhibitor and the barley trypsin inhibitor (Odani 
et .!!_., 1983a), is shown in Figure 36. The homology between these·. two 
proteins is self evident. Identical residues are found at 66 out of 
the total of 122 (ragi) and 121 (barley) positions with all 10 cysteine 
residues being conserved. Also to be noted is the strong homology 
around one of the reactive sites of the ragi trypsin/ t~:. -amylase inhibitor 
34 (Arg -Leu) and the reactive site of the barley trypsin inhibitur. 
Such strong homology clearly indicates that these two proteins are 
related through a process of divergent evolution. 
The ragi trypsin/ rfi. -amylase inhibitor also seems to have 
similarities with the maize trypsin inhibitor. The maize inhibitor was 
sequenced by Hochtrasser et .!!_. (1970) and the sequence proposed has 
sixty five amino acids. Based on the fact that the total number of 
residues found 1n the tryptic digestion of the inhibitor represented 
only one third of the total am1no acids determined from the molecular 
weight and percentage am1no acid composition, they suggested that the 
native maize inhibitor was a polymer of a subunit which consisted of 
65 amino acids residues. In Figure 37a the primary structure of the 
maize trypsin inhibitor is shown and in Figure 37b peptides derived 
from the treatment of the maize inhibitor with trypsin and chymotrypsin 
ar~aligned with segments of the rap trypsin/!$.. -amylase inhibitor. As 
can be seen, for most of the tryptic and chymotryptic peptides from 
the maize inhibitor, matching peptides can be found in the ragi 
trypsin/!$. -amylase inhibitor. It should be noted that the ma1ze 
trypsin inhibitor peptides which match with the ragi trypsin/~ -amylase 
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1. Se1: Val§ Thr Ser Cys Ile Met§ Ile Pro~ 2. Phe Gly Asp Ser Cys Ala Asp Ala Leu Phe His 
1. Asn Pro Leu Ser Ser Cys Arg Trp Tyr Val Ser Thr Arg Thr 
2. Asn Pro Leu Arg Ala Cys Arg Thr Tyr Val Val Ser Gln Ile 
1. §Gly Val Gly Pro Arg* Leu Ala I Thr I Gln Glu Met Lys Ala 2. His Gln Gly Pro Arg* Leu Leu Thr Ser Asp Met Lys Arg 
1. Arg Cys Cys Arg Gln §Gl" Ala Ile Pro Ala Tyr Cys Arg 
2. Arg Cys Cys Asp Glu Leu Ser Ala Ile Pro Ala Tyr Cys Arg 
1. Cys Glu Ala Val Arg Ile Leu§ Asp Gly Val Val Thr Ser 2. Cys Glu Ala Leu Arg Ile Ile Met Gln Gly Val Val Thr Trp 
1. Ser §Gln His Arg Leu Leu Gln§ Leu§ Gly 2. Gln Ala Phe Ala Tyr Phe Lys Asp Ser Pro Asn 
1. Cys Pro Arg Gln Val §Arg* Ala Phe §Pro Lys Leu Val 
2. Cys Pro Arg Glu Arg Gln Thr Ser Tyr Ala Ala Asn Leu Val 
1. ]ill Glu Val Glu Cys Asn Leu Ala Thr Ile His Gly Gly Pro 
2. Pro Gln Glu Cys Asn Leu Gly Thr Ile His Gly Ser Ala 
1. Ph• ~Le" Sor §L'" Gly Ala Gly Glu 2. Tyr Cys Pro Glu Leu Gln Pro Gly Tyr Gly 
Figure 36 - Comparison of the primary structures of the ragi trypsin/ 
d. -amylase inhibitor (.1) and the barley trypsin inhibitor 
(2) (Odani et al., 1983a). The identical residues are enclosed in boxes; 
( ... ) indicates gap; (*) indicates trypsin inhibitory reactive sites. 
Parameter values: u=lO, v=l2, d=lO. Distance measure=572. Similarity 
coefficient= 0. 530; z= - ;11.~53 (significant homology). 
Ser Ala Gly Thr Se~ Cys Val Pro Pro (Ser,Gly,Cys,Pro,His,Asx) Ala Ile 
T-I 
Leu Arf Thr Gly Ile Pro Gly Arg Leu Pro Pro Leu Glx Lys Thr Cys Gly Ile 
T-Il CT-IV CT-III 
Gly Pro Arg Gln Val Gln Arg Leu Gln Asx Leu Pro Cys Pro Gly Arg Arg 
CT-V CT-VI CT-f 
-Gln Leu Ala Asx Met Ile Ala Tyr Cys Pro Arg Cys Arg 
CT-VII 1 CT-II 
Figure 12! - The amino acid sequence of the trypsin inhibitor from maize 
seeds (Hochstrasser ~ al. ,1970). The nomenclature of the 
peptides is that used by the authors. ! denotes a tryptic peptide and 
CT denotes a chymotryptic peptide obtained from the cleavage of a 
tryptic peptide: 
l.ISerlVal Gly Thr Ser Cys 
2. Ser Ala Gly Thr Ser Cys 
1. :::.er Cys Arg Trp Tyr Val Ser · Thr Arg Thr Cys Gly Pro Arg Leu Ala 
2. Arg Thr Cys Gly Pro Arg 
1. Ala Val Arg Ile Leu Met Asp Gly Val Val Thr Ser Ser Gly Gln His Glu Gly 
1. Arg Leu Leu Gln Asp Leu Pro Gly Arg Gln Val Gln Arg Ala Phe 
2. Leu Gln Asx Leu Pro &.....o'----'-'Gly Arg Gln Val G1x Arg 
1. Ala Pro Lys Leu Val Thr Glu Val Glu Cys Asn Leu Ala Thr Ile His G1y Gly 
1. Pro Phe Cys Leu Ser Leu Leu Gly Ala Gly Glu 
Figure 37b - Comparison of the amino acid sequence of the ragi trypsin/ 
«-amylase inhibitor (1) with fragments of the maize trypsin 
inhibitor (2) (Hochtrasser et ~-, 1970). Identical residues are enclosed 
in boxes. ( ... ) indicates gap. 
139 
inhibitor in Figure 37b do not occur in the sequence order suggested 
(mo) 
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by Hochtrasser et al~ but are scattered around the inhibitor molecule, 
and also not concentrated in any particular region. Inspection of the 
alignment of the ragi inh~bitor sequence and the maize inhibitor 
peptides and consideration of.the specificities of trypsin and 
(<910) 
chymotrypsin, strongly suggests that Hochtrasser et alA did not recover 
all the possible tryptic and chymotryptic peptides from their digests. 
This implies that the maize inhibitor sequence in fact contains more 
than the 65 amino acids suggested by 
of fact, 1n their report Hochtrasser 
these workers. Also, as a matter 
(1'11o) 
~ al~ do not present experimental 
evidence to substantiate the overlappings proposed. Thus, although 
the apparently fragmentary nature of the sequence data for the maize 
trypsin inhibitor does not permit a very meaningful comparison, the 
limited information available does suggest that homology exists with 
·thr ragi trypsin/~:(. -amylase inhibitor. 
The alignment of positions 70 to 122 of the ragi trypsin/ 
~-amylase inhibitor with the pancreatic secretory trypsin inhibitor 
(Kazal) and the alignment of positions 69 to 121 of the barley trypsin 
inhibitor (Odani et al., 1983b) with the pancreatic secretory trypsin 
inhibitor are presented in Figures 38a and 38b, respectively. Only 
the similarity in the second alignment is sufficient to be called 
homology. The values of z of both alignments, which determine the 
level of statistical significance 9f an alignment, have borderline 
values, but the invariant positions in both alignment are almost the 
same. 
Ikenaka et al (1974) have shown that the region around 
the reactive site of the pancreatic secretory trypsin inhibitor 
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1.. Asn Ile Leu Gly Arg /Glu !Ala Lys Cys Thr Asn Glu Val Asn Gly Cys Pro Arg 
2. Trp Gln G1y Ala Phe Glu Gly Ala Tyr Phe Lys Asp Ser Pro Asn Cys Pro Arg 
1. Ile Tyr Asn Pro Val Cys Gly Thr Asp Gly Ser Asn Leu 
2. Glu Arg Gln Thr Ser Tyr Ala Ala Asn Leu Gln Asn 
l.ILeu,Cys Met Glu Asn Lys G1u Arg Gln Thr!Pro,Val,Leu!Ile Gln Lys Ser!Gly I 
2. Leu Gly Thr Ile His Gly Ser Ala Tyr Cys Pro Glu Leu Gln Pro Gly Tyr Gly 
1. Pro Cys 
2. 
Figure 38a - Comparison of the amino acid sequence of the pancreatic 
secretory trypsin inhibitor (Kazal) (1) (Greene and Bartelt, 
1969) with segment 69 to 121 of the barley trypsin inhibitor (Odani ~ al., 
1983a). Identical residues are enclosed in boxes. ( ... )indicates gap. 
Parameters values: u=10, v=12, d=10. Minimum distance measure=464. 
Similarity coefficient=O.l89. z•-3.402 (significanthomology). 
1. Asn Ile Leu Gly Arg I Glu I Ala Lys Cys Thr Asn Glu Val Asn Gly Cys Pro Arg 
2. Ser Ser Gly Gln His Glu Gly Arg Leu Leu Gln Asp Leu Pro Gly Cys Pro Arg 
1. Ile Tyr Asn Pro Val Cys Gly Thr Asp Gly Tyr Ser Asn 
2. Gln Val Gln Arg Ala Phe Ala Pro Lys Leu Glu Val 
1------' 
l.!Leu,Cys ~et Glu Asn Lys Glu Arg Gln Thr Pro Val,Leullle Gln Lys SeriGly I 
2. Leu Ala Thr Ile His Gly Gly Pro Phe Cys Leu Ser Leu Leu Gly Ala ... G1y 
1. Pro Cys 
2. Glu ... 
Figure 38b - Comparison of the amino acid sequence of the pancreatic 
secretory trypsin inhibitor (Kazal) (1) (Greene and Bartelt, 
1969) with segment 70 to 122 of the ragi trypsin/ tfi.. -amylase inhibitor 
(2). Identical residues are enc lose·d in box-s; ( ... ) indicates gap. 
Parameters values: u=lO, v=l2, d=lO. Minimum distance measure=474. 
Similarity coefficient=O.l71; z= -2.627 (insignificant homology). 
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(Kazal) and the Streptomyces subtilisin inhibitor are similar, and 
Laskowsk.i and Kato (1980) pointed out that this similarity is sufficient 
to be called homology. However, the remainder of the molecules appear 
to be unrelated. The similarities around the reactive site of both 
inhibitors were taken as an indication that the pancreatic secretory 
trypsin inhibitor and the Streptomyces subtilisin inhibitor families 
may have a distant divergent relationship (Laskowski and Kato, 1980). 
However, as the similarities between these inhibitors seem to be 
restricted to the regions around the reactive sites and the 
subsidiary enzyme-inhibitor binding site, and no details on the 
three dimensional structure of the inhibitors are known, a decision on the 
the precise evolutionary relationship between these inhibitor families 
cannot be made (Laskowski and Kato, 1980). 
Subsequent to our report (Campos and Richardson, 1983) 
of the amino acid sequence of the ragi trypsin/ r!i. -amylase inhibitor 
and its homology with the wheat ~-amylase inhibitor (0.28)and the 
barley trypsin inhibitor, Odani et ~· (1983b) have discussed the 
homology between the ragi trypsin/ ~-amylase inhibitor, the barley 
trypsin inhibitor and the pancreatic secretory trypsin inhibitor. 
They suggested a tandem two domain structure for the ragi trypsin/~­
amylase inhibitor and the barley trypsin inhibitor as follows: 
H-(proteinase inhibitory domain)-( ~-amylase inhibitory domain)-OH , 
and also suggested that the regions in the ragi trypsin/ 0:. -amylase 
inhibitor and barley trypsin inhibitor homologous to the pancreatic 
secretory trypsin inhibitor constituted the ~-amylase inhibitory 
domain. Their suggestion imply an extraordinary divergent evolution 
of these inh1bitors from a common ancestor. However, whilst the 
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regions around the reactive sites of the pancreatic secretory trypsin 
inhibitor and the Streptomyces subtilisin inhibitor are homologous, 
comparison of the amino acid sequence of the Streptomyces subtilisin 
inhibitor with the ragi trypsin/~-amylase inhibitor and barley trypsin 
inhibitor does not reveal ·any homology and furthermore, the invariant 
positions when the sequences of the pancreatic secretory trypsin 
inhibitor and Streptomyces subtilisin inhibitor are compared are 
different from the ones which are observed when the pancreatic secretory 
trypsin inhibitor 1s compared with the ragi trypsin/~-amylase inhibitor 
or with the barley trypsin inhibitor. It seems thus that taking into 
consideration sequence similarities, a divergent relationship between 
them seems to be unlikely, although a very distant divergent relationship 
between the pancreatic secretory trypsin inhibitor and the ragi trypsin/ 
~-amylase inhibitor or between the pancreatic secretory trypsin inhibitor 
and the Streptomyces subtilisin inhibitor cannot be discarded. 
The list of proteins which show a significant degree of 
similarity with the ragi trypsin/~-amylase inhibitor also includes 
the 0.53 (Maeda et ~·, 1983) and 0.28 (Kashlan and Richardson, 1981) 
~-amylase inhibitors from wheat. The two ~-amylase inhibitors are 
highly homologous (Maeda et al., 1983), and when both of them are 
-- --
compared with the ragi trypsin/ ~-amylase inhibitor sequence (Figures 
39a and 39b) the similarities observed are sufficient to be called 
homology. Also of interest is the fact that the invariant positions 
of both alignments are almost the same and the invariant positions 
1n these alignments are als~invaviant in the alignment of the 0.53 
and 0.28 inhibitors (see Figure 2), thus giving further indication 
of the divergent relationship between these proteins. 
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When the barley trypsin inhibitor and the wheat~-amylase 
inhibitors are compared the invariant positions obtained are the same as 
in the comparison of the wheat ~-amylase inhibitors with the ragi trypsin/ 
~-amylase inhibitor. While this work was in progress, Odani et al. (1983a) 
published a report in which they showed a homology between the barley 
trypsin inhibitor and the 0.28~-amylase inhibitor from wheat. Their 
alignment is almost identical to the one presented here (Figures 39a and 
39b), with the exception of some matches in the C-terminal region of both 
inhibitors. This difference is explained by the weak homology in this 
region. 
In a report on the am1no acid sequence of the castor bean 
(Ricinus communis) reserve protein, which 1s composed of a small and a 
large subunit joined by a disulphide bridge, Sharief and Li (1982) drew 
attention to an apparent homology between the small subunit and positions 
116 to 149 of the sweet plant protein Thaumatin I from the fruit of 
Thaumatococcus daniellii. Also a homology was apparent between positions 
1 to 25 of the large subunit and positions 11 to 38 of the Bowman-Birk 
type inhibitor from lima bean (Sharief and Li, 1982). Both similarities 
are sufficient to be called homology and indeed the homology between the 
large subunit and the lima bean trypsin inhibitor can be extended to all 
menbers of the Bowman-Birk inhibitor family and all the invariant positions 
are centred around the reactive site of the inhibitors. However, if one 
compares the whole sequence of the sweet plant protein thaumatin I with 
the small subunit of the castor bean protein the similarities then observed 
are not sufficient to be called homology. The same observation is found 
when the whole of the large subunit is compared with the whole lima bean 
trypsin inhibitor. molecule. 
~en the whole sequence of both subunits of the castor 
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l.lser IVai Gl Y tbr I•• t · ·ICy•! II• I Pro I Gly Het Ala Ilo Pro ft;. ... Pro ILo•J••P Sor ey, Arg Trp 
2. Ser Gly Pro Trp Ser Trp Cys Asn Pro Ala Thr Gly Tyr Lys Val Ser Ala Leu Thr Gly Cys Arg Ala 
1. Arg Gln 
2. Gln Gln 
Leu Glu Ala§le .•. Pro Ala Tyr Cys Arg Cys 
Leu Ala Asp Ile Asn Asn Glu Trp Cys Arg Cys 
....__ _ _, 
Glu Ala Val Arg Ile Leu Met Asp Gly~ 
Gly Asp Leu Ser Ser Met Leu Arg Ala~ 
I. . :. Gin Arg IAlal Pho Alai Pro I Ly• Lou Val Thr Glu Val Glu ey, I A•n I Lou Ala Thr 
2. Lys Leu Thr Ala Ala Ser Val Pro Glu Val Cys Lys Val Pro Ile Pro Asn Pro Ser Gly 
1., Gly !Pro Phe Cys Leu Ser Leu Leu Gly .•• Ala Gly Glu 
2. Gly Val Cys Tyr Gly Asp Trp Ala Ala Tyr Pro Asp Val 
Ile His Gly 
Asp Arg Ala 
Figure 39a Comparison of the primary structures of ragi trypsin/~ ·amylase inhibitor (1) and 
the wheat 0.28oc:·amylase inhibitor (2) (Kashlan and Richardson, 1981). The identical 
residues are enclosed in boxes. ( ... )indicates gap. Minimum distance measure= 1032; similarity 
coefficient= 0.169; z= ·4.425 (significant homology). Parameters values: u=lO, v=l2, d=lO. 
1.1 Sor [val Gly Thr S.r ICy• Ill• ho Gly i Mo< Ah ll• Pro Hi, A•n hoi I..u !A•p Sor Cy• Arg Trp Tyr 
2. Ser Gly Pro Trp Met Cys Tyr Pro Gly Gln Ala Phe Gln Val Pro Ala Leu Pro Gly Cys Arg Pro Leu 
1. Glu Ala~Pro Ala Tyr Cys GluiAla ~al Arg Ile Leu MetiAspiGly Val Val Thr 
2. Ala Asp Ile Ser Glu Trp Pro Gly Ala eu Tyr Ser Met Leu Asp Ser Met Tyr I.ys 
l. Ser Ser IGly IGln His Glu Gly Arg Leu Leu Gln Asp Leul Prol Glyl Cys [Pro IArgl ... GlniVali··· 2. Glu His Gly Val Ser Glu Gly Gln Ala Cys Thr Gly Ala Phe Pro Ser CysiArg Arg Glu Val Val Lys 
1. Gln ArgiAlaiPhe Ala Pro Lys Leu Val Thr Glu Val Glu Cys Asn Leu I Ala IThr Ile His!GlyiGly 
2. Leu Thr Ala Ala Ser 11£: Thr Ala Val Cys Ar<;., Leu Pro Ile Val Val Asp Ala Ser Gly Asp Gly Ala 
1. Pro Phe [ Cy s I· .. Leu Ser Leu Leu Gly Ala Gly Glu 
2. Tyr Val Cys Lys Asp Val Ala Tyr Pro Asp Ala Ala 
Figure 39b - Comparison of the primary structures of ragi trypsin/~ ·amylase inhibitor ( 1) and 
the wheat 0.53 ~-amylase inhibitor (2) (Maeda et !l·, 1983). The identical residues 
are enclosed in boxes. ( ... )indicates gap. Minimum distance measure=l032; similaritv 
coefficient= 0.187; z= -5.153 (significant homology). Parameters values: u=lO, v=J2, d=JO. 
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bean reserve protein is compared with the ragi trypsin/ a -amylase 
inhibitor, the similarities found are sufficient to be called homology. 
In the alignment obtained the homologous regions are clustered around 
the N-terminal end of the ragi trypsin/ a -amylase inhibitor. A much 
I 
strong similarity 1s found when residues 1 to 95 of the ragi trypsiri/ 
a-amylase inhibitor are compared with both subunits of the castor bean 
protein. As can be seen in Figure 40a the small and large subunits 
of the castor bean protein can be aligned with the residues 1 to 35 
and 36 to 95, respectively of the ragi trypsin/« -amylase inhibitor. 
In the castor bean protein the two subunits are joined by disulphide 
bridge (Sharief and Li, 1982) and it is worth mentioning that when the 
large and small subunits of the castor bean protein are aligned with 
the barley trypsin inhibitor, the C-terminal of the small subunit and 
the N-terminal of the large subunit are situated in a position 
innnediately adjacent to the reactive site of hte ragi trypsin/~ -amylase 
. h. b . ( 34 ) Th. . h . b "1 . 1n 1 1tor Arg -Leu . 1s suggests t e poss1 1 1ty that the castor 
bean protein may be synthesized as a single polypeptide precursor 
(Odani et al., 1983c) and that a post-translational modification may 
occur consisting of the cleavage of the peptide bond Arg-Gln which 
would give rise to the two subunits. In this context it is useful 
to recall the indication by Sharief and Li (1982) that the native 
castor bean reserve protein seems to be resistant to hydrolysis by 
proteolytic enzymes. 
The castor bean reserve protein can also be aligned with 
the barley trypsin inhibitor (Figure 40b) and the invariant positions 
which are observed are almost the same as in the case of the 
alignment between both subunits of the castor bean protein and rhe ragi 
trypsin/d.. -amylase inhibitor. After our publication of a paper 
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I. Se r . v.. Gl y Thr Ser I Cy'l' •. Pro Gl y Mot Ala llo pro Hi•, .. n I Pro I Leu I"• Sor I Cy•J Ar. Tr,ryr I 
2. Pro Ser Gln Gln Gly Cys Arg Gly Gln Ile Gln Glu Gln Gln 'Asn ~- .• Leu Arg Gln Cys Gln Glu Tyr 
1. Val Ser Thr Arg Thr 
2. Ile Lys Gln Gln Val 
Cys,Gly,Val 
Ser Gly Gln 
Gly Pro Arg* Leu Ala Thr Gln Glu Met Lys Ala,Argl··· Cys Cys 
Gly Pro Arg Arg ·. . . . • . Gln Glu Arg Ser Leu Arg Gly Cys Cys 
1. Arg Gln,Leu,Glu Ala Ile Pro Ala Tyr Cys Arg Cys Glu Ala ValiArg , ... ... ~Leu Met Asp Gly 
2. Asp His Leu Lys Gln Met Gln Ser Gln Cys Arg Cys Glu Gly Leu Arg Gln Ala Ile Gln Gln. Gln Gln 
1. Val Val Thr Ser Ser Gly Gln His Glu Glyl Arg~u Leu Gln Asp Leu Pro Gly Cys Pro Arg Gln Val 
2. Leu Gln Gly Gln Asn Val Phe Glu Ala Phe Arg Thr Ala Ala Asn Leu Pro Ser Met Cys Gly Val Ser 
1. Gln Arg* Ala Phe Ala Pro 
2. Pro Thr Gln Cys Arg Phe 
Figure 40a - Comparison of the primary structure of the castor bean reserve protein (2) 
(Sharief and Li, 1982) with positions 1 to 95 of the ragi trypsin/ a: -amylase 
inhibitor (1). Identical residues are enclosed in boxes. ( ... )indicates gap. (*)indicates 
trypsin inhibitory reactive sites. Minimum distance measure=788; similarity coefficient=O.l71; 
z= -4.069 (significant homology). Parameters values: u=lO, v=l2, d=lO. 
1. Phe Gly Asp Ser Cys Ala Pro,Gly,Asp Ala Leu Pro His Asn Pro Leu Arg Ala,Cys,Arg Thr,Tyr,Val 
2. Pro Ser Gln Gln Gly Cys Arg.Gly Gln Ile Gln Glu Gln Gln Asn Leu Arg Gln Cys Gln Glu Tyr Ile 
1. Val Ser I Gln I Ile Cys His Gln Gly Pro Arg* Leu 'Leu Tbr Ser Asp Met Lys IArgl Arg lcys Cys Asp I 
2. Lys Gln Gln Val Ser Gly Gln Gly Pro Arg Arg Gln Glu Arg Ser Leu ... Arg GlyjCys Cys Asp 
1. Glu Leu Ser Ala Ile Pro Ala Tyr Cys Arg Cys Glu Ala Ile ... GTI] Met I Gln IGly Val Val 
2. His Leu Lys Gln Met Gln Ser Gln Cys Arg Cys Glu Gly Gln Ala Ile Gln Gln Gln Gln Leu 
1. Thr Trp,Gln,Gly Ala Gly Ala Tyr Phe Lys Asp Ser Pro Asn Cys Pro Arg Glu Arg Gln Thr 
2. Gln Gly Gln Asn Val Ala Phe Arg Thr Ala Ala Asn Leu Pro Ser Met Cys Gly Val Ser Pro 
1. Ser Tyr Ala Ala Asn 
2. Thr Gln Cys Arg Phe 
Figure 40b - Comparison of the primary structure of the castor bean reserve protein (2) (Sharief 
and Li, 1982) with positions 1. to 95 of the barley trypsin inhibitor (1) (Odani ~ 
al., 1983a). Identical residues are enclosed in boxes. ( ... )indicates gap. (*)indicates 
trypsin inhibitory reactive site. Minimum distance measure= 724; similarity coefficient= 0.238; 
z= -8.048 (significant homology). Parameters values: u=lO, v=l2, d=lO. 
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describing the amino acid sequence of the ragi trypsin/ ex -amylase 
inhibitor (Campos and Richardson, 1983) and while this work was still 
in progress, Odani et ~ (1983c), reported the homology between the 
castor bean reserve protein, the barley trypsin inhibitor and the 
ragi trypsin/ c( -amylase inhibitor. In this report they also agreed that 
the homology between both subunits of the castor bean reserve protein 
and the barley trypsin inhibitor and the ragi trypsin/ c( -amylase 
inhibitor is more conceivable than the one between its small subunit 
and the sweet plant protein thaumatin I or the one between the large 
subunit and the segments of the amino acid sequences of menbers of 
the Bowman-Birk inhibitor family. 
The alignment of the ragi trypsin/ t1. -amylase inhibitor with 
the apparently homologous protein barley trypsin inhibitor, castor 
bean reserve protein, the 0.28oC-amylase inhibitor and the O.S3oC-amylase 
inhibitor is shown in Figure 41. This alignment is highly tentative 
and it may not be the best alignment to show the relationships between 
these proteins. As summarized in Table XVII the similarities between 
each of the proteins is sufficient to be called homology. 
It should be noted that in the alignment shown in Figure 41 
some of the invariant positions which are obtained when, say, the castor 
bean reserve protein and the barley trypsin inhibitor are aligned using 
the computer method, are lost in the tentative ~lignment proposed in 
Figure 41. This is in part due to the sheer number of possible 
alignments between these five sequences, which makes the task of finding 
an optimal alignment virtually impossible. A computer porgram was 
developed to compute the alignment of an ~ number of amino acid 
sequences, based on the algorithm proposed by Gotoh (1982). Unfortunately 
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BTl - Phe fcly l·.. • •• Asp Ser Cys Ala 
..... , ... 
1 
.. r·· .... ,. Asn Pro Leu Arg Ala Cys Arg Th~ Tyr/Val,Val Ser 
RAI - 5er Val Gly •.. Thr Ser Cys Ile Pro Gly Met Ala lle Pro His Asn Pro Leu Ser Ser Cys Arg Trp Tyr Val Ser Thr 
0.53- Ser Gly Pro Trp ... Met Cys Tyr Pro Gly Gln Ala Phe Gln Val Pro Ala Leu Pro Gly Cys Arg Pro Leu Leu Lys Leu 
0.28- Ser Gly Pro Trp Ser Trp Cys Asn Pro Ala Thr Gly Tyr Val Lys Ser Ala Leu Thr Gly Cys Arg Ala Met lvaljLys Leu 
CBRP- ••• Pro Ser Gln Gln Gly Cya •.• Arg IGlyl Gln Ile Gln Glu Gln Gln Asn Leu Arg Gln Cys Gln Glu Tyr Ile Lys Gln 
BTl -jGln I Ile 
RAI - Arg Thr 
0.53-
0.28-
CBRP· 
BTl - Pro Ala Tyr Cys Arg Cys Glu Ala lLeuj Arg Ile •.• 
RAI- Pro Ala Tyr Cys Arg Cys Glu Ala Val ArgIle .•• 
••• 3- ... .., ···rrY· ... 0.28- Asn Asn Glu Trp Cys Arg Cys Gly Asp Leu Ser Ser .•. 
CBRP- Gln Ser Gln ••. Cys Arg Cys Glu Gly Leu Arg Gln Ala 
BTl -
RAI -
0.53-
0.28-
CBRP-
BTl -
RAI -
..• Ala Tyr Phe Lys Asp Ser 
..• Arg Leu Leu Gln Asp Leu 
Gln Ala Gly Thr Gly Ala Phe 
Phe 
... ... Lys Glu Val 
Arg Thr Ala Ala Asn 
Thr Pro Gln Glu Cys 
Thr Glu Val Glu Cys 
Leu 
Leu 
Pro Asn 
Pro Gly 
Pro Ser 
Pro Gly 
Pro Ser Met 
0.53- Cys Arg Leu Pro lle Val Val Asp,Ala 
Cys 
Cys 
Cys Arg Leu 
Cys Gly 
Ser Leu ••• 
Ile Met Gln Cys GVal,Val Thr Trp Gln Gly Ala Phe Glu Gly 
Leu Met Asp Cys Val Val Thr Ser Ser Gly Gln His Glu Gly 
Met Leu Asp Ser Met Tyr Lys Glu His Gly ·val Ser Glu Gly 
Met Leu Arg Ala(valiAla Gln Glu Leu Gly Val Arg Glu Gly 
Ile Gln Gln 
Val 
Met 
.•.. Gln'[~ Ser Tyr Ala Ala Asn •.. Leu Val 
..• Gln Arg Ala Phe Ala Pro Lys .•. Leu Val 
Lyo "'"/"'~ .. • "' Th< Th< Alo Vol 
Lys Leu Thr .•. Ser Val Pro Glu Val 
Ser Pro Th Gln Cys Arg Phe 
0.28- Cys Lys Val Pro lle Pro Asn Pro Ser Gly Asp Arg Ala Gly Val Cys 
Pro Glu Leu GlniProlGly Tyr Gly 
Leu Ser Leu Leu Gly Ala Gly Glu 
His Asp .•. Val Ala Tyr,Prol Asp Ala Ala 
Asp Trp Ala Ala Tyr Pro Asp Val ... 
Figure 41 ·-Comparison of the amino acid sequences of barley trypsin inhibitor (BTl) (Odani et al., 1983a), ragi 
trypsin/"' -amylase inhibitor (RAI), 0.53 wheat c1> -amylase inhibitor (0.53) (Maeda!!. al., 1983), 0.28 
«-amylase inhibitor (0.28) (kashlan and Richardson,l981) and castor bean reserve protein (Sharief and Li, 1982). 
Identical residues are enclosed in boxes. ( .•. )indicates gap. 
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Table XVII - A matrix based on the am1no acid sequence comparisons of 
the ragi trypsin/~ -amylase inhibitor (RAl), barley 
t~ypsin inhibitor (BTl) (Odani £! al., 1983a), castor bean reserve 
protein (CBRP) (Sharief and Li, 1982), 0.28 wheat ~-amylase inhibitor 
(0.28) (Kashlan and Richardson, 1981) and 0.53 <i-amylase inhibitor -
(0.53) (Maeda£! al., 1983). The values of~ and of the minimum distance 
measure of each alignment are. plotted in the lower half and upper half 
respectively.-
RAl BTl CBRP 0.28 0.53 
RAl ~ 572 788 1032 1018 
BTl 
-21.453 ~ 724 1038 1010 
CBRP 
- 4.069 -8.048 ~ 1054 1062 
0.28 - ·4.4Z5 -4.116 -2.958 ~ 610 
0.53 - 5.153 ~ -5.496 -2.765 -21.211 
\ 
I 
I 
I 
I 
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the complexity of this algorithm is exponential-in time. This means 
that the algorithm is only viable if aplied to very short sequences. In 
practice the sequences are of considerable length and it could easily 
take several hundreds hours to compute the "optimal" alignment of the 
sequences. 
The ma~ze trypsin inhibitor is excluded from the alignment 
shown in Figure 41, due to the apparently fragmentary nature of its 
sequence data, although it is believed likely that a reassessement 
of its amino acid sequence will confirm the suggestions made about 
its homology with the ragi trypsin/~ -amylase inhibitor family members. 
- The pancreatic secretory trypsin inhibitor is also excluded on the 
grounds that the data available are not sufficient to allow a decision 
on whether the similarities with the barley trypsin inhibitor and the 
ragi trypsin inhibitor are indicative of a divergent or convergent 
relationship. 
Taking into account the facts so far discussed, it ~s 
reasonable to argue that the ragi trypsin/ eX. -amylase inhibitor and the 
homologous barley trypsin inhibitor do not fit into any of the inhibitor 
families proposed by Laskowski and Kato (1980) and that a new family 
should be created to accomodate them. This family should include the 
0.28 and the 0.53o<-amylase inhibitors from wheat.and the castor bean 
reserve protein. It remains to be seen whether the presence of tA. -amylase 
inhibitors and trypsin/ c1.. -amylase inhibitors is unique to this family, 
as the possibility that members of other inhibitor families may also 
have tA.-amylase inhibitory activity, apparently has not been investigated. 
In this connection, Mundy et ~ (1983) and Hejgaard ~ ~ (1983) have 
recently described the isolation and N-terminal sequence of a subtilisin/ 
~-amylase inhibitor from barley seeds. It is interesting that the 
dual inhibitory activity in the protein molecule was recongnised due 
to the fact that while working with an ~-amylase and a subtilisin 
inhibitor, they saw that the N-terminal sequence of both inhibitors 
were the same (Mundy, J., personal communication). Although data on 
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the complete amino acid sequence of this subtilisin/ ~-amylase inhibitor 
has yet to be published, the N-terminal sequence of its 40 amino acids 
bears no homology either with menbers of the ragi trypsin/ e~t -amylase 
inhibitor family or with members of other inhibitor families. However, 
this N-terminal sequence is strongly homologous to the N-terminal 
sequence of a subtilisin inhibitor from rice and thus they will 
probably constitute another new family. 
The determination of the homology of a seed reserve protein 
with proteinase and ~-amylase in~ibitors may also serve as a starting 
point in a more precise comprehension of the genetic and physiological 
relationships between these proteins, although any homology does not 
necessarily confirm the hypothesis that proteinase inhibitors are a 
special kind of reserve protein. However, at least in the case of the 
ragi trypsin/ oe;. -amylase inhibitor, it has been shown to be hydrolysed 
in vitro by an endogenous proteinase from ragi seeds and its 
mobilisation during germination resembles the mobilisation of:. a reserve 
protein (Pattabiraman, T.N., personal communication). 
It also rema1ns to be clarified what is the exact evolutionary 
relationship between the pancreatic secretory trypsin inhibitor and the 
members of the ragi trypsin/~ -amylase inhibitor family. As discussed 
before, the similarities between the pancreatic secretory trypsin 
inhibitor and the menbers of the ragi trypsin/~ -amylase inhibitor 
family are sufficient to be called homology, while the same holds for 
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the similarities between the pancreatic secretory trypsin inhibitor 
and the Streptomyces subtilisin inhibitor, but there is no apparent 
homology between the Streptomyces subtilisin an·.d the ragi trypsin/ d.-
amylase inhibitor family menbers. The statistical analysis of the 
alignment ruled.out the possibility that the similarities observed 
in the sequences were due to- chance alone. 
In making any comparisons of the amino acid 
sequences of the ragi trypsin/~:( -amylase inhibitor, the 
barley trypsin inhibitor and the 0.28 and 0.53 ~-amylase 
inhibitors from wheat, it would be of interest to elucidate 
the positions of the intramolecular disulphide bridges in 
these inhibitors. At present the only one of these inhibitors 
for which details of the disulphide bridges are available 
is the_0.53 ~-amylase inhibitor from wheat which was recently 
reported by Maeda et al. (1983b). In this inhibitor there are 
4 disulphide bridges and one free cysteine residue, the 
locations of which are shown below: 
·-
r• ~ ,, 
,. 
SH. ,. 
•' :: 'I 
20 40 60 80 J 100 
It should be noted however that Maeda et al. (1983b) were 
unable to ascertain the exact disulphide bridge partners of 
residues 20 and 99, either of which could have been bonded 
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to cysteine residues 41 or 42. 
In the comparison of the am1no acid sequences of 
the 0.28 and 0.53 ~-amylase inhibitors (Figure 2), the 
cysteine residues are distributed in a~most identical 
positions, and so it would be reasonable to expect that the 
topological relationships between the disulphide bridges in 
these inhibitors might be very similar, except that the 0.28 
inhibitor has the possibility of forming 5 disulphide bridges 
as it contains an additional cysteine residue (Kashlan and 
Richardson, 1981). However in the alignment of the ragi 
trypsin/ ~-amylase inhibitor with either the 0.28 or the 
0.53 wheat ~-amylase inhibitors (Figures 39a and 39b), only 
8 cysteine residues (0.28) and 7 cysteine residues (0.53) 
occupy identical positions, thus indicating that the 
topological relationships of the disulphide bridges in the 
wheat ~-amylase inhibitors and in the trypsin (barley) and 
trypsin/ ~-amylase (ragi) inhibitors belonging to the 
ragi trypsin/ ~-amylase inhibitor family are likely to be 
different. 
Laskowski and Kato (1980) have pointed out that 
the ~asiest family characteristics to appreciate at a glance 
are the topological relationships between the disulphide 
bridges. This does not appear to hold for the ragi trypsin/ 
~-amylase inhibitor family if the wheat a-amylase inhibitors 
are included. It should be said however that the suggestion 
of dividing the inhibitors into families was made primarily 
for inhibitors of proteolytic enzymes (Laskowski and Kato, 
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1980) and that. in fact jud~ing by the identical distribution 
of cysteine residues in the ragi trypsin/d -amylase inhibitor 
and in the barley trypsin inhibitor, the topological 
distribution of the disulphid~· bridges in these two 
inhibitors will probably be the same. 
Finally, in conjunction with ~ny further studies 
on the location of the disulphide bridges 1n these inhibitors 
it would also be desirable to determine the region(s) in the 
amino acid sequences of the ragi trypsin/ o( -amylase inhibitor 
and in the 0.28 and 0.53<X-amylase inhibitors which are 
responsible for the inhibition of ~-amylase, as it would 
provide further ins.ight not only in the relationship between 
structure and inhibitory activity, but also into their 
evolutionary relationships. 
Another line of possible future research in 
this area would be to examine as many of the extant 
proteinase inhibitors for the possesion of inhibitory 
activity towards amylase (or other enzymes), and the converse 
to see if any of the ~-amylase inhibitors presently known 
have other inhibitory activities. This research is indicated 
since it seems extremely unlikely that the ragi (this works 
Manjunath ~ .~., 1983) and the barley (Mundy ~ ~·, 1983) 
bifunctional inhibitors are the only ones present in the 
plant kingdom. 
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3. 3. Prediction of~ Secondary Structure of the Trypsin/<(. -Amylase 
Inhibitor from Ragi (Indian Finger Millet, Eleusine coracana Gaertn. 
The prediction of the secon.dary structure of the rag1. 
trypsin/"- -amylase inhibitor is presented in Figure 42. As no 
experimental data on the secondary structure contents of the inhibitor 
was available (e.g. from circular dichroism), a preliminary predictive 
run was made which indicated a 26% of ct.-helix content. From this 
percentage the optimal decision constants were chosen (Garnier et al., 
1978) and an optimized prediction made, which gave to the inhibitor 
a 28% ct. -helix, 47% of extended chain, 12% of reverse turn and 13% of 
random coi 1. 
In the secondary structure prediction presented 1.n Figure 
42, positions 25, 26, 28, 70 and 83 are occupied by serine, threonine, 
threonine, ser1.ne and proline, respectively. As shown before, there is 
a significant level of heterogeneity in all of these positions with 
alanine, lysine, alanine, proline and alanine also occupying positions 
25, 26, 28, 70 and 83, respectively. In order to ascertain if these 
heterogeneities altered the predicted conformation of the region 
where they occur, predictive runs were made and in every case no 
alteration in predicted conformation was observed. 
In a study on the conservation of chain reversal regions 
1.n proteins, Chou and Fasman ( 1979) found that in the C-peptides of 
proinsulin, in 7 proteinase inhibitors of the pancreatic secretory 
trypsin inhibitor (Kunitz) family and in 12 species of pancreatic 
ribonuclease, despite the relatively low sequence conservation in these 
sets of proteins, ~-turns were predicted to be highly conserved. For 
example, in the proteinase inhibitor set, where the sequence 
1. Ser Val Gly Thr Ser Cys Ile Pro Gly Met Ala Ile Pro His Asn Pro Leu Asp Ser Cys Arg Trp Tyr Val Ser Thr Arg Thr E E E E E E E E E E. E E E T c T T T T E E E E E E E E T 
2. Phe "Gly Asp Ser Cys Ala Pro Gly Asp Ala Leu Pro His Asn Pro Leu Arg Ala Cys Arg Thr Tyr Val Val Ser Gln Ile T T T T T c T T T c c T T c T T T T T E T T T E E E E 
1. Cys Gly Val Gly Pro Arg*Leu Ala Thr Gln Glu Met Lys Ala Arg Cys Cys Arg Gln Leu Gln Ala Ile Pro Ala Tyr Cys Arg T T G C C E ~ H H H H H H H H H H H H E E E E T T H H H 
2. Cys His Gln Gly Pro Arg*Leu Leu Thr Ser Asp Met Lys Arg Arg Cys Cys Asp Glu Leu Ser Ala Ile Pro Ala Tyr Cys Arg T T T c T T c c T T T T T T T T T T T T T T c T T T T T 
1. Cys Glu Ala Val Arg Ile Leu Met Asp Gly Val Val Thr Ser Ser Gly Gln His Glu Gly Arg Leu Leu Gln Asp Leu Pro Gly H H H H H E E E E E E E E E c c c c E E E E E E T c T T 
2. Cys Glu Ala Leu Arg Ile Ile Met Gln Gly Val Val Thr Trp Gln Gly Ala Phe Glu Gly Ala Tyr Phe Lys Asp Ser Pro Asn T H H H E E E E E E E c c c c c c c c T T T T T T c T T 
1. Cys Pro ~g Gln Val Gln Arg*Ala Phe Ala Pro Lys Leu Val Thr Glu Val Glu Cys Asn Leu Ala Thr Ile His Gly Gly Pro c E E E E E E E E c c c H H H H H H H H H H E E T T c c 
2. Cys Pro Arg Glu Arg Gln Thr Ser Tyr Ala Ala Asn Leu Val Thr Pro Gln Gln Cys Asn Leu Gly Thr Ile His Gly Ser Ala c T T T T T T c T c T c c c c c T T T T T T T T T T T c 
1. Phe Cys Leu Ser Leu Leu Gly Ala Gly Glu E E E E E .c c H H H 
2. ~yr Cys Pro Glu Leu Gln Pro Gly Tyr Gly T c T T E c T T T c 
Figure 42 - Prediction of the secondary structures of the trypsin/~ -amylase inhibitor from ragi seeds (Indian finger 
millet, Eleusine coracana Gaertn.) (1) and the trypsin inhibitor from barley (2) (Odani et al., 1983a). 
(*):Trypsin inhibitory reactive site; T:(l-turn; C: Random coil; E: Ext~nded chain; H:o(-helix. 
...... 
\J1 
-...! 
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conservation LS 20%, they predicted a 85% ~-turn conservation. They 
interpreted these results as an indication that chain reversal regions 
play an essential role in keeping intact the active structural domains 
in hormones and enzymes for their specific biological function. T~ese 
studies, also on a predictive basis, were later supported by Tlomak 
and Nowak (1981). Their studies included the pancreatic secretory 
trypsin inhibitor (Kazal) family. Besides supporting the prediction 
of a conservation of chain reversal, they also suggested that in these 
two proteinase inhibitors families, there Ls a region conserved Ln 
the vicinity of the active site, composed of one (3-turn with an 
adjacent extended chain structure. This suggestion in interesting, 
as it may explain why residues such as proline, which strongly 
favours the formation of ~-turn (Chou and Fasman, 1978), are frequently 
found in the vicinity of the active site of proteinase inhibitors. 
In an attempt to check these suggestions, the prediction of the 
secondary structure of the barley trypsin inhibitor (Odani ~ al., 
1983a) was done. As can be seen in Figure 42, the predicted secondary 
structures of the ragi trypsin/~ -amylase inhibitor and the barley 
trypsin inhibitor are rather different, despite their strong sequence 
homology, and as far as these two inhibitors are concerned, do not 
give positive evidence for the suggestions of Chou and Fasman (1979) 
and Tlomak and Nowak ( 1981). In order to extend these observations to 
other inhibitor families, the secondary structure of some inhibitors 
of the Bowman-Birk family were also predicted and compared (Figure 43). 
In this family, the me.rrbers are strongly related and their predicted 
secondary structures are also highly homologous, with a high content 
of reverse chain (around 78%). However, due to this high ~-turn content 
a decision on the hypothesis of ~-turn conservation cannot be made. 
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* Ser Ser His His His Asp 1.. Ser Ser Asp Glu Pro Ser Glu Ser Ser Glu Pro Cys Cys Asp Ser !=Ys Arg Cya Thr Lys Ser l·h c c c c c c c c c c T T T T T T T T T T T T T T T T T c 
S.r Val His His Gln Asp Ser Glu Pro * 2. Ser Asp Ser Glu Ser Ser His Pro Cya Cya Asp Leu Cys Arg Cys Thr Lya Ser lh E E c c c c c c c c c T T T T T T T T T E T T T T T T c 
3. Val Cys Cys Aen Gly Cya Leu Cya * Asp Arg Arg Al< 
.T T T T T T T T T T T c 
Glu * Asp Asp Ser Ser Lya Pro Cys Cya Asp Gln Cya Ala Cya Thr Lye Ser Aar 
T T T T T T T T T T E E T T T T T c 
4. 
* Cya Kia Cya Ala Asp His Ile Arg Leu Aen Ser Cya Ser Ala Cya Lye Ser Cys Met Cys Thr Arg Sel 
T T E T T T T T T T T T T T T T T T T T T T T 
Pro Pro Gln 
1. C T T 
Cys Gln Cys Ala Asp Ile Arg Leu Asp His * Ser Cys Ser Ala Cys Leu Ser Cys Het Cys Thr Arg Se1 
T E E E T T T T T T T T T T T T T T T T T T T 
Pro Pro Gln 2
• C T T 
* 
3. Pro Pro Tyr Phe Glu Cys Val Cys Val Asp Thr Phe Asp His Cys Pro Ala Ser Cys Asn Ser Cys Val Cys Thr Arg Se1 c T T T E E E T T T T T T T T T T T T T T T T T T T T 
* 4. Pro Pro Gln Cys Arg Cys Ser Asp Het Arg Leu Asn Ser Cys His Ser Ala Cya Lys Ser Cya Ile Cya Ala Leu Se1 c T T T T E T T T T T T T T T T T T T T E E E T T T 
1. Met Asp Gly Lys Cys Arg Cys Leu Asp Thr His Asp Phe .•• Cya Tyr Lye Pro Cys Clu Ser Het A&p Lys Asp Asp As1 T T T T T E E E T T T T T T T c T T T T T T T T T T 
2. Het Asp Gly Gln Cys Arg Cys Leu Asp Thr His Asp Phe ••. Cys His Lye Pro Cys Lye Ser Arg Asp Lys Asp T T T T T T T T T T T T T T T c T T T T T T T T 
3. A an Pro Pro Gln Cya Arg Cys Thr Asp Lys Thr Cln Cly Arg Cys Pro Val Thr Clu Cys Arg Ser c c T T T T T T T T T T T T c T T T T T T T 
4. Tyr Pro Ala Gln Cys Phe Cys Val Asp Ile Thr Asp Phe Cys Tyr Glu Pro Cya Lys Pro Ser Glu Asp Asp Lys Cl• T T T T E E E E T T T T T T T c T T c c c c T T T T 
Figure !2 - Prediction of the secondary structures of the mung bean trypsin inhibitor (l}::(Zhll!!l!!. !!.·, 19112), 
adzuki bean trypsin inhibitor (Yoshikawa!!!!.·, 1979) (2), peanuts trypsin inhibitor (3) (Norioka an· 
Ikenaka, 1983), and the soybean Bowman-Birk illh~bitor·.:,lt) .,Odani and lkenaka, 1973). (*) indic.At<!S ·reas;tive 
(illhibitory) aite 0 T: --turn; C: random coil; E: extended chain; H: ~ -helix. 
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An interesting feature in the predicted secondary structure 
of the ragi trypsin/ Gl -amylase inhibitor, the. barley trypsin inhibitor 
and the inhibitors from the Bowman-Birk family is their high content of 
·(3-~turn~which may provide an additional factor for the remarkalJ:~~ 
thermal stability of these inhibitors (Ryan, 1973; Richardson, 1977, 
1980, 1981; Liener and Kakade, 1980). 
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3.4. The ComPlete Amino Acid Sequence of the «-Amylase Inhibitor from 
Seeds of Ragi (Indian Finger Millet, Eleusine coracana Gaertn) 
3.4.1. Amino Acid Analysis 
The results of the amino acid analysis of the d.-amylase inhibitor 
from ragi are presented in Table XIII~ The values obtained are in good 
agreement with the amino acid composition calculated from the sequence 
except for the values of Asp, Ala and Val. 
It should be noted that the amino acid composition of the ragi 
~-amylase inhibitor shown in Table ~II is remarkably different from that 
of the trypsin/&.. -amylase inhibitor 1.n the same tissue (Table VI). 
3.4.2. N-Terminal Analysis 
The N-terminal sequence analysis of the reduced and 
carboxymethylated ~-amylase inhibitor was performed by the DABITC-PITC 
double coupling method. The sequence obtained is given below: 
The identity of Ile2 and Ile 11 was ascertained by compar1.son with 
peptides Chl-4 and Ch3-4. 
3.4.3. Tryspin Digestion 
15 mg of the reduced and carboxymethylated inhibitor were 
subjected to hydrolysis with trypsin, under the conditions described 
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:I able XVIII - The amino acid composition of the d. -amylase inhibitor from 
seeds of ragi (Indian finger millet, Eleusine coracana 
Gaertn.). 
Amino Acid Analysis Sequence 
_CM-Cys 6.59 7 
Asp 8.29 7 
Thr 1.90 2 
Ser 15.22 16 
Glu 2.53 2 
Pro ND 4 
Gly 8.68 9 
Ala 17.21 20 
Val 4.03 5 
Met 0.10 0 
Ile 4.46 5 
Leu 5.23 5 
Tyr 1.68 2 
Phe 0.14 0 
Lys 2.03 2 
His 0.21 0 
Arg 8.66 9 
Trp ND 0 
· ND= Not determined. 
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in Section 2.2.6.3.1. Attempts were made to purify the fragments 
produced directly by RP-HPLC (Figure 44), but only a few of the peptides 
obtained were pure enough to allow direct sequencing on them (Table 
XIX). In order to obtain a better separation, the tryptic digest (12 
mg) was fractioned on a Biogel P-4 column, equilibrated in 0.005M 
ammonium bicarbonate (Figure 45). Each of the pooled fractions was 
subjected to RP-HPLC; the HPLC chromatograms of the HPLC separations 
of peaks 2, 3 and 4 are shown in Figures 46, 47 and 48, respectively. 
No pure peptides were obtained from the RP-HPLC of peak T1. The 
sequences, elution times and positions in the sequence of each of the 
peptides purified are presented in Table XX. 
Peptides T-9, ~and T3-7 (positions 1-19) 
Ala-Ile-~-~-~-Gln-Val-Ser-Ser-Ala-Ile-Gly-Pro-Cys-Leu-Ala-Tyr-
Ala-Arg 
The identity' of Ile2 was ascertained by subjecting each peptide to a 
cycle of degradation by the "Dansyl-dman" method. 
Peptides !1:1, ~' !l:l• T3-3 and T3-4 (positions 20-34) 
Peptides T-5 and T4-4 (positions 34-41) 
Ser-~-Asn-~-Ala-fu-Arg 
36 . d b b. . h . d The identity of Leu was ascerta~ne y su Ject~ng t e pept~ es to a 
cycle of degradation by the "Dansyl-Edman" method, and by semi-
quantitative am~no acid analysis by the dansyl-chloride method. 
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Figure 44 - RP-HPLC separation of the trypsin digest of the ~-amylase 
inhibitor from ragi seeds (Indian finger millet, Eleusine 
coracana Gaertn.) on a C-18 p~Bondapak column (0.5 x 25cm) with a 
linear gradient of 70% (v/v) acetonitrile in 0.1% (v/v) trifluoracetic 
acid at a flow rate of 1.0 ml/min. Fractions which were fully or 
partially sequenced are numbered. Dotted line inaicates concentration 
of acetonitrile. 
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Table XIX - Peptides obtained by the digestion with trypsin of the ~-
amylase inhibitor from seeds of ragi (Indian finger millet, 
Eleusine coracana Gaertn.) 
Peptide No. 
and Position 
in Sequence 
T-1 (93-95 
T-2 (56-60) 
T-3 (42-47) 
T-4 (76-79) 
T-5 ( 35-41) 
T-6 (61-68) 
T-7 (69-75) 
T-8 ( 77-82) 
T-9 (1-19) 
Elution 
Time 
4 
6 
13 
18 
25 
26 
28 
43 
60 
Sequence 
Val-Asn-Asn 
Val-~-_lli-Leu-Asn-Ala-Q!l,-Lys 
Ala- Se r-~- i le-~ -.Q.!y-Ar.g 
Ala-~-~-~-~-Gln-~-~-Ser-Ala-Ile-Gly-
Pro-Cys-Leu-Ala-Tyr-Ala-Arg 
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Tl T2 T3 T4 
1.4 
1.2 
60 80 100 120 
VOLUME (ml) 
Figure 45 - Chromatography of the products of the digestion by trypsin 
of the ~-amylase inhibitor from seeds of ragi. (Indian Finger 
millet. Eleusine coracana Gaertn.) on a Biogel P-4 column (0.8 x 190cm) 
in O.OSM ammonium bicarbonate (flow rate 6 ml/h., fraction size 1.4 ml). 
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Figure 46 - RP-HPLC separation of fraction T-2 from the trypsin digestion 
of the c(_-amylase inhibitor from ragi seeds (Indian finger 
millet,.Eleusine coracana Gaertn.) on a C-18 p-Bondapak column 
(0.5 x 25cm) with a linear gradient of 70% (v/v) acetonitrile in 0.1% 
(v/v) trifluoracetic acid at a flow rate of 1.0 ml/min. Fractions 
which were fully or partially sequenced are numbered. Dotted line 
indicates concentration of acetonitrile. 
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Figure 47 - RP-HPLC separation of fraction T-3 from the trypsin digestion 
of the ~-amylase inhibitor from ragi seeds (Indian finger 
millet, Eleusine coracaca Gaertn.) ·on a C-18 p-Bondapak colunm 
(0.5 x 25 em) with a linear gradient of 70% _(v/v) acetonitrile in 0.1% 
(v/v) trifluoracetic acid at a flow rate of 1.0 ml/min. Fractions 
which were fully or partially sequenced are numbered. Dotted line 
indicates concentration of acetonitrile. 
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Figure 48 RP-HPLC separation of fraction T-4 from the trypsin digestion 
of the ~-amylase inhibitor from ragi seeds (Indian finger 
millet, Eleusine coracana Gaertn.) on a C-18 ~-Bondapak column 
(0.5 x 25cm) with a linear gradient· of 70% (v/v) acetonitrile in 0.1% (v/v) 
trifluoracetic acid at a flow rat of 1.0 ml/min. Fractions which were 
fully or partially sequenced are numbered. Dotted line indicat~ 
concentration of acetonitrile. 
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Table XX - Peptides obtained by the RP-HPLC separation of Biogel P-4 
fractions T2 to T4 from trypsin digestion of the ~-amylase 
inhibitor from seeds of ragi (Indian finger millet, Eleusine coracana 
Gaertn.) 
Peptide No. 
and Position 
in Sequence 
Th.l ( 20- 34) 
T2-2 (20-34) 
T2-3 (20-34)" 
T2-4 ( 80-92) 
T2-5 (1-19) 
T2-6 (76-92) 
T2-7 (76•92) 
T3-1 (61-68) 
T3-i (48-55) 
T3-3 (20-34) 
T3-4 (20- 34) 
Elution 
Time 
33 
34 
35 
57 
59 
62 
63 
27 
30 
35 
36 
Sequence 
Gly-Al a-Q.!z.-!!:.!-!!:.!-Pro- Ser-Ala-Ser-~-Gln­
~-Q.!z,-Val-Arg 
Ser-Arg 
Ala- Ile- Ser-~-Ql::i.-Gln-Val-~-~-Ala- I le-
Gly-Pro-Cys-Leu-Ala-Tyr-Ala-Arg 
~.:,Glx-Y&-Ar~-~-~-Tyr-Ala-.!,k-~-_&!-
Ser-.!.k-As£-fr!-Ser-Arg 
~-_gz-Y!!_-Ar8-~-f.!.2.-Tyr-fu-.!,k-~-fu-
Ser-~-As£-fr!-Ser-Arg 
,Y&-Ser-Q.!l.-~-~-fu-£!1.-Lys 
fu-fu-~-~-~-~-Leu-Lys 
Q!y-fu-.QJz-!l!-_&!-f.!.2.- Ser- Ala- Ser-~-Gln-
Ser-Q.!l.-Val-Arg 
Q.!.z.-Ala-Qlrfu-!!_!-~-~-!!2_-~-~-~-
Se r-Q.!x,-Y!!_-Ar g 
Table XX- (Cont.) 
Peptide No. 
and Position 
in Sequence 
Elution 
Time 
T3-5 (83-95) 38 
T3-6 ( 80-92) 56 
T3-7 (1-19) 60 
T4-l (42-47) 11 
T4-2 (42-4 7) 12 
T4-3 ( 76-79) 17 
T4-4 (35-41) 23 
T4-5 (61-68) 24 
T4-6 (69-75) 26 
T4-7 ( 80-92) 49 
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Sequence 
Asn-Asn 
~-Pro-Tyr-~-..!.1!:_-Ser-~-Ser-..!.1!:_-Asp-~-
Ser-Arg 
fu-.!..!!:_-Ser-~-Q1l_-QJE_-Val-Ser-~-fu-.D.£. 
Gly-Pro-Cys~Leu-Ala-Tyr-Ala-Arg 
.!!!!.-ThE.-~-As£_- Arg- Arg 
.:!!!.!.-.:!!!.!.-:Ala-~-Ar g-Ar g 
~-Glx_-~-Ar_a 
Se r-~-~-Ala-fu-~-Arg 
Val-~-Q!.y_-~-~-fu-Q1l_-Lys 
~S~~Ser-lli-.!:!:£-Glx_-Ar~ 
~-~-Tyr-~-~-~-~-~-I1e-Ase_-2-
Ser-Arg 
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Peptides T4-1, T4-2 and!:] (positions 42-47) 
Peptide ~ (positions 48-55) 
The identity of Leu54 was ascertained by semi-quantitative am1no acid 
analysis by the dansyl-chloride method and by comparison with peptide 
Ch4-l. 
Peptide T-2 (positions 56-60) 
Peptides T-6, !l:l' and T4-5 (positions 61-68) 
. d . f. L 64 . d b b. . . d T3 1 The 1 ent1ty o eu was ascerta1ne y su JeCt1ng pept1 e - to 
3 cycles of degradation by the "Dansyl-Edman" method, by semi-
quantitative amino acid analysis by the dansyl-chloride method and 
by comparison with peptides Th-7, Th-11 and Th-12. 
Peptides T-7 ~ T4-6 (positions 69-75) 
'd . f 1 72 . d b . . . . 'd The 1 ent1ty o I e was ascerta1ne y sem1-quant1tat1ve am1no ac1 
analysis by the dansyl-chloride ·method and by comparison with peptide 
Ch4-6. 
Peptides T-4 and ~ (positions 76-79) 
173 
Peptide T-8 (positions 77-82) 
£!1..-.Y.!!_-Arg-Leu-Pro-Tyr 
The identity of Leu80 was ascertained by semi-quantitative amino acid 
analysis by the dansyl-chloride method and by comparison with peptides 
T2-4, T3-7 , T4-7 . Peptide T-8 arose due to the ·rather unusual cleavages 
of the peptide bonds Cys 76-Gly and Tyr 82-Ala, the later being a 
chymotrypsin cleavage site. Cleavage at the carboxyl side of cysteine 
by trypsin have been reported before in the bovine ~-crystallin Bp chain 
by Driessen et al. (1983). 
Peptides T2-6 and !1:2 (positions 76-92) 
~-Qly-Val-Arg-Leu-Pro-Tyr-~-Ile-~-Ala-Ser-Ile-Asp-Cys-Ser-Arg 
Th . d . f 80 . d b . . h . d T2 4 e 1 ent1ty o Leu was ascerta1ne y compar1son w1t pept1 es - , 
T3-6 and T4-7 and by subjecting peptides T2-6 and T2-7 to four cycles 
of degradation by the "Dansyl-Edman" method. 
79 In peptides T-8, T2-6 and T2-7 the peptide bond Arg -Leu 
was not cleaved by trypsin. This is probably due to the proximity of 
proline at position 81. 
Peptides T2-4, T3-6 and T4-7 (positions 80-92) 
The identity of Leu80 , ne84 and Ile 88 were ascertained by subjecting 
the peptides to 5 cycles of degradation by the "Dansyl-Edman" method, 
by N-terminal analysis by the dansyl-chloride method and by semi-
quantitative amino acid analysis by the dansyl-chloride method. 
Peptide T3-5 (positions 83-95) 
.!1.!-,!k-~-fu_-~-Ile-Asp-~-~-Arg-Val-Asn-Asn 
Peptide T3-5 is the product of an anomalous tryptic cleavage at the 
82 peptide bond Tyr -Ala. As the same peptide was also obtained in the 
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chymotryptic cleavage of the inhibitor (see peptides Chl-2 and Ch2-3), 
most probably its presence in the tryptic digest is due to a chymotrypsin 
contamination in the trypsin preparation utilised. The identity of 
84 88 Ile and Ile were ascertained by semi-quantitative amino acid analysis 
by the dansyl-chloride method. 
Peptide T-1 (positions 93-95) 
Val-Asn-Asn 
--· ----
Peptide T-1 was identified as the C-terminal peptide, as it lacked 
arginine and lysine. 
76 Apart from the cleavage of the peptide bonds Cys -Gly and 
. 82 
Tyr -Ala, the observed cleavage sites in the digestion of the ~-amylase 
inhibitor with trypsin were consistent with the specificity of 
trypsin. The existence of peptides T-8 (Gly 77-Val-Arg-Leu-Pro-Tyr) 
might suggest that the residue at position 76 (cysteine) was mistakenly 
identified, since neither trypsin or chymotrypsin (the usual contaminant 
of trypsin preparations) normally cleave at the carboxyl side of cysteine. 
In this case special attention was dedicated to this region of the 
inhibitor molecule and in all cases, the residue at position 76 was· 
positively identified as cysteine (see peptides T-4, T2-6, T2-7, 
Ch4-7, Th-11 and Th-12). 
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3.4.4. Chymotrypsin Digestion 
15 mg of the reduced and carboxymethylated inhibitor 
were subjected to chymotrypsin digestion, under the conditions described 
in Section 2.2.6.3.2._-The fragments obtained were initially fractioned 
on a Sephadex G-50 column, equilibrated in O.OSM ammonium bicarbonate 
(Figure 49) and each of the pooled fractions was subsequently s~bjected 
to RP-HPLC. The chromatograms of the HPLC separation of peaks 1, 2, 3 
and 4 are shown in Figures SO, 51, 52 and 53, respective~Y The 
sequences, elution times and positions in the sequence of each of the 
peptides obtained are presented in Table XXI. 
Peptide Ch1-4 (positions 1-15) 
2 11 17 . The identities of Ile , Ile and Leu were ascertamed by subjecting 
the peptides to a cycle of degradation by the ~'Dansyl-Edman" method. 
and by semi-quantitative amino acid analysis by the dansyl-ch1oride 
method. Also the specificity of chymotrypsin, as well as the comparison 
with peptides Ch3-4 and Ch4-S helped to ascertain the identity of Leu 17 . 
Peptide Ch3-4 and Ch4-S (positions 9-17) 
The cleavage of the peptide bond Ser8-Ser, which gave n.se to peptides 
Ch3-4 and Ch4-S, does not correspond to the usual specificity of 
chymotrypsin. Further examples of cleavage by chymotrypsin at the 
carboxyl side of serine will be given later (see peptides Ch1-1, Ch2-1, 
Ch4-2 and Ch4-7 below). The identity of Ile 11 and Leu 17 was ascertained 
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Figure 49 - Chromatography of the products of the digestion by chymotrypsin 
of the «.-amylase inhibitor from seeds of ragi (Indian finger 
millet, Eleusine coracana Gaertn.) on a Sephadex G-50 column (0.8 x 190 
em) in O.OSM annnonium bicarbonate (flow rate 6 ml/h., fraction size 1.4 
ml). 
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Figure 50 - RP-HPLC separation of fraction Ch-1 from the chymotrypsin 
digestion of the ~-amylase inhibitor from ragi seeds 
(I~dian finger millet; Eleusine coracana Gaertn.) on a C-18 ~-Bondapak 
column (0. 5 x 25cm) with a linear gradient of 70% ( v/v) acetonitrlle 
in 0.1% (v/v) trifluoracetic acid at a flow rate of 1.0 ml/min. 
Fractions which were fully or partially sequenced are numbered. Dotted 
line indicates concentration of acetonitrile. 
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Figure 51 - RP-HPLC separation of fraction Ch-2 from the chymotrypsin 
digestion of the ~-amylase inhibitor from ragi seeds 
(Indian finger millet, Eleusine coracana Gaertn.) on a C-18 p-Bondapak 
colunm (0.5 x 2Scm) with a linear gradient of 70% .(v/v) acetonitrile 
in 0.1% (v/v) trifluoracetic acid at a flow ratw of 1.0 ml/min. 
Fractions which were fully or partially sequenced are numbered. Dotted 
lines indicate~ concentration of acetonitrile. 
- ... .. 
...... 
... 
1.5 
13 
c 
..;:t 
r-1 
N 
!:il 1.0 u 
~ 
~ p:: 
0 
en 
~ 
. 5 .. 
~ 
...... 
.. 
.. 
.... 
3 
~ 
20 
.. 
.. 
.... 
.. 
.. 
... 
IJJ 
. 
40 
TIME( . ) m~n 
4 
... 
... 
..... 
... 
... 
.... 
60 
179 
. 
• 20 
...... 
-
!:il 
-40 
,....:1 
..... p:: 
.E-< 
..... 
s 
E-< 
. !:il 
u 
< 
~ 
60 
. 
80 
-
Figure 52 - RP-HPLC separation of fraction Ch-3 from the chymotrypsin 
digestion of the ~-amylase inhibitor from ragi seeds 
(Indian finger millet, Eleusine coracana Gaertn.) on a C-18 u-Bondapak 
column (0.5 x 25cm) with a linear gradient of 70% (v/v) acetonitrile 
in 0.1% (v/v) trifluoracetic acid at a flow rate of 1.0 ml/min. 
Fractions which were fully or partially sequenced are numbered. Dotted 
line indicates concentration of acetonitrile. 
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Figure 53 - RP-HPLC separation of fraction Ch-4 from the chymotrypsin 
digestion of the ~-amylase inhibitor from ragi seeds 
(Indian finger millet, Eleusine coracana Gaertn.) on a C-18 p-Bondapak 
column (0.5 x 25cm) with a linear.gradient of 70% (v/v) acetonitrile 
in 0.1% (v/v) trifluoracetic acid at a flow rate of 1.0 ml/min. 
Fractions which were fully or partially sequenced are numbered. Dotted 
line indicate~concentration of acetonitrile. 
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Table XXI - Peptides obtained by the RP-HPLC separation of Sephadex G-
SO fractions Chl to Ch4 from chymotrypsin digestion of the 
~-amylase inhibitor from ragi seeds (Indian finger millet, Eleusine 
coracana Gaertn.) 
Peptide No. 
and Position 
1.n Sequence 
Elution 
Time 
Chl-1 
Chl-2 
Chl-3 
Chl-4 
Ch2-l 
Ch2-2 
Ch2-3 
Ch2-4 
Ch3-1 
Ch3-2 
Ch3-3 
Ch3-4 
Ch4-l 
Ch4-2 
Ch4-3 
Ch4-4 
( 18 -26) 32 
( 83-9 5) 38 
(18 -36) 41 
(1-15) 
(18-26) 
(43-54) 
(83-95) 
(65-82) 
56 
32 
33 
39 
so 
(43-51) 15 
(57-64) 28 
(37-42) 29 
(9-17) 46 
(52-54) 5 
(65-70) 7 
(43-51) 15 
(55-64) 32 
Sequence 
Ala-Ile-~-~-~-~-Asp-~-Ser-Arg-Val-
Asn-Asn 
£!!-Gln-~-Gly-Val-Arg-Ser-Leu 
QlL-~-~-Leu 
A1a-Arg-Q!y-~-Gll_-~-Ala-Pro-Ser 
~-~-Asp-Ar~-Arg-~-Ala-~-~-Cys-Ser-Leu 
Asn-Asn 
Cys-Gly-Val-Arg-Leu-Pro-Tyr 
Lys-Ser-fu-A!!-~-Ars_-.Y.!!_-~-Q!z-Leu 
Table XXI- (Cont.) 
Peptide-No. 
and Position 
-in Sequence 
Ch4-S 
Ch4-6 
(9-17) 
(71-82) 
Elution 
Time 
47 
49 
182 
Sequence 
Pro-Tyr 
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by subjecting the peptides to 2 cycles of degradation by the "Dansyl-Edman" 
method and by semi-quantitative amino acid analysis by the dansyl-chloride 
method. 
Peptide Ch1-3 (positions 18 -36) 
Ser-Leu 
The cleavage of the peptide bond Ser26 -Ala gave rise to peptides Chl-1 
Ala-Ala-Pro-Ser) . The data from semi-quantitative amino acid analysis 
----
by the dansyl-chloride method of peptides Ch1-1 and Ch2-1, provide 
support to the fact that Ser28 is the C-terminal residue of both 
peptides: both peptides lack cysteine, glutamine, arginine, valine and 
leucine. The peptide corresponding to positions 27 to 36 was not 
recovered. Peptides Ch1-1 and Ch2-1 are further examples in the present 
sequence, of cleavage at the carboxyl side of serine by chymotrypsin. 
Peptide ~ (positions 37-42) 
Peptide ~ (positions 43-54) 
ID£-A1a-Asp-Arg-Arg-Ala-Ala-fx!-Asn-Cys-Ser-Leu 
Peptides Ch3-1 and Ch4-3 (Thr-Ala-Asp-Ar~-Arg-Ala-Ala-~-As~) and 
Ch4-l (~-Ser-Leu) resulted from the cleavage of the peptide bond 
Asn 51-Cys in peptide Ch2-2. Residue 54 was identified as leucine from 
the specificity of chymotrypsin. Semi-quantitative amino acid analysis 
by the dansyl-chloride method of peptides Ch2-2 and Ch4-l provided 
184 
further confirmation of the identity of the residue at position 54. 
Peptide Ch4-4 (positions 55-64) 
!:.Y2..-~-~-Ala-Ser-Arg-Val-Ser-Q.!y_-Leu 
Peptide Ch3-2 (positions sj-64) 
Ala-Ala- Ser-Arg_-Val-~-Qlr-Leu 
Peptide Ch3-2 constitutes another example of the cleavage by chymotrypsin 
at the carboxyl side of serine. 
Peptide Ch2-4 (positions 65-82) 
~-Ala-Qly-~-Ala-~-~-Ile-Pro-~-Arg-Cys-Gly-Val-Arg-Leu-Pro-
Tyr 
The identity of Ile 72 was ascertained by comparison with peptides Ch4-6. 
The cleavage of the peptide bond Ser 70 -Ser gave rise to peptides Ch4-2 
Arg-Leu-Pro-Tyr). Again, this constitutes another example of the 
cleavage by chymotrypsin at the carboxyl side of serine. The identities 
72 . 80 . Ile and Leu were ascerta1ned by subjecting the peptides to 2 cycles 
of degradation by the "Dansyl-Edman" method, by semi-quantitative amino 
acid analysis by the dansyl-chloride method and by comparison with 
peptides T2-4, T3-6 and T4-7. 
Peptides Chl-2 and Ch2-3 (positions 83-95) 
·Ala- Ile- Ser-Ala- Ser-: I le-Asp-fE-Ser- Arg-Val-Asn- Asn 
The identities of Ite 84 and Ile 88 were ascertained by subjecting the 
peptides to 2 cycles of degradation by the "Dansyl-Edman" method and 
by semi-quantitative amino acid analysis by the dansyl-chloride method. 
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The treatment of the ~-amylase inhibitor with chymotrypsin 
led to the expected cleavages at the carboxyl side of tyrosine, leucine 
and asparagine. In addition cleavages were also observed at the 
carboxyl side of serine and threonine. Cleavages at threonine residues 
were also observed in the· amino acid sequence determination of the 
trypsin/ ~-amylase inhibitor from ragi seeds (this work), and have 
also been reported before by Croft (1980). Cleavage at the carboxyl 
side of serine residues have not been reported before. 
· 3.4.5. Staphylococcus aureus (Strain V-8) Protease Digestion 
10 mg of the reduced and carboxymethylated protein was used 
for digestion with the Staphylococcus aureus (Strain V-8) protease, 
under the conditions described in Section 2.2.6.3.4. The purification 
of the resulting peptides was performed by fractionating the digest 
on a Sephadex G-50 column equilibrated in 0.05M ammonium bicarbonate 
and subsequently subjecting each one of the pooled fractions (Figure 
54) to RP-HPLC .. The chromatograms of the HPLC separ~ti0n of peaks 
2 and 3 are shown in Figures 55 and 56, respectively. No pure peptides 
were recovered from the RP-HPLC separation of peak 1. The sequences, 
elution times and positions in the sequence of each of the peptides 
are presented in Table XXII. 
Peptides V2-4 and ~ (Positions 1-20) 
2 11 15 . The identities of Ile , Ile and Leu were ascertawed by subjecting 
the peptides to 2 cycles of degradation by the "Dansyl-Edman" method 
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Figure 54 - Chromatography of the products of the digestion by Staphylococcus 
aureus (strain V-8) protease digestion of the ~-amylase inhibitor 
from seeds of ragi (Indian finger millet, E1eusine coracana Gaertn.) on a 
Sephadex G-50 column (0.8 x 190 em) in O.OSM ammonium bicarbonate (flow 
rate 6ml/h., fraction size 1.4 ml). 
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Figure 55 - RP-HPLC separation of fraction V-2 from the Staphylococcus 
au reus (strain V- 8) protease of the ~-amylase inhibitor 
from rag1 seeds (Indian finger millet, Eleusine coracana Gaertn.) on a 
C-18 ~-Bondapak column (0.5 x 25cm) with a linear gradient of 70% 
(v/v) ace~onitrile in 0.1% (v/v) trifluoracetic acid at a flow rate of 
1.0 ml/min. Fractions corresponding to peptides which were fully or 
partially sequenced are numbered. Dotted line indicatesconcentration 
of acetonitrile. 
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Figure 56 - RP-HPLC separation of fraction V-3 from the Staphylococcus 
aureus (strain V-8) protease of the ~-amylase inhibitor from 
ragi seeds (Indian finger millet, Eleusine coracana Gaertn.) on a C-18 
p-Bondapak column (0.5 x 25 em) with a linear gradient of 70% (v/v) 
acetonitrile in 0.1% (v/v) trifluorscetic acid at a flow rate of 1.0 
ml/min. Fractions corresponding to peptides which were fully or partially 
sequenced are numbered. Dotted line indicatesconcentration of 
acetonitrile. 
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Table XXII - Peptides obtained by the RP-HPLC separation of Sephadex G-50 
fractions V2 and V3. from Staphylococcus aureus (strain V-8) 
protease digestion of the ~-amylase inhibitor from ragi seeds (Indian 
finger millet, Eleusine coracana"Gaertn.) 
Peptide No. 
and Position 
in Sequence 
V2-l (23-45) 
V2-2 (58-83) 
V2-3 (58-83) 
V2-4 (1-22) 
V3-l (86-95) 
V3-2 (84-95) 
V3-3 (9- 21) 
V3-4 (1 -22) 
Elution 
Time 
33 
47 
so 
52 
24 
32 
43 
51 
Sequence 
Ala-~-Pro-.§!!.-A!!,-~-~-.Q!E_-~-.9b:,-Y!!_- . 
~rg-Ser-Leu-Asn-Ala-Ala-Ala-Arg-Thr-Thr-Ala-
Asp 
~-~-Ar~-~-~-Qll-~-~-~-Gly-Lys-
Ala-Ser-Ser-Ile-Pro-Gly-Arg-Cys-Gly-Val-Arg-
Leu-Pro-Tyr-Ala 
Ala-Ser-Ser-Ile-Pro-Gly-Arg-Cys-Gly-Val-Arg 
Leu-Pro-Tyr-Ala 
Q.!x_-Pro-~-~-~-Tyr-_lli-Arg-.Q.!l,-Ala-Gly 
~-~-,lli-Asp-~-~-Ar_&-Y!!_-~-Asn 
lli.- Ser- Ala-Ser- Ile-As:e_-~-Ser-Arg-Y!!_-Asn-Asn 
Ser-Ala-Ile-~-Pro-~-Leu-Ala-!r;-~-Arg-Gly-A1 
fu-!.!!;_-Ser-~-Gly-~-.Y!1,-Ser-~-fu-!.!!;_-
190 
and by comparison with peptides Ch3-4 and Ch4-6. 
Peptide V3-3 (positions 9-21) 
Ser:~-Ile_-Gly-K.!.2.-~-~ -A1a-~-~-Arg-Gly-A1a 
The identities of Ile 11 an~ Leu15 were ascertained by subjecting the 
peptide to 2 cycles of degradation by the "Dansyl-Edman" method, by 
semi-quantitative amino acid analysis by the dansyl-chloride method 
and by comparison with peptides Ch3-4 and Ch4-5. 
Peptide V2-1 (positions 21-57) 
Al'a-Ala-K.!.2.-~-fu-~-~-Q!!!.-Ser-£!l,-Val-ArJl-~-~-Asn-Ala-Ala-
Ala-Arg-Thr-Thr-Ala-Asp 
Th . d . f L 36 . d b . . h . d T 9 e 1 ent1ty o eu was ascerta1ne y compar1son w1t pept1 es - , 
T6-12 and Th-6. 
Peptides V2-2 ~~(positions 58-83) 
;.. . 
,.~;. 
Ala-~-Arg-~-Ser-Glr~-~-Ala-Q.ll-Lys-Ala-Ser-Ser-Ile-Pro-
Gly-Arg-Cys-Gly-Val-Arg-Leu-Pro-Tyr-Ala 
The identity of Leu64 was ascertained by comparison with peptides Th-11, 
Th-12 and Th-3 and by semi-quantitative amino acid analysis by the 
dansyl-chloride method. 
Peptide V3-2 (positions 84-95) 
The identities of Ile84 and Ile88 were ascertained by N-terminal analysis 
by the dansyl-chloride method and by semi-quantitative amino acid 
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analysis by the dansyl-chloride method. 
Peptide V3-l (positions 86-95) 
The identity of Ile 88 was ascertained by subjecting the peptide to 2 
cycles of degradation by the "Dansyl-Edman" method. 
The observed cleavage sites ~n the digestion of the ~-
amylase inhibitor with Staphylococcus aureus (strain V-8) protease, were 
not consistent with the specificity of the enzyme (Drapeau, 1977). Under 
the digestion conditions utilized here, only 3 fargments would be 
expected, as the molecule has only 2 aspartic acid residues and no 
glutamic acid residues. However, six fragments were recovered and none of 
them resulted from the cleavage of Asp-X peptide bonds. Instead, the 
fragments obtained were derived from the cleavage of Ser-Ser, Gly-Ala, 
Ala-Ala, Ala-Ile and Ser-Ala peptide bonds. Similar non-specific cleavages 
have previously been reported in the literature. For example, cleavage 
on the C-terminal side of some glycine and alanine residues was reported 
in Escherichia coli ribossomal protein L-11 (Dognin and Wittman-Liebold, 
1977). Also, Richardson (1979) reported cleavage at the carboxyl side 
of glycine in the aubergine protease inhibitor. Cleavage at the carboxyl 
side of serine residues was reported in the ~-crystallin Bp chain by 
Driessen et al (1983). It is not certain whether the non-recovery of the 
--
. pep tides expected to result from the cleavage of the 45 Asp -Arg and 
Asp 89 -Cys peptide bonds was due to the loss of the peptides during the 
purification of the digest by molecular exclusion chromatography or that 
' the peptides were eluted together from the RP-HPLC column mixed with 
other peptides o~, alternatively, that these peptide bonds were not 
actually cleaved. However, in the analysis of the peptides resulting 
from the RP-HPLC separation of peak 3 (Figure 56), the fraction 
eluted at 35 minutes was shown to have a peptide with arginine at 
the N-terminal. Unfortunately this peak was composed of at least 3 
\ different peptides and so their sequences could not be established. 
3.4.6. Thermolysin Digestion 
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5 mg ot the reduced and carboxymethylated inhibitor was 
subjected to thermolysin hydrolysis, under the conditions described in 
Section 2.2.6.3.3. The purification of the resulting peptides was done 
by subjecting the hydrolysate directly to RP-HPLC without previous 
purification (Figure s7). The sequences, elution times and positions ~n 
the sequence of the peptides purified are presented in Table XXIII. 
Peptide ThS (positions 1-6) 
The identity of Ile2 was ascertained by subjecting the peptide to a 
cycle of degradation by the "Dansyl-Edman" method and by semi-quantitative 
amino acid analysis by the dansyl-chloride method. 
Peptide Th9 (positions 1-9) 
The identity of Ile2 was ascertained by subjecting the peptide to a 
cycle of degradation by the "Dansyl-Edman" method and by semi-quantitative 
am~no acid analysis by the dansyl-chloride method. · 
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Figure 57 - RP-HPLC separation of peptides obtained by the digestion 
of the ~-amylase inhibitor from ragi seeds (Indian finger 
millet, Eleusine coracana Gaertn.) with thermolysin. The separation 
was performed on a C-18 p-Bondapak column (0.5 x 25cm) with a linear 
gradient of 70% (v/v) acetonitrile in 0.1% (v/v) trifluoracetic acid 
at a flow rate of 1.0 ml/min. Fractions which were fully or partially 
sequenced are numbered. Dotted line indicates concentration of 
acetonitrile. 
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Table XXIII - Peptides obtained by the RP-HPLC separation of the 
thermo1ysin digest of the ~-amylase inhibitor from ragi 
seeds (Indian finger millet, Eleusine coracana) 
Peptide No. Elution 
and Position Time Sequence 1n Sequence 
Th-1 (48-53) 7 Ala-Ala-~-Asn-~-Ser 
Th-2 (36-38) 8 Leu-Asn-Ala 
---
Th-3 (64-68) 13 ~-Asn-Ala-.Q_!z-Lys 
Th-4 ( 39-47) 14 Ala-.!!,!-Ar,Si-I.h.;:-Th r- Ala- AsE- Arg- Arg 
Th-5 (1-6) 17 _.!!.!-I le-Ser-~-Q.!1_-Gln 
Th-6 (23-32) 22 Ala-Ala-Pro-Ser-Ala-Ser-~-Gln-Ser-Gly 
Th-7 (11-17) 23 Ala-Q!y-Pro-~-.~eu-Ala-Tyr 
Th-8 (10-17) 24 Ala-Ile-Qly-~-~-Leu-Ala-Tyr 
Th-9 (1-9) 29 !!,!-lli-Ser-~-Qly-Gln-Val- Ser- Ser 
Th-10 (18-26) 30 Ala-Arg-.Q.!z-~-Q!x_-lli-.Q.!z-~-Ala-~-Ser 
Th-11 (64-79) 47 Leu-~-~-Gli:-~-lli-~-~-Ile-I!2.-.Q.!z-Arg_-
~-.Q_!z-Val-Arg 
Th-12 (64-79) so 
~-Q.!y_-Val-Arg 
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Peptide Th8_ (positions 10-17) 
.Ala- I le-Qlr-Pro-~-Leu-Ala-Tyr 
Peptide Th7 (positions 11-17) 
I le- Glx:-~-~-Leu-Ala-Tyr 
Peptide Thl0 (positions 18-26) 
Peptide Th6 (positions 23-32) 
~-Ala-Pro-Ser-~-Ser-~-~-Ser-Gly 
Peptide_ Th2 (positions 36-38) 
Leu-Asn-Ala 
The identity of Leu36 was ascertained by N-terminal analysis by the 
dansyl-chloride method and by semi-quantitative amino acid analysis 
by the dansyl-chloride method. 
Peptide Th4 (positions 39-47) 
Peptide Thl (positons 48-53) 
Peptide !h1 (positons· 64-68) 
The identity o.f Leu64 was ascertained by N-terminal analysis by the 
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dansyl-chloride method, and by semi-quantitative amino acid analysis 
by the dansyl-chloride method. 
Peptides Th11 and Th12 (positions 64-79) 
Lue-Asn-Ala-Gly-Lys-Ala-ser-ser-Ile-Pr~Gly-Arg-Cys-Gly-Val-Arg 
64 72 
The identities of Leu and Ile were ascertained by N-terminal amino 
acid analysis by the dansyl-chloride method and by semi-quantitative 
amino acid analysis by the dansyl-chloride method. 
The observed cleavage sites in the digestion of thedt-
amylase inhibitor with thermolysin were consistent with the broad 
specificity of the enzyme. The direct fractionation of the digest by 
RP-HPLC without prior separation of the components by molecular exclusion 
chromatography, prevented II the purification of many peptides, as some 
of the peaks collected were composed of more than one peptide (Figure 
57.)). However, the peptides which were needed to establish consistent 
overlapping were recovered, namely Th4, Th10, Th11 and Th11. 
The complete amino acid sequence of the ragi r:J. -amylase 
inhibitor is shown in Figure 58. The only region in the sequence which 
lacks support from good overlapping segments (3 or more residues) of 
peptides is the sequence of residues 54 to 58. However, the sequence 
is entirely compatible with the results of the amino acid analysis of 
the inhibitor (Table XIII). The molecular weight of 9314 is in good 
agreement with the value calculated from 80S-polyacrylamide gel 
electrophoresis (Figure Sa). 
\ The ragi ~ -amylase inhib~or has an odd number of cysteine 
residues (7) and in this aspect it resembles the 0./53 ~-amylase 
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inhibitor from wheat (Maeda et al)., 1983) which also has an odd number 
~ 
of cysteine rsidues. 
~ 
Also notable is the high isoelectric point of 
this inhibitor (above 10) which reflects its high content of basic 
residues (9 arginine and 2 lysine residues) and the small number of 
strongly acidic residues (2 aspartic acid residues). Although the 
rag~-amylase inhibitor was reported to possess a 10% content of 
carbohydrate (Shivaraj and Pattabiraman, 1981), no evidence was found 
to confirm it during this work. The presence of such a high content 
of carbohydrate in a protein, would be detected during acid hydrolysis 
of peptides derived from chemical or enzymatic hydrolysis of the 
protein. 
Another noteworthy feature of the ragicC-amylase inhibitor 
is its unusually high content of alanine and serine residues, which is 
unique among trypsin and~-amylase inhibitors. The inhibitor is 
devoid of methionine, phenylalanine, histidine, and tryptophan residues. 
It is perhaps worth noting that the 0.28 inhibitor from wheat is also 
devoid of phenylalanine and histidine and that the 0.53 inhibitor 
contains only low levels of these amino acids. 
3.4.7. Sequence Comparison 
The ragi.C-amylase inhibitor has no apparent homology with 
the trypsin/~-amylase inhibitor found in the same tissue or with 
other~-amylase inhibitors which have been sequenced so far (Aschauer 
et al., 1981; Kashlan and Richardson, 1981; Maeda et al., 1983; 
Hejgaard et al., 1983) or with any of the plant proteinase inhibitors 
(Ramshaw, 1982). 
Gene duplication is a phenomenon which is thought to be the 
main process responsible for the evolution of the majority of the 
extant proteins and certainly most enzymes (Doolittle, 1981). The 
presence of internal sequence homology, which may constitute a sign 
of ancestral gene duplication, has been demonstrated to occur among 
all members of the Bowman-Birk inhibitor family (Richardson, 1977, 1980, 
1981~ Laskowski and Kato, 1980~ Ryan, 1981) and among members of the 
pancreatic secretory trypsin inmhibitor (Kazal) family (Laskowski and 
Kato, 1980). Regarding the ragi ~-amylase inhibitor one of the 
noteworthy features of its sequence is the presence of two regions of 
similar sequence in the molecule. As illustrated in Figure 59, the 
sequences between positions 8 and 47 and between 53 and 92 , can be 
aligned and out of 40 residues in these regions, there are ten pairs 
of matching residues. However, when the alignment was analysed to find 
out whether the similarity between these two regions is indicative of 
homology, i.e. common ancestry, the results were indecisive as the 
value of _!(-2.893) for the alignment was just below the value where 
the hypothesis of homology is accepted. This does not necessarily mean 
that gene duplication has not occurred, but merely that the similarity 
between them is too weak to be statistically significant. 
3. 5 Prediction of the Secondary Structure of the f!:. -Amylase Inhibitor 
from Ragi (Indian Finger Millet, Eleusine coracana Gaertn) 
The predicted secondary structure of the ragiaC-amylase 
inhibitor is presented in Figure 60. The values of the decision constants 
(see Section 2.2.8) were chosen after a preliminary predictive run 
where the decision constants were set to zero. The predicted secondary 
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dansyl-chloride method, and by semi-quantitative am~no acid analysis 
by the dansyl-chloride method. 
Peptides Thll and Thl2 (positions 64-79) 
Th . d . . f L 64 d I 1 72 . · · e 1 ent1t1es o eu an e were ascerta1ned·by N-termlnal aw1no 
acid analysis by the dansyl-chloride method and by semi-quantitative 
am1no acid analysis by the dansyl-chloride method. 
The observed cleavage sites 1n the digestion of the cf..-
amylase inhibitor with thermolysin were consistent with the broad 
specificity of the enzyme. The direct fractionation of the digest by 
RP-HPLC without prior separation-of the components by molecular exclusion 
chromatography, prevented the purification of many peptides, as some 
of the peaks collected were composed of more than one peptide (Figure 
57). Howev~r, the peptides which were needed to establish consistent 
overlapping were recovered, namely Th4, ThlO, Thll and Thll. 
The complete am1no acid sequence of the ragi a:-amylase 
inhibitor is shown in Figure 58. The only region 1n the sequence which 
lacks support from good over1apping segments (3 or more residues) of 
peptides is the sequence of residues 54 to 58. However, the sequence 
is entirely compatible with the results of the amino acid analysis of 
the inhibitor (Table XIII). The molecular '"eight of 9314 is in good 
agreement with the value calculated from SDS-polyacrylamide gel 
e.lectTophore.sis{FtC\IIt • So.) 
The T~gi ~-amylas~ inhibitoT has a~ odd oumb~T of c~st~\na 
Figure 58 - The complete amino acid sequence of the ~ -amylase 
inhibitor. T = tryptic peptides, C = chymotryptic peptides, 
Th = thermolysin peptides, V = StaPEX1~~~~~~s aureu~ (strain V-8) 
peptides. .------.) peptide sequenced by the DABITC-PITC double 
coupling·method and/or the dansyl-Edman method; (-- -- --) regions 
of peptides which were not sequenced or gave unsatisfactory results 
10 20 30 
ALA ILE SER CYS GLY GLN VAL SER SER ALA ILE GLY PRO CYS LEU ALA TYR ALA ARG GLY ALA GLY ALA ALA PRO SER ALA SER CYS GLN SER GLY VAL ARG 
+---------------------~ - -- -
T- 9 I T 2- 5 I T3 - 7 --
- + 
T2-11 T2-2,T2-3 ~B-3 ,B-4 
Ch1-4 -+ Ch 1-1 -~ 
Ch3-41 Ch4-5 -~ Ch1-3 
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+------------------IT~,-----------------+ 
- - v 3-2 
~ 
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inhibitor from wheat (Maeda~~·, 1983) which also has an odd number· 
of cysteine residues. Also notable 1B the high isoelectric point of 
this inhibitor (above 10) which reflects its high content of basic 
residues (9 arginine and 2 lysine residues) and the small number of 
strongly acidic residues (2 aspartic acid residues). Although the 
ragi 6..-amyl.ase inhibitor was reported to possess a 10% content of 
carbohydrate (Shivaraj and Pattabiraman, 1981), no evidence was found 
to confirm it during this work. The presence of such a high content 
of carbohydrate in a protein, would be detected during acid hydrolysis 
of peptides derived from chemical or enzymatic hydrolysis of the 
protein. 
Another noteworthy feature of the ragi ~-amylase inhibitor 
1s its unusually high content of alanine and ser1ne residues, which 1s 
un1.que among trypsin and c£-amylase inhibitors. The inhibitor 1s 
devoid of methionine, phenylalanine, histidine, and tryptophan residues. 
It is perhaps worth noting that the 0.28 inhibitor from wheat is also 
devoid of phenylalanine and histidine and that the 0.53 inhibitor 
contains only low levels of these am1no acids. 
3.4. 7. Sequence Compcrison 
The ragi d-amylase inhibitor has no apparent homology with 
the trypsin/ eli-amylase inhibitor found in the same tissue or with 
other 6: :_amylase inhibitors whic;h have been sequenced so far (Aschauer 
~ ~-, 1981; Kashlan and Richardson, 1981; Maeda ~ ~·, 1983; 
liejga2rd et ~-, 1983) or with any of the plant proteinase inhibitors 
(Ramsha\ol, 19$1.). 
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Gene duplication is a phenomenon which 1s thought to be the 
ma1n process responsible for the evolution of the majority of the 
extant proteins and certainly most enzymes (Doolittle, 1981). The 
presence of internal sequence homology, which may constitutes a sign 
of ancestral gene duplication, has been demonstrated to occur among 
all menbers of the Bowman-Birk inhibitor family (Richardson, 1977, 1980~ 
1981; Laskowski and Kato, 1980; Ryan, 1981) and among menbers of the 
pancreatic secretory trypsin inhibitor (Kazal) family (Laskowski and 
Kat.o, 1980). Regarding -the ragi ~-amylase inhibitor one of the 
noteworthy features of its sequence. is the presence of two regions of 
similar sequence in the molecule. As illustiated 1n Figure~ , the 
sequences between positions 8 and 4 7 and between 53 and 92, can be 
aligned· and out of ·4Q residues 1n these regions, there are ten pa1rs 
of matching residues. However, when the alignment was analysed to find 
out whether the similarity between these two regions is indicative of 
homology, i.e. common ancestry, the results were indecisive as the 
value of~ (-2.893) for the alignment was just below the value where 
the hypothesis of homology is accepted. This does not necessarily means 
that gene duplication has not occurred, but .merely that the similarity 
between them is too weak to be statistically significant. 
3.5. Prediction of the Secondary Structure of the ct:-Amvlase Inhibitor 
from Ragi (Indian Finger Millet, Eleusine coracana Gaertn) 
The predicted secondary structure of the ragi oC-amylase 
inhibitor is presented in Figure 60. The values of the decision constants 
(see SQe.tion 2.2, 8.) "'~;.e. chosen after a preliminarl pl'ed:ic:.ti"e run 
wh~Te th4 d4ci-s.ion c.onsta.i\tS ~Te StZ.t to zero. The -predi c..t~ s.e.e.onaas:v 
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10 ~0 ~Ser Ala Ile Gly Pro Cys Leu Ala Tyr Ala Arg Gly Ala Gly Ala 
Leu Lys Ser Ala Ala Ser '0 Gly Asn Ala Gly Arg Val Ser Leu Lys 
30 ~Pr:§Ala Ser Cys Gln Ser Gly Val Arg Ser Leu Asn,Ala,Ala 
Ser· Ser Ile Pro Gly Arg cys Gly Val Arg LeJ•Pro Ty.r Ala Ile 
. ~0 Ala Arg Thr Thr Ala Asp Arg I Arg I 
Ile 
Q 
Ser Ala Ser Asp Ser Cys Arg 
~ 
Figure 59 - Homologous reg~ons ~n the amino acid sequence of the 
e~:.- amylase inhibitor from ragi seeds (Indian finger 
millet, Eleusine coracana Gaertn.). Identical residues are enclosed 
in boxes. Minimum distance measure= 34.5; similarity coefficient= 
0.25; z= -2.893 (insignificant homology). Parameters values: v=l, 
u=l, d=l. 
Ala Ile Ser Cys Gly Gln Val Ser Ser Ala Ile Gly Pro Cys Leu Ala Tyr 
E E E T T T T T T T C C T E E E E 
Ala Arg Gly Ala Gly Ala Ala Pro Ser Ala Ser Cys Gln Ser Gly Val Arg 
E T T T C C C C T T T T T T T C E 
Ser Leu Asn Ala Ala Ala Arg Thr Thr Ala Asp Arg Arg Ala Ala Cys Asn 
C C C C C C E C T T T T T T T T T 
Cys Ser Leu Cys Ser Ala Ala Ser Arg Val Ser Gly Leu Asn Ala Gly Lys 
T T T T C E E E E E C C C C C T T 
Ala Ser Ser Ile Pro Gly Arg Cys Gly Val Arg Leu Pro Tyr Ala Ile Ser 
C T E E T T T T T ·a E E E T T E. ~ 
Ala Ser Ile Asp Cys Ser Arg Val Asn Asn 
E. £ E T T T T T T T 
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Figure 60 -.Prediction of the secondary structure of the c(-amylase 
inhibitor from ragi seeds (Indian finger millet, Eleusine 
coracana Gaertn.). (T): (3-'tum; (C): random coil; (E): extended chain; 
(H): cJ... -helix. 
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structure of the ragi ~-amylase inhibitor has no similarities either 
with the ragi trypsin/ ~-amylase inhibitor or with other·«-amylase 
inhibitors so far sequenced. However, notable 1n the predicted secondary 
structure 1s the absence of a: -helix and the high content (50%) of 
P-turn, which at least in part, accounts for the thermal stability 
of the-inhibitor noted by Shivaraj and Pattabiraman (1980, 1981). 
-· 
3.6. The Complet!:_ Amino !£ii Sequence of the Protease Inhibitor PI-I 
from the Tracy_~ Cultivar of Soybean (Glycine max L. Merr) 
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The seeds of soybean are a very rich source of protein 
inhibitors ·of proteinases. On average these proteins comprise 6% of the 
proteins of d~hulled, defatted, soybean meal (David et !!.!.·, 1977). Two 
of these inhibitors, the so called Bowman-Birk (Birk et al., 1963) and 
Kunitz (Kunitz, 1946) inhibitors, were the first proteinase inhibitors 
ever to be isolated from plants. The Bowman-Birk inhibitor was initially 
sequenced by Odani et al (1971), but subsequently Odani and Ikenaka 
(1977a) showed that five proteinase inhibitors (named A, B, C-II, D-II, 
and E-I) could be isolated from an unnamed soybean cultivar, using 
eM-cellulose chromatography. Further studies (Odani and Ikenaka, 1976,. 
1978) showed that "the inhibitors A and B were identical with the 
Bowman-Birk inhibitor (inhibitor B merely being a deamidated form of 
inhibitor A); whilst inhibitors C-II and D-II were shown to have 
sequences which. were un1que but highly homologous to the Bmvman-Birk 
inhibitor. Inhibitor E-1 is a shortened version of D-II (Odani and 
Ikenaka, 1977b, 1978), lacking the first 9 N-terminal residues (Figure 
61). 
Other workers have also reported a similar multiplicity 
of closely related proteinase inhibitors in s9ybean seeds. For example, 
David et ~· (1977) reported that during a search for proteins \vith a 
high content of methionine and half-cystine, they isolated five . 
different but closely related inhibitots. of proteinases from seeds of 
the Tracy cultivar of soybean. These inhibitors were.named.PI-1, PI-II, 
PI-III, PI-IV and PI-V .. Immunological. test:s indicated that inhibitors 
D-II - Ser Asp Gln Ser 
C-II - Ser Asp His Ser 
BBI -
D-ll - Set 
C-II 
- Met 
BBI - A~'U 
D-II -
C-II -
BBI 
BBI 
Pro Pro Gln 
Pro Pro Gln 
Pro ?ro Gln 
Asp Asp 
Lys Glu Asn 
Ser Ser 
~er Ser 
Cys Ser 
Cys His 
Cys Arg 
Tyr Asp Asp ·Asp Glu Tyr Ser Lys Pro Cys Cys Asp Leu Cys Met Cys 
Asp Asp Glu Ser Ser Lys Pro Cys Cys Asp Leu Cys Met Cys 
Asp Asp Glu Ser Ser Lys Pro Cys Cys Asp Gln Cys Ala Cys 
Gln Asp Ile Arg Leu Asn Ser Cys His Ser Asp Cys Lys Ser Cys 
Ala Asp Ile Arg Leu Asn Ser Cys His Ser Ala Cys!Asp Arg,Cys 
Arg Leu Asn Ser Cys His Ser Ala Cys Lys Ser Cys 
Cys Arg Cys Leu Asp Thr Asn Asp Phe Cys Tyr Lys Pro 
Cys 
Cys 
Figure 6 1- Comparison of the amino acid sequences of the soybean 
-20L~ 
Thr 
Thr 
Thr 
Met 
Ile 
"·~ Ala Ser 
Lys Ser 
Ser Asp 
Ser Asp 
(Glycine ~) double headed proteinase inhibitors (Odani and 
Ikenaka, 1976). 'The reactive sites are shown by asterisks. Identical 
residues are enclosed in boxes. 
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PI-I through IV 1:vere similar in antigenic properties, but little cross 
reaction occurred between PI-V and the group PI-I - IV. Both group of 
inhibitors were double-headed, but only PI-V inhibited trypsin and 
chymotrypsin. Inhibitors PI-I - IV inhibited only trypsin at two 
different reactive sites. Furthermore, sequence analysis dem~nstrated 
that the N-terminal sequence of the PI-IV inhibitor was the same as the 
Bowman-Birk inhibitor from the unnamed japanese variety of soybean, 
and PI-II was shown to have the same N-terminal sequence as inhibitor 
E-1 (David et al., 1977). Following these studies, a collaborative 
effort was set up between the laboratories of Dr. Richardson and Dr. 
Foard,.with the aim of establishi~g the amino acid sequence of 
inhibitors' PI-I, PI-II and PI-IV. Inhibitor PI-IV was shown to have 
the same sequence as inhibitor D-II by Kashlan (1980), and here the 
results of the sequencing of inhibitor PI- I are presented. 
3. 6. L N.;;Terininal Analysis 
The N-terminal amino acid \-las determined by the dansyl-
chloride method. ~.,oN-terminal amino acids, aspartic acid and glutamic 
acid, were found. However with the determination of the N-terminal 
sequence of the native form of the inhibitor by the DABITC-PITC double 
coupling method, two sequences differing only at the N-terminal amino 
acid were obtained: 
Glu-Txr-Ser-~-Pro 
The analysis of the fragments· obtained by the trypsin digestion of the 
reduced and carboxymethylated inhibitor (see below) confirmed that the 
preparation was contaminated with the inhibitor PI-II (these two 
206 
inhibitors differ only in that inhibitor PI-II has an additional amino 
acid at theN-terminal- see Figure E#). 
3.6.2. Tryptic Digestion 
The fragments produced by the cleavage of the reduced and 
carboxymethylated inhibitor (20 mg) with trypsin were separated in a 
Biogel P-4 column, equilibrated in 0.05M pyridine-acetate buffer, pH 
5. 7 (Figure 62). Only fraction V could be directly sequenced without 
further purification, and it was shown to be composed of the peptides 
Ser-Arg-Asp-Asp , 
Ser-Arg and. 
Asp-Asp 
The remaining fractions (I - IV) were further purified by high voltage 
paper electrophoresis at pH 6. 5 and pH 1. 9. The sequencing of the 
peptides thus obtained (Table XXIV) was sufficient to establish the 
almost complete identity of inhibitor PI-I with inhibitors PI-II and 
D-II (Figures 6'3 and 61 ) . PI-I differ from PI-II and D-II only by 
having a deletion at the N~terminal and by a microheterogeneity at 
pqsition 30 (Ser/Pro) 
In the cultivar Tracy of soybean, the Bowman-Birk inhibitor 
constitutes 4% and the remaining structurally related inhibitors PI-I 
to PI-IV constitute about 2% ·of total protein (Foard et ~·, 1982). 
Inhibitors PI-I and PI-II have almost completely homologous sequences; 
PI-II and PI-IV differ from one another only in that PI-IV has an 
additional aspartic acid at the N-terminus and a microheterogeneity 
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Figure 62 · - Chromatography of the tryptic digest of the proteinase inhibitor 
'PI-I from soybean (Glycine~) cultivar Tracy, on a Biogel 
P-4 column (0.8 x 190cm) in 0.05M pyridine acetate buffer, pH 5.4 (flow 
rate 6ml/h., fraction size 1.4ml). Those fractions indicated by bars, 
representing peaks I to V) were pooled and freeze-dried. 
,) 
Peptide 
Number 
I 
II 
III 
IV 
v 
VI 
VII 
VIII 
Table XXIV 
--
Fraction Mobilit~ Sequence Number pH 6.5 pH 1. 9 · 
PI-Tl - 0.87 - Asp Glu Tyr Ser' Lys Pro Cys Cys Asp Leu Cys Met Cys Thr Arg 
PI-T2 - 0.82 - Glu Tyr Ser Lys Pro Cys Cys Asp·Leu Cys Met Cys Thr Arg 
PI-Tl - 1. 86 o.so Ser Met Pro Pro Gln Cys Ser Cys Glu Asp Ile Arg 
PI-T2 - 0.73 - Pro . 8 C Leu Asn S Cys H1s er Asp ys Lys er · · 
PI-T4 - 0.41 ·- Ser Cys Met Cys Thr Arg 
PI-T4 o·.o - Ser Glu Pro Gly Gln Cys Arg 
PI-T2 - 1.80 0.57 Cys Leu Asp Thr Asn Asp Phe Cys Tyr Lys Pro Cys Lys 
PI-TS - 0.21 - Ser Arg Asp Asp 
Peptides resulting from trypsin digest of soybean (Glycine ~) cv. Tracy protease inhibitor 
P~I ~nd purified by high voltage paper electrophoresis. 
N 
0 
co 
30 1 . · .10 . 20. Pro 
Asp-Glu-Tyr Ser-Lys-Pro-Cys-Cys-Asp-Leu-Cys-Met-Cys-Thr-Arg-Ser-Met-Pro-Pro-Gln-Cys-Ser-Cys-Glu-Asp-Ile-Arg-Leu-Asn- 8er 
I III IV · 
II 
. . 40 50 . . 60 
Cys-Hls-Ser-Asp-Cys-Lys-Ser-Cys-Met-Cys-Thr-Arg-Ser-Gln-Pro-Gly-Gln-Cys-Arg-Cys-Leu-Asp-Thr-Asn-Asp-Phe-Cys-Tyr-Lys~Pro-
v VI VII 
Cys-Lys-Ser-Arg-Asp-Asp 
VIII 
Figure 63 - The complete amino acid sequence of the soybean (Glycine max) cv. Tracy protease inhibitor PI-I. 
N 
0 
\0 
210 
PI-IV - Ser Asp Gln· Ser Ser Ser Tyr Asp Asp Asp Glu Tyr Ser Lys Pro Cys Cys Asp Leu Cys Met Cys 
Pl-V Asp Asp Glu Ser· Ser Lys Pro Cys Cys Asp Gln Cys Ala Cys 
PI-II - Asp Glu Tyr Ser Lys Pro Cys Cys Asp 4u Cys Met Cys 
PI~I ;Asp1 Glu Tyr Ser Lys Pro Cys Cys Asp Leu Cys Met Cys 
-··-..1 
PI-IV - Thr Arg Ser Met Pro Pro Gln Cys Ser Cys Glu Asp lle Arg Leu Asn Ser Cys His Ser Asp Cys 
PI-V - .Thr Lys Ser Asn Pro Pro Gln Cys Arg Cys Ser Asp Met Arg Leu Asn Ser Cys His Ser Ala Cys 
PI-II -- Thr Arg Ser Met Pro Pro Gln Cys Ser Cys Glu Asp_ Ile Arg Leu Asn Ser Cys His Ser Asp Cys 
PI-I 
- Thr Arg Set Met Pro Pro Gln Cys Ser Cys Glu Asp lle Arg Leu Asn Pro C Ser ys His Ser Asp Cys 
PI-IV - Lys_ Ser Cys Met Cys Thr Arg Ser Gln Pro Gly Gln Cys Arg Cys Leu Asp Thr Asn Asp Phe Cys 
PI-V 
- Lys Ser Cys lle Cys Ala Leil Ser Tyr Pro Ala Gln Cys Phe Cys Val Asp Ile Thr Asp Phe Cys 
PI-II - Lys Ser Cys. Met Cys Thr Arg Ser Gln Pro Gly Gln Cys Arg Cys Leu Asp Thr i);n Asp Phe Cys 
PI-I - Lys Ser Cys Met Cys Ihr Arg Ser Gln Pro Gly Gln Cys Arg Cys Leu Asp Thr Asn Asp Ph.e Cys 
PI-IV - Tyr Lys Pro Cys Lys Ser Arg Asp Asp 
PI-V Tyr Glu Pro Cys Lys Pro Ser Asp Asp Lys Glu Asn 
PI-II - Tyr Lys Pro Cys Lys Ser Arg Asp Asp 
PI-I - Tyr Lys Pro Cys Lys Ser Arg Asp Asp 
Figure L- Comparison of the amino acid sequence of inhibitors PI-IV (Kashlan, 1981), Pl-V 
(David~ al., 1977), PI-II (David et ~·, 1977) and PI-I. Identical residues are 
enclosed in boxes. 
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at position 30 (Ser/Pro) (Figure 63). Although the pnmary structure 
of PI-III is not yet known, its amino acid composition and the 
inhibition specificity (David~~·, 1977) closely resembles inhibitors 
PI-I, PI-II and PI-IV). 
The possibility of interconversion of these inhibitors 
. . \ 
through the loss of N-terminal amino acids 1s evident and indeed the 
existence of PI-I and PI-II differing only by one am1no acid at the 
N-terminal 1s a positive indication. Supporting this idea 1s the fact 
that in order to get homogeneous samples of inhibitors PI-I. to PI-IV 
for sequencing, .it was frequently necessary to recromatograph them 
when several minor inhibitor bands for each inhibitor were. obtained 
(D.E. Foard - personnal connnunication). Similar facts were reported by 
Odani and Ikenaka (1976) for the isolation of the four double headed 
inhibitors of the japanese cultivar of soybean. Similar indications 
of interconversion of. inhibitors through the loss of N-terrninal amino 
,acids was established for inhibitors I and I' and II and·II' from 
Ph_~olus vulgaris (Yoshikawa et al., 1979; Kiyohara et al., 1981). 
However, it remains uncertain whether these interconversions are artifacts 
of the purification procedure or post-translational modifications or 
if the different forms of these inhibitors are products of different 
genes. The presence of multiple forms of the same inhibitor is also 
cormnon 1n animals, but at least in the case of the" -1-proteinase 
inhibitor from rat serum, these multiple forms are derived from the 
sequential addition of sialic acid to the parental molecule (Ikehara 
et ~·, 1981). 
Qualitative differences in proteinase inhibitors see'IM~ to -' 
be common among soybean cultivars. Harking with the Fiskerby V cultivar, 
Wilson and Wilson (1982) and Wilson .et al. (1982) found a different 
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pattern of lmv molecular weight. proteinase inhibitors, despite the 
fact that they used the same procedure of purification as Odani and 
Ikenaka (1977) with the Japanese cultivar of soybean. As the former 
workers assayed their inhibitors only through inhibition of trypsin, 
and immunologically, using antisera raised against the Bowman-Birk 
inhibitor, it is difficult to decide whether the content of proteinase 
inhibitors in the cultivar Tracy and FiskerbyV are similar or not. 
However, despite the general electrophoresis patterns being quite 
similar in both cultivars (Wilson~ al., 1982) the Fisketby V inhibitors 
react strongly with antisera raised against the Bowman-Birk inhibitor, 
while the inhibitors PI-I to PI-IV form a fully cross~reactive group that 
does not cross react with the Bowman-Birk inhibitor (David et al., 
1977; Lin et al., 1980). 
In the cul'tivar Tracy an inhibitor with similar inhibitory 
specificity as inhibitor C-II is apparently absent. Although inhibitors 
·PI-I to PI-IV are double-headed, their active sites. are specific for 
trypsin only, while C-II. can inhibit trypsin, chymotrypsin and elastase; 
the trypsin and chymotrypsin reactive sites are in ~ifferent positions 
in the molecule, but the elastase and chymotrypsin reactive sites are 
the same (Figure 6 ). The absence of this type of inhibitor, which may 
be functionally different from the. others inhibitors found in the same 
seeds, ·as it has different specificity from them, deserves some comment. 
Studies of legume proteinase inhibitors in the resting and in the 
germinating seed have been hindered by the multiplicity of homologous 
inhibitors in these plants (Lorensen~ al., 1981). Furthermore, the 
uncritical use of the term "isoinhibitor", has led to some confusion 
as sometimes inhibitors of close structural homology (e.-g. C-II, D-II 
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and the Bmvrnan-B'-'irk inhibitor) but with different specificities towards 
proteases are called isoinhibitors. The use of this term refering to 
them is inadequate for two different reasons. Firstly ; although they 
are homologous, their sequences are different and this raises the 
possibility that their cleavage by proteinases may also be different, 
and this might allow their differential degradation. Secondly, if their 
biological function is associated with specific inhibitory activity 
towards one or more proteinases, the use of the term -"isoinhibitor" 
refering to them, disregards '"hat may be a fundamental difference 
between them. This multiplicity of inhibitors may allow the precise 
control of proteinases present in a certain stage of development. This 
matter is specially relevant since at present the release (Wilson, 1980), 
degradation (Wilson et aL, 1982) and appearence of new forms of 
inhibitors during germi,nation (Wilson and Chen, 19.83) is well established 
As the ability of these -proteins inhibiting proteinases 1s thought 
to be associated with their biological role, the answer of precisely· 
what kind of inhibitory activity is released, degraded or formed is of 
decisive importance. 
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